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 Aptamers are an emerging class of molecules that are valued for their ability to 
bind with high affinity and specificity to a desired target. These DNA or RNA ligands 
can be synthesized easily in the lab making them much more stable, reproducible, and 
cost-effective than other affinity reagents such as antibodies.  These molecules possess 
a diverse and versatile set of abilities upon binding, making them useful not only in 
biotechnology and diagnostics, but also in therapeutics.  
 Aptamers are typically generated through an in vitro process called SELEX 
(Systematic Evolution of Ligands by EXponential Enrichment). SELEX is an iterative 
process whereby a library of random sequences is exposed to a target, and bound 
sequences are selected and amplified making a pool enriched for improved binding 
over the original library. This process can be repeated until the best binding sequence 
dominates the pool. In this way, aptamers can be generated to nearly any conceivable 
target or molecule, overcoming the immunological limitations in generating 
antibodies. By manipulating the conditions within this selection process, aptamers can 
also be generated to bind in non-physiological environments, giving them the ability to 
perform in diverse applications. 
 To help accelerate the discovery of aptamers, we developed a modular 
microcolumn technology that decreases reagent consumption, while permitting 
 multiplex SELEX, allowing for more sophisticated selection schemes. By 
characterizing aptamer enrichments for all the available parameters, we have 
significantly increased the selection efficiency, while illustrating the failures of simple 
binding theories to non-classical modes of selection. We have also demonstrated the 
power of high-throughput sequencing for early identification of aptamers before they 
fully converge. This was used to validate a new method which optimizes selection 
time over individual selection cycle efficiencies. Surprisingly, our results also show 
the new method significantly improves selection efficiency, bringing into question 
some common beliefs derived from SELEX theory. Finally, we scaled our 
microcolumn technology to an automatable 96-well microplate format, and 
demonstrated its utility by characterizing and validating specific, non-specific, and 
background binding behavior of several RNA aptamers. The results reveal binding 
behaviors that fundamentally limit the performance and sensitivity of aptamer 
selections. 
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CHAPTER 1 
DEVICES AND APPROACHES FOR GENERATING SPECIFIC HIGH-
AFFINITY NUCLEIC ACID APTAMERS
‡
 
 
ABSTRACT 
High-affinity and highly specific antibody proteins have played a critical role 
in biological imaging, medical diagnostics, and therapeutics. Recently a new class of 
molecules called aptamers has emerged as an alternative to antibodies. Aptamers are 
short sequences of nucleic acids that can be generated and synthesized in vitro to bind 
to virtually any target in a wide range of environments. They are in principal less 
expensive and more reproducible than antibodies, and their versatility creates 
possibilities for new technologies. Aptamers are generated using libraries of random 
nucleic acid sequences that are subjected to affinity selections for binding to selected 
target molecules. This is commonly done through a process called Systematic 
Evolution of Ligands by EXponential enrichment, or SELEX, in which target-bound 
sequences are isolated from the pool, amplified to high copy numbers, and then 
reselected against the desired target. This iterative process is continued until the 
highest affinity sequences dominate the pool of nucleic acid molecules. Traditional 
selections require a dozen or more laborious cycles to converge on and isolate 
aptamers, and they can takes months to complete as well as consume large quantities 
of reagents. However, new devices and insights from engineering and the physical 
sciences have contributed to a reduction in the time and effort needed to generate 
                                                 
‡
 The following article was written for submission to the journal: Applied Physics Reviews.  Szeto, K. 
and Craighead, H.G. Devices and approaches for generating specific high-affinity nucleic acid 
aptamers. 
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aptamers. As the demand for these new molecules increases, more efficient and 
sensitive selection technologies will be needed. These new technologies will need to 
use smaller samples, exploit a wider range of chemistries and techniques for 
manipulating binding, and integrate and automate the selection steps. Here, we review 
new methods and technologies that are being developed towards this goal, and we 
discuss their roles in accelerating the availability of novel aptamers. 
 
INTRODUCTION 
 Antibodies are a class of proteins that are highly selective and have high 
binding affinity for foreign and potentially harmful antigens that are encountered in 
the body. In an organism’s immune response, proteins mutate into a vast library of 
antibody candidates and are screened in the immune system for their ability to bind to 
the antigen. Candidates that cannot bind the antigen are eliminated, while candidates 
that can recognize the antigen are retained and form an enriched pool of good binders. 
The surviving proteins can then be amplified and further mutated, screened and 
enriched to allow the binding affinity to mature until a small group of high affinity 
antibodies are generated.  Harvested from organisms, these antibodies have become 
indispensable affinity reagents in research and medicine, used for applications such as 
imaging specific proteins and their structures in cells and tissues, diagnostics to detect 
and quantify the presence of molecules, and even in therapeutics. However, antibodies 
have a number of weaknesses that limit their technological application. For example, 
antibodies must be produced in vivo and harvested from a host organism, which results 
in problems with reproducibility such as the total yield and variability of antibody 
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types between batches. In addition, new antibodies require significant investments in 
time and cost from researchers, and can only be generated to target molecules that 
elicit an immune response. In contrast, a simpler and more generalized class of tight 
binding molecules based on nucleic acids could address the limitations of antibodies 
and enable new generations of affinity reagents and biotechnologies to emerge. 
Nucleic acids have long been recognized as the simple molecular template on 
which all of life and its processes are encoded. Despite having only four constituent 
bases, the information content and complexity that can be achieved through their 
unique combinations is astronomical. Although dwarfed by the potential sequence and 
structural diversity of proteins of a similar length, which can utilize twenty different 
amino acids, sequences of nucleic acids can also form complex three dimensional 
structures and acquire comparable functionalities to proteins (a known feature of 
naturally occurring RNA sequences such as tRNA and rRNA). These intrinsic 
properties make nucleic acids the perfect molecular analogues to amino acids for 
generating functional biomolecules as alternatives to antibodies.[1-3] These nucleic 
acid molecules called aptamers, can be generated through in vitro selections. This is 
often done through an iterative process called Systematic Evolution of Ligands by 
EXponential enrichment (SELEX). SELEX involves generating a library of DNA or 
RNA molecules with random sequences (~10
15
 different sequences), screening the 
library for sequences that bind to the target of interest, partitioning the bound 
sequences from the unbound sequences, and amplifying the bound sequences into a 
new pool enriched for good binders (see Figure 1.1). This process can be continued 
until the strongest binding sequences enrich and dominate the pool. If the enriched  
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Figure 1.1. Simple process diagram illustrating and relating the different in vitro 
selection methods. The outer cycle (Green) is the classical SELEX cycle which iterates 
through binding, partitioning and amplifying target-bound sequences (represented in Red). 
The inner cycle (Violet) is non-SELEX in which cycles of binding and partitioning are 
performed without amplification. Combining both methods, RAPID-SELEX (Green and 
Violet) systematically implements non-SELEX to save time where possible, but incorporates 
classical SELEX cycles with amplifications to replenish sequence copy numbers or to drive up 
concentrations. 
 
pool has converged on an aptamer, a sample of a few dozen candidates can be 
sequenced, and the dominant or consensus sequence identifying the aptamer can be 
determined. 
Although the basic combinatorial chemistry of the aptamer selection process 
conceptually resembles that of antibodies generated in vivo, in vitro aptamer selections 
provide researchers with much more freedom and control in designing their desired 
affinity reagent. Not only can researches choose from an array of natural or modified 
nucleic acids and sequence lengths for their initial library, but aptamers can be 
generated to bind to targets that would be toxic or non-immunogenic to an 
organism.[4] In fact, aptamers can be generated to virtually any target from individual 
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metal ions to whole live cells.[5,6] Because aptamer selections do not take place inside 
of an organism, the environmental conditions for binding need not be physiological. 
Instead, these conditions can be tailored to better accommodate the ionic 
strength/content, pH and even temperature required for the desired application. Most 
importantly, these selections can make use of the tremendous advancements for 
amplifying, sequencing, and synthesizing nucleic acids, many of which are now 
commonplace protocols. This not only guarantees reproducibility between synthesis 
batches (the sequence is known), but aptamers are also much faster and cheaper to 
synthesize and modify compared to antibodies, and makes sharing or acquiring new 
reagents as simple as reporting the aptamer’s sequence. Nucleic acids are also much 
more stable than antibodies and can be denatured into a linear sequence and reversibly 
folded back into its three dimensional structure, resulting in a much longer shelf life. 
For example, lyophilized nucleic acid molecules can last almost indefinitely even at 
room temperature, whereas proteins and antibodies must be frozen for long term 
storage. Finally, it is possible to link multiple aptamers to generate multivalent 
aptamers that can bind multiple identical targets or bind multiple sites on a single 
target to enhance target recognition, or even to create aptamers that recognize novel 
combinations of target molecules.[7-12] 
The potential impact for aptamers and their resultant technologies is just 
beginning to be understood. However, as the demand for these powerful new 
molecules increases, so has the need for more powerful selection methods. In this 
review, we discuss the evolution of in vitro selections from simple bench-top 
techniques, to more efficient and informative technologies and ultimately into 
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miniaturized and fully automated chip-based devices. The basic principles and unique 
contributions of each technology toward improved aptamer selections are highlighted. 
Finally, we conclude with a discussion on the general advantages and disadvantages 
common among many of the technologies and propose roles that engineering and 
physics can play in further advancing this developing field of science. 
 
CLASSICAL APTAMER SELECTIONS 
Basic selection principles 
The basic principles for in vitro evolution and selection of aptamers were first 
described over twenty years ago.[1-3] This conceptually simple optimization problem 
requires the determination of the total concentration for both the library and target 
molecules that maximizes the enrichment of the highest affinity aptamer. Given n 
types of sequences, the enrichment Ei for a sequence of type i can be expressed as the 
ratio of its fractional representation among all bound sequences to its starting fraction: 
   
[    ] ∑ [    ]
 
   ⁄
([    ]  [  ]) [ ] ⁄
    ( ) 
where [T:Si] and [Si] are the concentration of bound and unbound sequences of type i, 
respectively. This must be maximized for sequences with the highest affinity (lowest 
dissociation constant Kd) given the set of n equilibrium binding equations: 
[    ]  
[  ][ ]
     [ ]
            ( ) 
where [T] is the unbound target concentration and Kd,i is the dissociation constant for 
sequences of type i. Using the conservation equations: 
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where [S] is the concentration of all unbound sequences, the optimum total 
concentrations for the target [T]T and the library [S]T that maximize Equation 1 for 
high affinity sequences can be determined. This problem cannot be solved analytically 
for n > 2 and must be solved separately for each selection cycle as the relative 
frequency of sequences changes after every binding step, thus minimizing the total 
number of selection cycles needed to converge the pool onto an aptamer sequence. A 
number of theoretical efforts have attempted to address this optimization problem 
using numerical methods and/or approximations.[13-24] However, these theories 
assume equilibrium solution binding since time dependent models double the number 
of parameters (Kd is the ratio of the kinetic binding off-rate and on-rate: koff/kon) and 
generally require a significant amount of prior information about the initial library, 
such as the distribution of sequences ([Si]) and affinities (Kd,i) to the target. In contrast, 
many selections are not performed in true equilibrium or with free molecules in 
solution, and little to no information is known about the initial library or its interaction 
with the target. In addition, the molecules cannot always be considered point particles 
as selections are often effected by molecule size and orientation.[25,26] Although 
some theoretical work has been done to fill these information gaps,[27-31] most 
parameters remain experimentally unknown, and researchers have adopted simple 
intuitive schemes to enforce competitiveness and stringency during selections, such as 
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gradually increasing the ratio of library to target molecules (i.e. the fold-excess of 
library to target) and/or reducing the quantity or concentration of target molecules. 
These selections are typically performed in one of three ways. (1) Filtering target 
molecules out of solution and a thus retrieving bound aptamers. (2) Filtering aptamers 
out of solution through a stationary phase of immobilized target molecules. (3) 
Spatially resolving and isolating target-aptamer complexes from unbound molecules 
by electrophoretic mobility differences. 
 
Filtering targets: nitrocellulose filter binding 
One of the first methods of selection was nitrocellulose membrane filtration, 
which adheres most closely to the theoretical models mentioned above (see Figure 
1.2.A). Generally, the target molecules and the nucleic acid library are mixed together 
in solution and allowed to approach equilibrium. Target molecules and any sequences 
bound to them can then be partitioned from the solution by rapidly filtering the 
mixture over a nitrocellulose membrane.[3,32-34] The membrane concentrates target-
bound sequences and allows unbound sequences to pass through. This process is fast 
and straight forward, and it is one of the most common partitioning methods used for 
selecting aptamers. However, since the non-specific affinity of nitrocellulose to amino 
acids is central to this technique, it only works well with protein targets. In addition, 
the large surface area of the filter enables a significant amount of free sequences to 
non-specifically adsorb to the membrane. This has been known to result in 
nitrocellulose binding sequences that can significantly hinder the enrichment of target-
binding aptamers, or completely dominate the enriched pool. Extensive washing, or  
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Figure 1.2. Schematics for the classical technologies used to partition binding sequences 
(Red) from non-binding sequences (Blue) when selected against target molecules (Orange). 
(A) Membrane filtration is used to non-specifically capture target molecules along with any 
bound sequences from an equilibrium mixture. Unbound sequences pass freely through the 
filter. (B) Affinity chromatography utilizes a column of backed resin which is functionalized 
with target molecules, and a library or pool of sequences which is passed through the column. 
Binding sequences are captured on target molecules while unbound sequences pass freely 
through the column. (C) Electrophoretic Mobility Shift Assays (EMSA) use gels to separate 
equilibrium mixtures containing bound and unbound sequences and targets. By applying an 
electric field, bound and unbound molecules, which have different sizes and charges, will 
migrate at different rates though the gel, which prevents the isolated populations from mixing. 
 
negative selections that remove filter-binding sequences, could be used to improve 
aptamer enrichments.[35] 
 
Filtering aptamers: affinity chromatography 
Another method that was initially applied to aptamer selections is affinity 
chromatography (see Figure 1.2.B). This technology is traditionally used to separate 
and purify components from a mixture of molecules, some of which have a specific 
affinity to or interaction with a stationary phase (resin packed into a column) through 
which the mixture flows. By immobilizing target molecules to an affinity resin, the 
injected nucleic acid library will become enriched for target-binding sequences, which 
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are retained within the column. Non-binding sequences simply flow through as waste. 
Sequence-bound targets can then be eluted off of the resin chemically. In contrast to 
nitrocellulose membrane filtration, affinity chromatography can be used to immobilize 
proteins as well as small molecule targets.[1] Given its simplicity and familiarity 
among many laboratories, affinity chromatography has become the dominant method 
for small molecule selections.[35-39] However, this method generally requires large 
quantities of target to achieve sufficiently high loading onto the entire column, and can 
suffer from non-specific binding of the nucleic acids to the resins requiring extensive 
washing or negative selections.[35] In addition, this method requires the incorporation 
of an affinity tag to target molecules for immobilization; and although this is 
commonplace for proteins, it can be difficult to achieve for small molecules and 
restricts the modes for aptamer binding. 
 
Isolating bound complexes: electrophoretic mobility 
Early selection methods also included Electrophoretic Mobility Shift Assays 
(EMSA) (see Figure 1.2.C). Like the older nitrocellulose filtering method, these 
selections allow target-sequence mixtures to equilibrate together in solution. However 
here, the bound and unbound populations can be spatially separated by adding the 
mixture to a gel and applying an electric field E.[40,41] Depending on their shape, size 
and charge, each population has a different mobility µ that causes unbound target, 
unbound sequences, and bound complexes to migrate through the gel with different 
velocities v.  
         ( ) 
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The gel prevents any mixing or significant dispersion of the isolated populations that 
would otherwise take place in solution. The band containing bound sequences can then 
be imaged with radioactivity (or fluorescence), cut out, and crushed to allow the 
sequences to easily diffuse back into solution. This selection method almost 
completely eliminates background binding as well as the need for washing or negative 
selections. However, the modifications required, especially radioactivity, are generally 
undesirable, and selections with different targets can have differing results and make 
separations difficult to resolve, especially with small targets. In addition, the 
separation step is slow and can be far from equilibrium, providing opportunities for 
bound sequences to dissociate during the lengthy process. 
 
IMPROVING CLASSICAL SELECTIONS 
Filtering targets: magnetic beads 
One of the key advantages of filter binding is its ability to easily and rapidly 
concentrate sequence-bound target molecules, while separating them out from a 
solution of unbound sequences. However, due to the nature of the filters, selections 
suffer from background binding and are limited to proteins. To resolve some of these 
limitations, techniques utilizing magnetic beads were devised (see Figure 1.3.A). 
[42,43]  Magnetic bead-based SELEX allows selections to be performed to any target 
that can be immobilized onto the beads. In addition, selections can be performed in 
smaller volumes with much less target, and the bead-bound target is rapidly 
concentrated and isolated from the bulk solution simply by using a permanent magnet. 
The magnetic beads can then be aggressively washed and concentrated again if  
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Figure 1.3. Schematics for improvements on the classical technologies used to partition 
binding sequences (Red) from non-binding sequences (Blue) when selected against target 
molecules (Orange). (A) Magnetic beads are used to capture target molecules along with any 
bound sequences from an equilibrium mixture into a small localized pellet. Unbound 
sequences remain in the bulk solution. (B) Capillary affinity chromatography utilizes a 
capillary with its inner wall functionalized with target molecules, and a library or pool of 
sequences which is passed through the capillary. Binding sequences are captured on target 
molecules while unbound sequences pass freely through the capillary. This flow regime can 
achieve such high resolutions, that individual binding species can be resolved into separated 
bands and isolated. (C) Capillary electrophoresis uses the high resolution and non-mixing 
regime of capillaries to separate equilibrium mixtures containing bound and unbound 
sequences and targets. By applying an electric field, bound and unbound molecules, which 
have different sizes and charges, will migrate at different rates though the capillary, which 
prevents the isolated populations from mixing. 
 
needed, and used directly in PCR amplifications. A variation on this technology uses 
magnetic beads in a slightly different manner. In a method called Aptamer Selection 
Express (ASExp), target molecules and the library are mixed together in solution just 
like in filter binding or EMSA. However, in this case, the library consists of double 
stranded sequences that must dissociate in order to reveal a single stranded aptamer. 
This imposes a binding threshold on potential aptamers and allows distinguishing 
single stranded target-binding sequences from double stranded non-binding sequences. 
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This difference is exploited by recovering single stranded sequences using magnetic 
beads coated with long, random, single-stranded sequences. Aptamers have been 
selected in a single round using this technique.[44] In another variation of this 
technique, the library is fluorescently labeled in order to quantify the level of binding 
after each round of SELEX. This method, called FluMag-SELEX, allows sensitive 
measurements of binding to be made due to the efficient concentration of target bound 
sequences on the magnetic beads, and eliminates the need for radioactivity-based 
measurements.[45]  
Magnetic bead-based techniques are of interest because the ability to 
manipulate the beads externally using magnetic fields has great potential for more 
sophisticated and automated technologies. A recent example of this, called Magnetic-
Assisted Rapid Aptamer Selection (MARAS), utilizes a magnetic field to not only 
isolate bead-bound sequences, but also to actively remove weakly bound 
sequences.[46] This additional sequence discrimination is achieved by placing an 
equilibrated mixture within a solenoid and applying an alternating current. This results 
in an alternating magnetic field whose strength and frequency can be adjusted such 
that lower affinity sequences begin to dissociate from the target molecules.  This is 
due to the viscous dissipative forces imparted on bound sequences as the beads 
oscillate within the field, enabling selections to be successfully performed in only a 
single cycle and has been shown to generate aptamers whose affinity increased with 
increasing field strength and frequency. 
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Filtering aptamers: miniaturized affinity chromatography 
There have been many new technologies developed towards advancing affinity 
chromatography. One example has been the miniaturization of affinity 
chromatography through the use of microcolumns, which are orders of magnitude 
smaller than conventional columns. By slowly injecting sequences into the packed 
microcolumns, the entire pool is efficiently sampled and high affinity aptamers are 
retained within the small column. The use of microcolumns was optimized for 
maximum enrichments of aptamers, revealing critical target concentrations that could 
be explained by geometric constraints for steric hindrance.[47,48] This concentration 
as well as the small column volume reduces the amount of target needed by several 
orders of magnitude. Furthermore, tests that varied the flow rates resulted in 
enrichment trends that scaled oppositely from the time-dependent kinetic binding 
model where the concentrations of unbound and bound molecules are also dependent 
upon their position x along the column:  
 [    ]( )
  
      [ ( )][  ( )]        [    ]( )    ( ) 
Also using the microcolumns, a modified SELEX method, called RAPID-SELEX, 
was demonstrated, which generalized the SELEX method to permit the systematic 
skipping of amplification steps.[49,50] This is advantageous as it significantly reduces 
the time and cost of performing selections. However, despite producing improved 
aptamer enrichments, RAPID-SELEX is viewed traditionally as less competitive than 
conventional SELEX due to diminishing sequence concentrations between infrequent 
amplifications. Together, these results highlight the importance of empirical 
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characterization and optimization of selection technologies. Interestingly, multiple 
microcolumns can be connected together allowing for simultaneous in-line negative 
selections, multiplexing, and parallelization. Recently, this technology was scaled up 
to a Microplate-based Enrichment Device Used for the Selection of Aptamers 
(MEDUSA), and has a 96-well microplate format to allow high-throughput and 
potentially automated plate-based selections and processing to be performed.[48] 
In a similar modification of affinity chromatography, MonoLEX utilizes a 
narrow affinity column in the form of a capillary.[51] As is typical of chromatographic 
separations, the aptamer library can resolve itself along the capillary into different 
populations of binders (see Figure 1.3.B). In a manner analogous to connecting and 
disconnecting microcolumns in series, by physically cutting the capillary column into 
small fragments (i.e. ~40 segments), aptamer populations can be isolated and 
recovered from each fragment individually and characterized with the highest affinity 
binders generally residing in earlier segments. The capillary columns’ efficient 
separation of subpopulations into narrow and well-resolved distributions allows 
MonoLEX to isolate aptamer candidates in a single round. 
Affinity chromatography has also been taken to the absolute lower limit of 
miniaturization by performing SELEX to targets immobilized on a single bead.[52] 
With this method, aptamers are generated by incubating a single target-functionalized 
microbead with a fluorescently labeled library. By significantly reducing the number 
of target molecules, it is assumed that only the highest affinity sequences can be 
bound, due to competition with low affinity sequences for the few available binding 
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sites. This can be seen in the limit where the concentration of unbound target [T] 
approaches zero: 
〈  〉  
[ ][ ]
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[T:S] is the total concentration of bound sequence (and target) molecules, so as the 
concentration of unbound sequences [Si] goes up, the average of the dissociation 
constant <Kd> of all bound sequences decreases. Once washed, the bead can be 
collected and subjected to PCR amplification. The fluorescently labeled library used in 
this method allows the level of binding to the bead to be monitored under a 
microscope during/after each cycle, and the bulk binding affinity to target molecules 
to be determined quickly via Fluorescence Anisotropy. Using this technique, high 
affinity aptamers were generated in just two rounds of SELEX, but only a single round 
may be necessary. Although not demonstrated, this simple process could be scaled up 
to include multiple single-target beads or even automated. However, identifying, 
isolating and handling single beads may limit this technology’s capacity for more 
streamlined processing. 
 
Isolating bound complexes: capillary electrophoretic mobility 
As discussed earlier, target-binding sequences can be distinguished from non-
binding sequences by a change in mobility when bound to target molecules. This is 
achieved primarily due to differences in the net charge between bound and unbound 
molecules. EMSA-SELEX has the advantage of equilibrium binding and (non-
equilibrium) separations on a gel, which eliminates the need for washing and negative 
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selections. However, the use of radioactivity and the need to cut and process gels 
makes this method tedious and difficult to adapt for higher throughput or more 
automated selections. This limitation has been overcome through the application of 
Capillary Electrophoresis (CE). CE-SELEX utilizes integrated fluidics with an electric 
field applied across the system (see Figure 1.3.C). Using a capillary with a small 
internal diameter allows separations to occur in solution rather than requiring a gel 
(see Eq. 5).[53-57] This is made possible by the laminar flow regime (low Renyolds 
number) of the capillary, which is largely free of turbulent flow and mixing (other than 
diffusion). In addition, sensitive UV detectors can be used to identify the band of 
bound complexes as populations of molecules migrate through the capillary, 
eliminating the need for radioactivity. These selections are fast and work well with 
large target molecules and result in efficient and high resolution separations. However, 
selections using different targets can vary greatly and the optimal binding and running 
conditions may need to be determined beforehand. In addition, separations with targets 
that only result in modest shifts in mobility can be nearly impossible to resolve. 
Resolution can be particularly problematic if the capillary is overloaded with 
sequences that can bury the desired peak. Therefore, CE-SELEX can only handle 
small volumes (~100 nL) and use starting libraries at incredibly high concentrations 
and several orders of magnitude less diverse (10
12
-10
13
) than conventional selections 
in order to prevent overloading and achieve good separations. 
With appropriate modifications, CE-SELEX has been used to estimate binding 
affinity during selections. This is because information can be obtained about the 
populations of unbound target, unbound sequences, as well as the bound complexes 
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and their gradual dissociation as they migrate past the detector .[58] In addition, 
distinguishing the various populations can be made easier by incorporating 
fluorescence capabilities into the selection. A novel CE-SELEX method based on 
these modifications, called Non-SELEX, was demonstrated, which completely 
eliminates all amplification steps allowing aptamers to be generated in a single 
round.[59] This method involves collecting the band of bound sequences and re-
injecting them into the CE system for additional cycles of purification. However, due 
to the small volume constraints, only a tiny fraction of the collected pool can be re-
injected for the next cycle, significantly limiting the number of sequences that can be 
sampled. Some recent optimization has been done using larger capillaries and multiple 
pool injections to improve sequence sampling after each cycle.[60] 
 
Automation and parallelization 
In addition to developing new and more efficient selection methods, researches 
have also accelerated aptamer discovery through robotic technologies. For example, 
semi-automated and parallel selections are possible using target-functionalized 
magnetic beads and microplates. Using an array of magnetic wands, magnetic beads 
and bound sequences can be captured, removed from solution and transferred to fresh 
wells on the microplate, allowing the automation of most of the selection steps apart 
from amplifications.[61,62] Completely automated selections have also been 
demonstrated that use magnets to retain beads in the microplate wells as solutions are 
exchanged instead,[63] although these protocols were later changed to incorporated 
membrane filtration to capture and wash the magnetic beads.[64-67] Affinity columns 
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have also been used in automated selections to filter out affinity-tagged targets and 
bound sequences.[68] However, an example that does not require any filtering uses 
simple immobilization of targets directly to the surface of microplates.[69] 
As an alternative to generally low-throughput automation, substantial scaling 
up though massive parallelization of selections allows the average time per target to be 
reduced proportionally, assuming steps for each target can be performed 
simultaneously. Using a similar target-functionalized 96-well microplate, multiplexed 
and massively parallelized SELEX has been demonstrated through simultaneous 
processing and analysis.[70] In addition, the 96-well microplate-based affinity 
microcolumns discussed earlier were also used to performed simultaneous processing 
and analysis.[48] These highly parallelized technologies are ideal compliments to 
automated microplate-based protocols and combining these two approaches may allow 
researchers to achieve automated and massively parallelized selections using similar 
robotics systems. 
 
INSTRUMENTATION FOR PARTITIONING AND DIRECT READOUT OF 
BINDING 
Sorting sequences with flow cytometry 
As interest in aptamers has grown, researchers with expertise outside of 
classical SELEX have begun to recruit sophisticated systems and instruments to help 
perform selections. This has been particularly fruitful with techniques that not only 
separate populations, but also provide information about the bulk binding behavior of 
the aptamer pools, as with CE-SELEX. One of these technologies, called flow 
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cytometry, is usually used to count or measure properties of cells at very high rates by 
rapidly interrogating individual cells in a flow stream (thousands per second). A 
specialized form of flow cytometry, called Fluorescence-Activated Cell Sorting 
(FACS), can be used to separate different populations. These systems have been 
applied to aptamer selections against whole cells using a method called FACS-
SELEX, which is useful not only for quantifying and sorting aptamer-bound cells from 
the bulk solution of unbound sequences, but can also be used to separate specific 
populations of cells, such as living cells from dead cells.[71,72] 
A key advantage of flow cytometric systems is the ability to probe one cell at a 
time. Therefore, a natural modification of these systems involves replacing cells with 
beads (see Figure 1.4.A). Selections with beads that are each bound to only a single 
type of sequence have been demonstrated where high affinity beads are identified by  
incubating them with their target and imaging the level of binding with fluorescently-
labeled targets[73] or antibodies (see Figure 1.4.B).[74] This method is unique in that 
the highest affinity aptamers are assayed and identified directly by the brightest beads. 
These beads can be picked up via a micropipette and sequenced, allowing selections to 
be completed in a single round. Using multiple colors, additional or alternative 
binding requirements (which are assayed fluorescently), can be imposed. A simple 
two-component test mixture of beads was used to demonstrate this kind of multicolor 
FACS detection. Recently, a true single sequence/bead selection called Particle 
Display utilizing the sorting capabilities of FACS was fully demonstrated.[75] 
Currently FACS technologies are restricted to detecting and sorting about 10
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beads/cells which significantly reduces the number of sequences that could be  
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Figure 1.4. Schematic for bead-based selections utilizing Fluorescence Activated Cell 
Sorting (FACS). (A) Beads, each of which are coated with many copies of a unique sequence, 
are partitioned into binding sequences (Red) and non-binding sequences (Blue) based on 
binding to fluorescently labeled target molecules (Orange).  Fluorescence measurements of 
each bead is used to identify brightly labeled beads which contain tight binding sequences and 
are sorted by imparting a charge on the bead and deflecting it in an electric field. (B) An 
example of a brightly labeled bead indicating the presence of a tight binding sequence as a 
potential aptamer candidate (Reproduced from Yang et al, Immunofluorescence assay and 
flow-cytometry selection of bead-bound aptamers, Nucleic Acids Res, 2003, 31,10, by 
permission of Oxford University Press) 
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screened in this format. Particle Display resolves this sampling limitation by 
performing the first selection cycle without FACS so that a full size library can be 
screened, generating a partially enriched pool which can be much more efficiency 
utilized via FACS. Interestingly, the fluorescent signature of target binding to the 
beads not only allows a proportional readout of binding affinity, but the near bulk 
binding characteristics of ~10
5
 copies of each sequence on its bead also overcomes the 
stochastic binding of single complexes and allows for unparalleled sensitivity and 
confidence in discriminating and sorting between high and low affinity sequences. 
Currently, FACS systems can also separate mixtures into six subpopulations or 
distribute individual sorted objects into the wells of microplates. This highlights 
FACS-based methods scalability, where the ability to analyze and sort using multiple 
colors and sorting channels can be advantageous for multiplexing or high-throughput 
parallelization through downstream microplate processes, especially for selections 
directly to fluorescent targets such as fluorescent proteins or dyes.[76] 
 
Imaging and detection with chips: surface-bound targets 
The ability to directly observe and image interactions between sequences and 
target molecules has tremendous advantages over a typically blind selection strategy. 
This can be as simple as observing binding events under an optical microscope, such 
as with the FACS-based methods. However, it is often difficult to fluorescently label 
target molecules, and this can have undesirable consequences in aptamer-target 
recognition. Furthermore, adding fluorescent antibodies complicates the selection 
process and is not always a possible alternative. A more general and straight forward 
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approach involves fluorescently labeling the nucleic acid library, as in the single-bead 
affinity selection discussed earlier. In addition, imaging can be done easily by 
immobilizing target molecules on a flat substrate. Selections are done by incubating a 
target-functionalized coverslip with a fluorescently labeled library. The coverslip can 
then be extensively washed and imaged under a microscope to find bright and highly 
localized spots indicating aptamer binding, and the aptamers recovered thermally 
through heat elution in solution. Using this simple method, an inexpensive and rapid 
one-step selection was demonstrated.[77] Simply monitoring selections this way is 
useful to ensure that binding is taking place and to assess the degree of background 
binding which may require additional washing or negative selections. In addition, the 
use of fluorescently labeled target molecules with the fluorescent library can be used 
to image both simultaneously and find co-localized spots of aptamers binding 
specifically to target molecules on the surface. This ability to visually discriminate 
between target-aptamer interactions from non-specific background binding can have 
significant advantages for improving aptamer enrichments.
 
A similar selection method, called NanoSelection, utilizes an Atomic Force 
Microscope (AFM).[78] This method incorporates fluorescently labeled sequences 
attached to beads using a similar single sequence/ bead scheme as the FACS-based 
methods. Using a fluorescence microscope-AFM hybrid system, beads that bind to a 
target-functionalized chip are imaged using the fluorescence microscope. The AFM is 
then used to generate a local image of the bead on the chip, and then the AFM’s tip 
used to physically “spear” or displace the bead from the surface for retrieval and 
analysis. Similarly to a single sequence/bead method discussed earlier, NanoSelection 
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was demonstrated successfully using a two-component text mixture of aptamers with 
non-aptamers and is best suited to small libraries on beads. In addition to locating 
bound beads, it should be possible to observe their dynamics while in solution, using 
their bound-state fluorescence intensity and duration to pinpoint the most tightly 
bound beads as well as their mobility when unbound, to determine relative binding 
affinities between candidate beads.  
In another method called AFM-SELEX, the library is biotinylated and bound 
directly to a streptavidin-functionalized AFM tip instead of to beads (see Figure 
1.5.A).[79] This method is particularly interesting because as the tip probes the target 
functionalized chip, sequences in the library that have an affinity for the target are 
forced to compete against the biotin-streptavidin interaction. This interaction is quite 
strong and acts as a binding threshold that sequences must surpass in order to detach 
from the tip and remain bound to the chip. In doing so, images of the chip surface as 
well as thousands of force curves are generated (see Figure 1.5.B). Successful 
selections using AFM-SELEX showed gradual increases in the average force exerted 
on the AFM tip using adhesion force analysis during each selection cycle. These 
results clearly indicate the enrichment of higher affinity aptamers to the target. 
Although this method provides a competitive binding threshold and data regarding the 
bulk binding behavior of the library, this technique has significant limitations in the 
number of library molecules that can be bound to the AFM tip and probed, and is 
currently not easily scalable for higher throughput aptamer selections. 
A technique that is naturally sensitive to surface bound molecules is Surface 
Plasmon Resonance (SPR), which excites plasmons in thin metal films and uses their  
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Figure 1.5. Schematics for chip-based technologies used to partition binding sequences 
(Red) from non-binding sequences (Blue) when selected against target molecules (Orange). 
(A) Atomic Force Microscopy (AFM) utilizes a library or pool of sequences bound to the 
AFM’s probe tip. By running the tip over a surface of target molecules which are immobilized 
onto a chip, tight binding sequences which can overcome their binding energy to the AFM tip 
can detach and bind to target molecules on the surface. (B) Example force and height AFM 
images acquired using a sequence-coated probe tip on a target coated chip surface. 
(Reproduced from Miyachi et al, Selection of DNA aptamers using atomic force microscopy, 
Nucleic Acids Res, 2010, 38,4, by permission of Oxford University Press). (C) Surface 
Plasmon Resonance (SPR) utilizes target molecules which are immobilized onto a chip. By 
flowing a library or pool of sequences over the chip, tight binding sequences can bind to target 
molecules on the surface while non-binding sequences flow past. This can be imaged and 
quantified through proportional changes in the surface plasmon conditions. (D) Example SPR 
response curves for various enriched pools showing the binding and unbinding of sequences. 
(Reprinted from Analytical Biochemistry, 342/10, Misono TS, Kumar PKR, Selection of RNA 
aptamers against human influenza virus hemagglutinin using surface plasmon resonance, 312-
317, Copyright (2005), with permission from Elsevier). (E) Microarrays utilize a library of 
predetermined sequences which are then addressed and synthesized in situ on specific 
elements of the chip array. By exposing fluorescently labeled target molecules to the array, 
tight binding sequences can bind to target molecules on the chip and individually identified 
through fluorescence imaging. (F) Example fluorescence image of individual sequences of a 
microarray binding florescent targets. (Reproduced from Fischer NO, Tok JBH, Tarasow TM, 
Massively Parallel Interrogation of Aptamer Sequence, Structure and Function. PloS one 3 (7). 
Copyright (2008) the Authors) 
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sensitivity to conditions near their surface to monitor binding kinetics (see Figure 
1.5.C). This is typically achieved by reflecting a p-polarized laser with angular 
frequency   (and speed of light c), in a medium with dielectric constant of   , of off 
of a thin film of metal (i.e. gold) and monitoring changes in the low intensity 
reflection angle    that satisfies the changing plasmon resonance condition of 
wavenumber  ( ). As molecules bind to and unbind from the surface, it changes the 
effective dielectric constant    of the medium in contact with the metal film with 
dielectric constant   . 
 ( )  
 
 
√
    
     
 
 
 
√           ( ) 
One key advantage of SPR systems is that they integrate fluidics and flow cells 
with surface-bound target selections and can have several flow channels, which 
potentially allow for multiplex or parallelized aptamer selections. By injecting and 
exposing sequences with concentration [S] to the chip surface, the pool’s bulk on-rate 
kon for binding can be estimated:  
 ( )  
    [ ]
   [ ]
[    (   [ ]   ) ]    ( ) 
where the R(t) is the time-dependent response of the SPR resonance angle and RMAX is 
maximum signal. Since this measurement is performed under flow, the concentration 
of unbound sequences is constant making the binding trends independent of the target 
concentration. In addition, washing/elution of sequences off the chip allows the bulk 
off-rate koff for unbinding to be estimated as sequences slowly dissociate and are 
collected for future selection cycles. 
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 ( )   ( )           (  ) 
SPR in SELEX was initially demonstrated as a clean-up selection following 
many cycles of nitrocellulose filter binding and was used to determine the bulk 
binding affinity of the final pool.[80] However, SPR has also been utilized as the sole 
SELEX platform, and showed steady increases in the time-dependent binding rates 
after each cycle, indicating the enrichment of higher affinity binders (see Figure 
1.5.D).[81] In addition, multiple fractions were collected during the dissociation step. 
Although not demonstrated, the highest affinity sequences are expected to take longer 
(on average) to dissociate due to a smaller koff and hence reside primarily in the later 
fractions. Fractionating the dissociation phase could be used as an off-rate threshold 
for aptamers in SPR-SELEX. Although off-rates can be determined easily in SPR, 
accurate determination of on-rate and the equilibrium binding affinity requires 
multiple concentrations of the library/pool to be probed in order to fit all the 
parameters of Eq. 9. In addition, since the determination of the on-rate requires the 
concentration of unbound sequences to remain constant at all times, limits on the 
possible flow rates that can be used have to be imposed, which must be low enough 
for efficient sequence sampling but high enough to overcome mass limited transport. 
 
Imaging and detection with chips: surface-bound sequences 
Performing selections with surface-bound molecules has resulted in a range of 
varying chip-based methods. With the emergence of technologies such as microarrays, 
precise localization and addressing of many different molecules onto a single chip can 
be achieved. This has been applied to multiplexing and parallelizing chip-based 
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selections with multiple surface-bound target molecules and concentrations.[82-85] 
Although initially only a few dozen isolated spots were placed manually on chip 
surfaces, automated and robotic systems have enabled much higher density arrays of 
molecules to be generated. Using modern lithographic techniques for microscale 
patterning, microarrays can now be fabricated with nearly 10
5
 individual spots. This 
high density configuration has been adopted as a means to probe individual sequences 
of a nucleic acid library with sensitivities and sampling depths comparable to Particle 
Display using FACS (see Figure 1.5.E). For aptamer selections, random and unique 
sequences are individually synthesized in situ and addressed on predetermined spots 
on the microarray. Fluorescently labeled target molecules can then be exposed to the 
array and imaged to identify potential aptamer candidates via bright localized spots 
(see Figure 1.5.F). In a selection method called CLADE (Closed Loop Aptameric 
Directed Evolution), a set of the brightest spots (~1%)  are identified and their 
associated sequences are controllably mutated and synthesized onto a new chip for 
additional selection cycles.[86,87] This is comparable to performing a pre-selection to 
compensate for the lower sampling capabilities of the microarray. By mutating the top 
performing sequences, tighter binding variants can be identified and further matured. 
Although microarray-based selections such as CLADE have tremendous 
potential, they require a small starting library of individually synthesized and 
predetermined sequences. For this reason, microarrays have also been used post-
selection to screen enriched pools which contain significantly fewer unique sequences 
and even fewer aptamer candidates, which can be identified through sequencing and 
chosen based on population metrics such as multiplicity or enrichment.[88-90] 
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Aptamers isolated from selections can also be studied and optimized through 
mutations and assayed on microarrays to identify key features which are critical to the 
highest affinity sequence such as the minimal aptamer structure, structure-function 
relationships, as well as conserved sequence motifs.[90-92] The majority of these 
selection microarrays rely on the imaging and detection of fluorescently-labeled 
molecules (target or library). However, since microarrays share a chip format with a 
number label-free detection methods, arrays of sequences have been generated and 
screened without fluorescent modifications to either the target or sequence. Using an 
array of electrodes, sequences on the array which are bound to gold nanoparticles can 
generate measurable current and/or voltage signals when bound to target molecules via 
electrochemical detection.[93] Although this technique can be used to screen multiple 
sequences simultaneously and is label-free, this method can only work with target 
molecules that are electroactive and will generate a sufficiently large signal upon 
binding to the electrode. As an alternative, arrays of sequences have also been 
generated and screened using SPR which does not require fluorescent labels or special 
properties of target molecules.[94] 
 
INTEGRATED SELECTIONS ON MICROFLUIDIC CHIPS 
Many researchers are interested in miniaturizing other selection technologies 
onto chips, as well as their possible automation. Initial efforts aimed to miniaturize 
conventionally large robotic systems used in automated SELEX.[95] This was done 
through the integration of a fluidic microchip, and was used to successfully select an 
aptamer through an automated process that incorporates all the steps from binding to 
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amplification. Although the binding step takes place off-chip in an affinity capillary 
and valving and other fluidic controls are performed using large external fluidic 
instruments, this microfluidic SELEX platform is a significantly smaller and simpler 
system than other automated technologies, and represents an important step toward 
more integrated chip-based solutions for fluidic selections. Recently, significant 
research efforts have focused on capitalizing even more on the micro- and nanoscale 
processes used in the fabrication of functional chips. This has led to the development 
of a number of devices that can be used to integrate and perform a number of 
selections steps. These new selections benefit not only from the reduced volumes and 
the unique phenomena that occur at the microscale, but also from the inherent 
scalability of the fabrication methods, putting chip-based multiplexed and automated 
aptamer selections within reach.  
 
Filtering targets: magnetic beads 
Due to their easy manipulation, magnetic beads have been incorporated into 
microfluidic systems to further improve the efficiency of aptamer selections. One of 
the first such devices is described in a method called Microfluidic SELEX (M-
SELEX) (see Figure 1.6.A). Here, a typical incubation with a library and target-
functionalized magnetic beads is allowed to bind and then is injected into a 
Continuous-flow Magnetic Activated Chip-based Separation (CMACS) device.[96] 
Magnetic beads and bound sequences are then magnetophoresed out of laminar input 
streams, into a non-mixing center stream for collection. This is done through a 
magnetic field gradient    generated by integrated ferromagnetic structures.  
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         (  ) 
Together, the magnetic beads and the CMACS device allow highly stringent selections 
with very low concentrations of bead-bound targets to be efficiently performed (see 
Eq. 7) and have resulted in an aptamer being isolated in a single cycle. A simpler 
MicroMagnetic Separation (MMS) chip was also demonstrated that does not limit the 
magnetic beads’ residence time in the microfluidic chip. In this case, ferromagnetic 
grids are used to capture and retain magnetic beads as they flow into the device, 
allowing a wider range of flow rates as well as long and extensive washes to be 
performed in the channel.[97,98] In a technique utilizing dilutions[99] called Volume 
Dilution Challenge (VDC), VDC-MSELEX uses the MMS chip to capture and re- 
concentrate magnetic beads following dilutions of up to one thousandth of the 
equilibrated solution, which helps to irreversibly dissociate aptamers with poorer off-
rates.[100] M-SELEX has also been coupled to high-throughput sequencing in a 
method called Quantitative Selection of Aptamers through Sequencing (QSAS), to 
analyze the copy numbers and enrichments of millions of aptamer candidates in 
multiple pools.[101] Recently, this has been further improved through a Quantitative 
Parallel Aptamer Selection System (QPASS), which utilizes a microarray of thousands 
of the top multiplicity aptamer candidates to measure each of their binding affinities in 
parallel.[89] 
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Figure 1.6. Examples of simple microfluidic devices which integrate the three basic 
methods of partitioning binding sequences from from non-binding sequences. (A) A 
microfluidic device which can capture and partition target-functionalized magnetic beads out 
of a solution equilibrated with a library or pool of sequences. Microfabricated ferromagnetic 
structures capture and direct magnetic particles as they are injected into the device and 
diverted into an isolated collection stream free from unbound sequences (Reproduced from 
Lou X, Qian J, Xiao Y, Viel L, Gerdon AE, Lagally ET, Atzberger P, Tarasow TM, Heeger 
AJ, Soh HT, Micromagnetic selection of aptamers in microfluidic channels. Proceedings of 
the National Academy of Sciences of the United States of America 106 (9):2989-2994, 
Copyright (2009), the Authors). (B) A microfluidic device which utilizes silica sol-gel matrix 
to immobilize and isolate multiple target molecules in a single channel. A library or pool of 
sequences is passed over the target sol-gel spots allowing binding sequences to diffuse and 
bind to targets within the sol-gel. Unbound sequences pass freely out of the device 
(Reproduced from Park SM, Ahn JY, Jo M, Lee DK, Lis JT, Craighead HG, Kim S, Selection 
and elution of aptamers using nanoporous sol-gel arrays with integrated microheaters. Lab on 
a chip 9 (9):1206-1212, Copyright (2009) with permission of The Royal Society of Chemistry) 
(C) A microfluidic device which integrates electrodes to achieve lateral electrophoresis. A 
continuously injected equilibrium mixture is separated orthogonally to the bulk flow of bound 
and unbound molecules into different collection channels through differences in their 
electrophoretic mobility (Reproduced from Jing M, Bowser MT, Isolation of DNA aptamers 
using micro free flow electrophoresis. Lab on a chip 11 (21):3703-3709, Copyright (2011), 
with permission of The Royal Society of Chemistry) 
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Filtering aptamers: sol-gel target immobilization 
A chip-based technology with similar characteristics of affinity 
chromatography was developed using sol-gel arrays as a solid support for target 
immobilization (see Figure 1.6.B).[102-104] Selections are achieved by trapping 
target molecules within a small drop of highly porous 3D silica matrix. Sequences are 
gently flowed across a sol-gel spot allowing them to enter and diffuse within the sol-
gel and bind to the target in its native state. A microfluidic chip is used so that the 
injections of the library are confined close to the sol-gel spots thereby increasing the 
efficiency of sampling. This chip also contains integrated microheaters, which allow 
bound sequences to be thermally eluted. Serialized multiplexed selections using this 
sol-gel device were demonstrated owing to the highly localized and addressable nature 
of each sol-gel spot and microheater. Recently, valving was integrated into the device 
to allow changes to the fluidic network such that parallelized multiplex sol-gel 
selections can occur while minimizing cross-contamination between spots during 
elution.[105,106] These integrated multiplex selections along with the significantly 
reduced amount of target is very attractive, however the binding and elution of 
sequences in the sol-gel spots is diffusion limited and may reduce the number of 
sequences that can be effectively sampled. 
 
Isolating bound complexes: micro free flow electrophoresis 
Mobility separations have also been integrated into microfluidic chips, taking 
advantage of the highly efficient selections that can be achieved by CE-SELEX. By 
Integrating electrodes, bound and unbound sequences are separated through their 
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different mobilities (Eq. 5). However, in normal CE-SELEX the amount of library that 
can be injected is significantly limited by the separation resolution of the capillary. 
This restriction can be eliminated by using micro Free Flow Electrophoresis (µFFE), 
which utilizes a lateral electric field to continuously separate an equilibrated sample 
sideways as its being injected forward under hydrostatic pressure (see Figure 
1.6.C).[107] Furthermore, the output of the device is partitioned into two streams 
allowing fluorescently labeled bound and unbound sequence populations to be imaged 
and continuously directed into separate collection fractions by adjusting the fluid flow 
rate and the electric field strength. µFFE also eliminates the need to time collections 
for desired fractions as in CE and was used to successfully isolate an aptamer in only a 
single cycle from a library over 100-fold larger than CE. 
 
Automation 
A key advantage for chip-base selections is the ability to fully integrate the 
entire selection process into a single device and ultimately automate it. Towards this 
goal, selection devices have been designed to incorporate many of the advantages 
from various technologies into a single microchip. For example, one such microfluidic 
device has two chambers connected by a channel filled with gel (see Figure 
1.7.A).[108-110]. One chamber contains integrated microheaters and is packed with 
target immobilized onto microbeads forming a microscale affinity column. 
Fluorescently labeled sequences are flowed through the column and captured onto the 
target-functionalized beads. Bound sequences are then thermally eluted and 
transported through the gel into the adjacent chamber via electrophoresis. This process 
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can be fluorescently monitored, optimized, and repeated many times if necessary, to 
further select, store and concentrate aptamers in the adjacent chamber free from 
contamination and other processes that may be taking place in the main chamber. The 
isolation chamber can be used to further integrate and automate amplification steps by 
capturing sequences as they are electrophoretically transported through the gel onto 
new beads for amplification. Integrated heaters and temperature sensors can then be 
used to thermocycle the chamber in the presence of amplification reagents.[110] This 
device can also be used to perform selections by capturing cells. A similar device was 
designed to integrate cell culture and simple valving onto the microfluidic chip to fully 
integrate the selection process and allow multiple cycles of selection to be performed 
entirely on-chip.[111] Interestingly, temperature-dependent selections at 37°C 
generated aptamers which showed maximum binding at this temperature[112] and 
integrating cell culture into the chips selection chamber utilized the integrated heaters 
and sensors to maintain a temperature of 37°C at all times. This demonstrates the 
ability to generate aptamers which may function optimally at physiological 
temperatures. 
Another microfluidic device was demonstrated that integrates all of the steps 
required for SELEX. This device utilizes magnetic beads to retain and manipulate 
target-bound sequences, and uses integrated microscale pumps, mixers and valves to 
introduce and direct fluids (see Figure 1.7.B). In addition, integrated microheaters and 
microtemperature sensors are used to perform on-chip thermocycling for PCR 
amplifications of enriched sequences, and all external controllers for the flow, valves, 
and other automated protocols are integrated onto a small hand-held system.[113,114]  
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Figure 1.7. Examples of fully integrated microfluidic devices which can perform and 
automate all of the selection steps. (A) A microfluidic device which uses target immobilized 
onto beads to capture injected sequences. Bound sequences can be heat eluted with electrodes 
and then electrophoretically transported through a gel-filled channel into an isolated chamber 
for further processing (Reprinted from Sensors and Actuators A: Physical, 195, Kim J, Hilton 
JP, Yang KA, Pei RJ, Stojanovic M, Lin Q, Nucleic acid isolation and enrichment on a 
microchip, 183-190, Copyright (2013), with permission from Elsevier). (B) A microfluidic 
device which utilizes and manipulates target-bound magnetic beads via integrated micro- 
valves, mixers and pumps. Target-bound sequences are similarly controlled and then amplified 
using micro- heaters and temperature sensors for thermocycling. (Reprinted from Biosensors 
and Bioelectronics, 25/7, Huang CJ, Lin HI, Shiesh SC, Lee GB, Integrated microfluidic 
system for rapid screening of CRP aptamers utilizing systematic evolution of ligands by 
exponential enrichment (SELEX), 1761-1766, Copyright (2010), with permission from 
Elsevier). (C) A high-throughput sequencing technique which can identify tight binding 
sequences. A microfluidic flow cell and automated fluidic and optical components allow a 
library of sequences to be sequenced. Flow vary concentrations of fluorescently labeled target 
molecules through the flow cell and imaging the bound-target intensity allows a binding 
affinity to be determined and assigned to each sequence (Reprinted by permission from 
Macmillan Publishers Ltd: Nature Biotechnology, Nutiu R, Friedman RC, Luo S, 
Khrebtukova I, Silva D, Li R, Zhang L, Schroth GP, Burge CB, Direct measurement of DNA 
affinity landscapes on a high-throughput sequencing instrument, 29 (7):659-664, copyright 
(2011)). 
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Recently, this device was improved to accommodate the transport of enriched 
sequences and additional reagents allowing multiple cycles of SELEX to be performed 
continuously and automatically, completely eliminating manual procedures.[115] This 
device has also been similarly adapted to perform Cell-SELEX by integrating separate 
reagent chambers for target and control cells which are coated with magnetic beads. A 
two-selection process (positive followed by negative SELEX) utilizing this 
microfluidic device allows for almost complete automation of the entire SELEX 
process for cell specific aptamers on-chip. 
Recently, high-throughput sequencing technologies have been modified to 
perform affinity measurements with fluorescently labeled targets (see Figure 1.7.C). 
Although not demonstrated as a selection technology, second generation sequencing 
systems already integrate programmable and automated fluidic systems that can 
provide various reagents to a microfluidic chip where sequences are assembled on the 
chip surface and determined fluorescently. This is achieved through integrated optics 
and detectors that can distinguish different bases using unique fluorescent labels. After 
sequencing, fluorescently labeled target molecules are injected at various 
concentrations and the binding intensity is measured and co-localized with each 
sequencing read.[116-118] These methods called HiTS-FLIP for DNA (High-
Throughput Sequencing-Fluorescent Ligand Interaction Profiling) and HiTS-RAP (-
RNA Affinity Profiling) or RNA-MaP (RNA on a Massively Parallel array) for RNA 
have been used to perform hundreds of millions of independent affinity assays, 
measuring the binding affinity for every read and completely eliminating the trial and 
error identification of high affinity aptamers. Although similar to microarrays, these 
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methods can sample orders of magnitude more sequences and do not require prior 
knowledge or design of the library or an enriched pool to be screened. In addition, the 
sequencing platforms contain multiple channels in each chip allowing for the 
possibility to multiplex with additional targets. A possibility for these systems is to use 
them to identify aptamers to targets without performing affinity selections at all (i.e. 0 
cycles of SELEX) as these sequencing methods can already probe similarly sized if 
not larger libraries than some of the selection technologies discussed in this review. In 
cases such as these, the elimination of non-binding sequences may be unnecessary, 
and the starting library may be assayed directly for potential aptamers. In this case 
having not been biased and enriched for any particular target, the sequenced library 
can be used to measure affinity profiles for multiple targets in serial injections. 
Ultimately, these assays can be used to characterize the SELEX process itself, and the 
usefulness of other quantitative methods for identifying aptamers, such as multiplicity 
or enrichment, as well as model their dynamics between rounds. Perhaps most 
interestingly, they provide a window into the (effective) affinity distribution of 
libraries and pools, which is a tremendously useful tool for probing the accuracy of 
theoretical SELEX models that require this information. As sequencing technologies 
improve and become even more sensitive, the utility of technologies such as HiTS-
FLIP and HiTS-RAP will become even more apparent. 
 
CONCLUSIONS AND FUTURE PROSPECTS 
A significant amount of progress has been achieved in the last two decades 
resulting in much more routine and efficient aptamer selections. New technologies are 
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continuing to improve these efficiencies and reduce the overall investment needed to 
select for new aptamers. Future work will no doubt continue to integrate, miniaturize 
and automate as many of the selection steps as possible, hopefully resulting in a 
variety of different technologies from which researchers can choose. Ultimately, no 
single technology is superior as each has its limitations that must be considered along 
with the intended application of the desired aptamer. For example, modifications to 
sequences and target molecules, such as affinity tags or fluorescent labels, can allow 
more selection techniques to be used, which result in highly stringent selections, 
significantly reduced reagent consumption, and the ability to manipulate and monitor 
binding interactions during ongoing selections. However, modifications can also 
introduce bias into the binding, and modifications for immobilizing molecules can 
result in steric hindrance or other unintended binding consequences, such as enhanced 
non-specific or even specific binding which are not present in solution-based 
selections. Combining the advantages of several technologies discussed may be a 
simple method for further improving selection efficiencies, while minimizing each 
technology’s unique sources of background binding, sequence bias, or other 
undesirable artefacts. In addition, other than using stringent or long washing 
conditions, incorporating thermodynamic thresholds for binding and dissociation is 
not yet commonplace, but may allow better discrimination between higher and lower 
affinity molecules. For example, using salt or thermal gradients to elute bound 
sequences decreases their effective affinity (see Eq. 12) and preferentially releases 
more weakly bound sequences. As the temperature T increases, or the salt 
concentration increases (causing a decrease in the free energy of binding   ), the 
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effective dissociation constant increases such that only the tightest bound molecules 
remain.  
    
      ⁄     (  ) 
These methods have been used in simple selection modes to successfully isolate better 
binding aptamers in as little as one cycle of SELEX.[119-122]  
Many technologies are now accomplishing successful aptamer selections in 
only a single round, completely eliminating the majority of the tedious cyclic 
processes of the traditional SELEX method. These are not only fast and efficient, but 
also allow selections to be performed with modified or non-natural nucleic acid 
libraries that cannot be amplified. In addition, minimizing amplifications also 
minimizes amplification-related bias from pools.[123,124] However, unless highly 
degenerate libraries are used, “enriched” aptamers are likely represented in the final 
pool with the same or similar frequency (i.e. copy numbers of 1) as lower affinity or 
even background binding sequences. This limitation can be partly alleviated by 
replacing the typical cloning and Sanger sequencing with high-throughput sequencing. 
This allows millions of sequences to be sampled so that bioinformatic techniques can 
find consensus sequences and conserved secondary structures with great statistical 
power. In contrast, basic cloning/sequencing typically allows only a few dozen 
sequences to be sampled, and is most reliable when individual aptamers have copy 
numbers that dominate the pool. However, much more information and confidence can 
be obtained from sequenced pools that have sufficiently diverse copy numbers and 
allow population metrics, such as multiplicity or enrichment, to help identify the 
highest affinity aptamers. This places the single-round selection methods at odds with 
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newly developed bioinformatic tools, and future methods (where possible) may need 
to consider maximizing the efficiency of selections with the utility of high-throughput 
sequencing methods. 
One particular opportunity for current and emerging technologies is the 
thorough characterization of their selection parameters. Recent studies have shown 
that in certain technologies, many of the core and intuitive assumptions of the SELEX 
model and basic binding kinetics are not well supported by the binding results. This is 
likely due to the added complexity of the more sophisticated technologies and 
immobilization schemes used. Many of the existing technologies might show 
significantly improved performances through simple characterization and 
optimization, revealing specific binding behaviors that can be modeled, to aid the 
development of more efficient protocols and more accurate SELEX theories. This will 
also allow for fairer comparisons between different methods and technologies that are 
currently evaluated primarily on the number of cycles needed and/or the binding 
affinity of the resulting aptamer. However, the majority of parameters such as times, 
flow rates, volumes, and concentrations are not typically discussed or justified in 
many technologies, and there is currently no system by which each can be calibrated 
to assess its true efficiency or effectiveness. Fair comparisons among all the available 
technologies is hindered due to differences in the selected targets; the library type, size 
and origin; as well as the sequencing and analysis methods used. These variations 
obscure the true advantages and disadvantages of each selection technology. A 
standardized target-library system would allow a thorough and fair comparison 
between methods, and high-throughput sequencing and analysis would allow for more 
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statistically sound metrics to be generated compared to a successful 
selection/reselection of a single high affinity aptamer, which is susceptible to the 
stochastics of binding. 
Although in vitro aptamer selections are used primarily in the biological 
sciences, they have been playing an increasingly important role in engineering new 
sensing technologies. Recent progress in aptamer selections for clinically relevant 
targets have demonstrated the utility of aptamers for imaging[125] and 
therapeutics[126,127] much like their protein analogues. However, their applications 
as affinity reagents for diagnostic purposes has contributed to a new field of research 
in aptamer-based biosensors and integrated microfluidic and point-of-care diagnostic 
devices.[128,129] Many of the technologies discussed in this review can be as easily 
used for screening and sensing target molecules as they can be used for performing 
selections and characterizing aptamer binding. However, new aptamer-based devices 
with enhanced functionality are still needed, and similar efforts toward developing 
valuable sensing platforms, as with the development of selection technologies, are 
required. Ultimately, novel sensor technologies are limited by the selection processes 
and the quality of the aptamers that are generated from them. Together, this represent 
an engineering challenge which can be tacked two-fold through technical innovations 
which stem from the physical sciences.  
Already, significant advancements have been made through clever engineering 
and the application of non-traditional instrumentation, providing researchers with 
access to a wider range of physical principles by which to affect the binding and 
enrichment of high affinity molecules. New sophisticated technologies and improved 
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analysis methods have helped reduce aptamer selections to only a few cycles or less. 
However, despite their tremendous reduction in time, many of these techniques and 
devices are costly and require resources that may not be generally available to most 
researchers. A significant amount of work may be necessary to improve the reliability 
and accessibility of many of these techniques before their selections can become more 
routine. Here too, there continues to be a growing role for engineering and physical 
sciences to further advance these technologies and continue to integrate the various 
selection steps. However, even among proven technologies, much of the selection 
dynamics is not known or well understood. Valuable contributions can be made 
through detailed characterizations to optimize these existing technologies, revealing 
the mechanics and true operating principles of their methods. Developing a common 
platform in which detailed comparisons can be made will also help to explain critical 
or subtle differences between technologies, and new theories and analytical methods 
will help enable more robust aptamer identifications in the future.  
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CHAPTER 2 
MULTIPLEXED MICROCOLUMN-BASED PROCESS FOR EFFICIENT 
SELECTION OF RNA APTAMERS
‡
 
 
ABSTRACT 
We describe a reusable microcolumn and process for the efficient discovery of 
nucleic acid aptamers for multiple target 
1
molecules. The design of our device requires 
only microliter volumes of affinity chromatography resin—a condition that maximizes 
the enrichment of target-binding sequences over non-target-binding (i.e., background) 
sequences. Furthermore, the modular design of the device accommodates a multiplex 
aptamer selection protocol. We optimized the selection process performance using 
microcolumns filled with green fluorescent protein (GFP)-immobilized resin and 
monitoring, over a wide range of experimental conditions, the enrichment of a known 
GFP-binding RNA aptamer (GFPapt) against a random RNA aptamer library. We 
validated the multiplex approach by monitoring the enrichment of GFPapt in de novo 
selection experiments with GFP and other protein preparations. After only three 
rounds of selection, the cumulative GFPapt enrichment on the GFP-loaded resin was 
greater than 108 with no enrichment for the other nonspecific targets. We used this 
optimized protocol to perform a multiplex selection to two human heat shock factor 
(hHSF) proteins, hHSF1 and hHSF2. High-throughput sequencing was used to 
                                                 
‡
 The following sections are reprinted with permission from: Latulippe, D.R.*, Szeto, K.*, Ozer, A., 
Duarte, F.M., Kelly, C.V. Pagano, J.M., White, B.S., Shalloway, D., Lis, J.T., and Craighead, H.G. 
2013. Multiplexed microcolumn-based process for efficient selection of RNA aptamers. Anal. Chem. 
85(6) pp3417-3424, doi: 10.1021/ac400105e, Copyright 2013 American Chemical Society, with 
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identify aptamers for each protein that were preferentially enriched in just three 
selection rounds, which were confirmed and isolated after five rounds. Gel-shift and 
fluorescence polarization assays showed that each aptamer binds with high-affinity 
(KD < 20 nM) to the respective targets. The combination of our microcolumns with a 
multiplex approach and high-throughput sequencing enables the selection of aptamers 
to multiple targets in a high-throughput and efficient manner. 
 
INTRODUCTION 
 Nucleic acid aptamers are short (100 nucleotide, nt) structured 
oligonucleotides that have been selected from large sequence-diverse libraries and 
shown to display high-affinity and specificity for a wide range of targets ranging from 
simple metal ions [1] to complex surface proteins on living cells [2].This combination 
of properties has led to growing interest in applications of aptamers in fields including 
therapeutics, chemical analysis, biotechnology, chemical separations, and 
environmental diagnostics [3]. Aptamers are identified from large libraries of random 
nucleic acid sequences via an iterative in vitro process called SELEX (systematic 
evolution of ligands by exponential enrichment) [4-6]. A typical SELEX round 
includes the following three steps: (i) binding, incubation of the library with the target; 
(ii) partitioning, separation of target-bound library sequences from unbound ones; and 
(iii) amplification, generation of a new pool of nucleic acids by making multiple 
copies of the sequences that bound to the target. These steps are then repeated in an 
iterative fashion to obtain an enriched pool and the target binding aptamers are 
identified via cloning and sequencing processes. 
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 Different selection strategies have been developed to separate or partition the 
free and target-bound sequences, a critical step to ensure the successful identification 
of only the strongest binding aptamers. Affinity chromatography is one such 
partitioning strategy that uses specific binding onto resin-immobilized targets to purify 
macromolecular solutes from dilute solutions [7]. It is a well-documented aptamer 
selection technique, given that it can achieve a level of purification greater than 95% 
in a single step and that numerous types of resin media are available to bind a wide 
variety of targets. However, there is limited understanding of the relationship 
governing the process parameters (target loading, resin volume, etc.) and the selection 
quality, and thus, many selection rounds (typically 12–15) are required to identify 
aptamers with the desired specificity and affinity for the target. This approach is 
particularly challenging when working with RNA libraries because it takes 
approximately 2 days just to complete the amplification step. Some work has been 
done to parallelize the use of libraries and the selection process to multiple targets in 
order to save time and reagents [8,9]. 
 Affinity chromatography-based selections are typically done in two different 
modes of operation. In batch mode, a small amount of target-immobilized resin (20–
200 μL) is incubated with the nucleic acid library, or alternatively, target-free resin is 
incubated with a mixed suspension of target and nucleic acid library [10-12]. Any 
unbound sequences in the supernatant are removed, and the target-bound sequences 
remaining on the resin are then exposed to other solutions for the subsequent 
processing steps. For this approach, the entire selection process is quite laborious, 
because each step must be done manually and repeated several times. This is 
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especially true when multiple targets are considered for selection. The second mode of 
operation, flow mode, uses small columns (0.5–3 mL) packed with resin [1,13,14]. 
The primary advantage of this approach is that the resin is physically confined within 
the column, allowing all of the selection steps to be automated by use of pumps and/or 
centrifuges and thus completed more efficiently than the batch strategy. This approach 
was used in one of the landmark papers on aptamers; Ellington and Szostak [6] used a 
3.5 mL column filled with dye-immobilized resin. However, there are a few 
limitations to this approach. The standard columns that have been used previously are 
not practical for the simultaneous selection of aptamers for multiple targets. These 
columns require more resin than the batch mode, as well as more of the immobilized 
target (e.g., protein), which can be both limiting and expensive. Thus, with the current 
affinity chromatography-based strategies, there is a noticeable lack of means to rapidly 
screen for aptamers to multiple targets in a high-throughput and efficient manner. 
 To address these limitations, we developed a process utilizing reconfigurable 
microcolumns of varying capacity for selecting RNA aptamers. The microcolumns 
require only microliter volumes of affinity chromatography resin (2–50 μL), they can 
be easily assembled in various configurations to accommodate multiple targets, and 
they can be easily integrated with common laboratory equipment. In addition, these 
microcolumns are not restricted to RNA and other nucleic acid aptamer selections but 
are also suitable for other affinity chromatography needs where small column volumes 
are desired. The assembly of microcolumns and aptamer selection process are shown 
in Figure 2.1 with the experimental details provided below. 
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Figure 2.1. Aptamer selection workflow for multiple targets by use of microcolumns. (A) 
Microcolumn filled with 10 μL of GFP-immobilized chromatography resin. (B) Multiplexed 
selection of RNA aptamers: (1) The starting RNA library is dynamically loaded onto multiple 
microcolumns that are connected in a serial configuration. (2) The devices are rearranged into 
a parallel configuration and the subsequent cycles in the process are done independently but 
simultaneously. (3) Unbound and weakly bound RNAs are washed away. (4) The remaining 
bound RNAs are eluted from each column separately. (5) The RNA molecules are reverse-
transcribed into cDNA and (6) a small fraction is analyzed via qPCR. (7) The remaining 
cDNA is PCR-amplified and then (8) transcribed back into RNA to make a new amplified 
pool for (9) the next selection round. The steps shown with dashed arrows are optional and are 
not necessarily done in each round. 
  
 We first evaluated the design space of our process using computer simulations 
of the binding kinetics of a model library over a wide range of experimental 
conditions. Next, we evaluated the performance of our microcolumns at those same 
conditions by monitoring the behavior of a known RNA aptamer (GFPapt) that binds 
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tightly to green fluorescent protein (GFP) and its derivatives [13]. Our results show 
that predictions based on simple kinetics fail to reproduce the behavior of low-affinity 
binders under flow, suggesting that typical SELEX processes based on theoretical 
kinetics are likely to be far from optimal. Furthermore, we observed the best 
performances at protein concentrations 100 times less than the capacity of the resin. 
We also empirically validated a multiplex approach by monitoring the enrichment of 
GFPapt in de novo selection experiments with GFP, two nonrelated protein 
preparations, and an empty microcolumn. To examine the utility of our device, 
multiplex and in-line negative selections were performed on two human heat shock 
factor (hHSF) proteins, hHSF1 and hHSF2. High-throughput sequencing was used to 
identify enriched candidate aptamer sequences for hHSF1 and hHSF2. Fluorescence 
electrophoretic mobility shift assays (F-EMSA) as well as fluorescence polarization 
(FP) confirmed the selection of novel high-affinity aptamers for hHSF1 and hHSF2. 
 
MATERIALS AND METHODS 
Selection Simulations  
Computational simulations were performed with a custom-made Matlab 
routine to test a wide variety of experimental parameters. The differential equations of 
association and dissociation kinetics (first-order with respect to each species) were 
numerically integrated with respect to time, distance along the microfluidic channel, 
and each aptamer type within the modeled library. Simulation conditions were set to 
mimic experimental conditions wherever possible including: (i) concentration of 
target, (ii) microfluidic dimensions, (iii) flow-rate during library loading, (iv) volume 
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and concentration of the library, and (v) flow-rate and duration of washing. A discrete 
distribution of KD within the starting library was assumed to be log-normal [15] with 
only 0.00011% of the aptamers being the strongest binders.  However our simulation 
results proved to be very insensitive to these initial conditions due to the significantly 
greater concentration of target than aptamers. The on-rate (ka) and off-rate (kd) 
constants for each aptamer were approximated to match select experimental 
conditions: kd*ka = 0.04. Further, the simulations included the presence of a 
background binding possibility for all aptamers. Regardless of the binding strength of 
the aptamers to the target, each aptamer was capable of binding to a non-specific 
binding site with an equilibrium binding constant of 10 µM with a non-specific 
binding site concentration of 100 µM; these parameters were determined to 
sufficiently match the background binding experimentally observed. 
 
Preparation of recombinant protein targets 
 Recombinant proteins were expressed in BL21(DE3)-RIPL E. coli cells 
(Agilent Technologies) transformed with plasmids that encode for hexahistidine-
tagged GFP, CHK2, UBLCP1, and dHSF, or GST-tagged hHSF1 and hHSF2. Two or 
four liter LB cultures supplemented with 100 µg/ml ampicillin were inoculated with 
starter LB culture derived from a single colony and grown at 37 °C until the OD600 
reached approximately 0.6. Protein expression was induced by the addition of IPTG to 
a final concentration of 1 mM. After an additional incubation, bacteria were collected 
by centrifugation and the resulting pellet was processed according to the 
manufacturer’s instructions for Ni-NTA Superflow (Qiagen) or Glutathione-agarose 
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(Thermo Scientific) resins. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was 
used to verify the purity and quality of the final protein product.  Resulting protein 
preps were dialyzed against 1× PBS (supplemented with 5 mM 2-mercaptoethanol and 
0.01% Triton X-100) and stored in small aliquots after addition of glycerol to a final 
concentration of 20%. 
 
Preparation of Protein-Immobilized Resins 
For each selection round, a fresh batch of protein-bound resin was prepared. 
Nickel–nitrilotriacetic acid (Ni-NTA) Superflow or glutathione–agarose resins were 
extensively washed with binding buffer [Ni-NTA binding buffer contained 25 mM 
tris(hydroxymethyl)aminomethane (Tris), pH 8.0, 100 mM NaCl, 25 mM KCl, and 5 
mM MgCl2; glutathione binding buffer contained 10 mM N-2-
hydroxyethylpiperazine-N-ethanesulfonic acid (HEPES)–KOH pH 7.6, 125 mM NaCl, 
25 mM KCl, 1 mM MgCl2, and 0.02% Tween-20] to remove any residual storage 
components. Hexahistidine- or GST-tagged proteins were prepared as described and 
immobilized onto the washed resin at 4 °C with constant mixing. The protein-bound 
resin was then degassed in a vacuum desiccator for approximately 20 min and 
carefully pipetted into the device (Figure 2.1.A) 
 
Nucleic Acid Library and GFP-Binding Aptamer 
A random library containing 5×10
15
 sequences of 120-nucleotide (nt) DNA 
templates, hereafter referred to as N70 library, was chemically synthesized by 
GenScript. It consists of a 70-nt random region flanked by two constant regions as 
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described elsewhere [16]. The GFP-binding RNA aptamer used in this work was 
previously identified as AP3-1 and characterized elsewhere [13].  
The 120-nt DNA library consists of a 70-nt random region flanked by two 
constant regions: 5’-AAGCTTCGTCAAGTCTGCAGTGAA-N70-
GAATTCGTAGATGTGGATCCATTCCC-3’.  The single-stranded DNA template 
library was converted to double-stranded DNA while introducing the T7 promoter 
using Klenow exo- (NEB) and Lib-FOR oligo: 5’-
GATAATACGACTCACTATAGGGAATGGATCCACATCTACGA-3’. The 
resulting library was later amplified in a 1 L PCR reaction using Taq DNA 
polymerase, Lib-FOR oligo, and Lib-REV oligo: 5’-
AAGCTTCGTCAAGTCTGCAGTGAA-3’. A single aliquot covering the complexity 
of the entire library was transcribed with T7 RNA polymerase in a 88 mL reaction 
yielding 1200-fold amplification. An aliquot of this RNA library corresponds to an 
average of 4 to 6 copies of each sequence in the 5×10
15
 library was used as the starting 
pool for selections.  
GFPapt, the 84-nt GFP binding RNA aptamer, has the following sequence: 5’-
AGCUUCUGGACUGCGAUGGGAGCACGAAACGUCGUGGCGCAAUUGGGU
GGGGAAAGUCCUUAAAAGAGGGCCACCACAGAAGCU-3’. The forward and 
reverse oligos used for qPCR analyses were GFPapt-FOR: 5’-
GCTTCTGGACTGCGATGGGAGCA-3’ and GFPapt-REV: 5’-
GCTTCTGTGGTGGCCCTCTTTTAAGGACT-3’.  
All of the oligos used in this work were obtained from Integrated DNA 
Technologies. 
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Microcolumn Selection and Amplification Protocol 
All of the solutions were degassed prior to use and introduced into the 
microcolumns via a standard syringe pump (Harvard Apparatus). First, yeast tRNA 
(Invitrogen) in binding buffer was introduced to block any possible nonspecific RNA 
binding sites. For each loading step, the RNA library was diluted in 1 mL of RNase-
free binding buffer, heat-denatured at 60 °C for 5 min, renatured by cooling down to 
room temperature while degassing, and then spiked with 200 units of RNase inhibitor 
(Invitrogen). A 10 μL aliquot was collected and used as a standard for the quantitative 
polymerase chain reaction (qPCR) analysis. Each device was then washed with 3 mL 
of binding buffer (supplemented with 10 mM imidazole for selections with Ni-NTA 
resin) to remove unbound RNA. Finally, the RNA–protein complexes were eluted 
from individual microcolumns by flowing elution buffer [binding buffer + 50 mM 
ethylenediaminetetraacetic acid (EDTA)] at a rate of 50 μL/min for 6 min. Eluted 
RNA and the input samples were phenol/chloroform-extracted and ethanol-
precipitated together with 1 μL of GlycoBlue (Ambion) and 40 μg of yeast tRNA 
(Invitrogen), and the resulting pellet was resuspended in RNase-free water. 
Both the resuspended pools and standards were reverse-transcribed with 
Moloney murine leukemia virus reverse transcriptase (MMLV-RT). For the 
optimization experiments, 10% of the selected pool and the input sample were reverse-
transcribed in a separate reaction for GFPapt quantitation. Residual RNA was 
eliminated by treating the samples with RNase H (Ambion). A small amount (less than 
5%) of the cDNA product was analyzed on a LightCycler 480 qPCR instrument 
(Roche) to determine the amount of RNA library and GFPapt that was retained on 
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each device. Two different sets of oligos were used to independently evaluate the 
amount of the RNA library/pool and GFPapt, respectively. The cDNA samples from 
each round were PCR-amplified and then subjected to phenol/chloroform and 
chloroform extractions and a final purification step on DNA Clean & Concentrator 
(Zymo Research) spin columns. A fraction of the purified PCR product was used to 
make the RNA pool for the next round of SELEX. A typical 72 μL transcription 
reaction consisted of 500 ng of DNA, 546 pmol of each ribonucleoside triphosphate 
(rNTP, Sigma), T7 RNA polymerase, 72 units of RNase inhibitor (Invitrogen), and 
0.12 unit of yeast inorganic pyrophosphatase (New England Biolabs). The reactions 
were incubated at 37 °C for various times depending on the desired amount of RNA 
for the next selection round. The resulting RNA pool was treated with DNase I 
(Invitrogen) to remove the template DNA, verified by denaturing polyacrylamide gel 
electrophoresis (PAGE) for length and purity, and finally quantified by Qubit BR 
RNA assay (Invitrogen). 
 
High-Throughput Sequencing data filtering, and clustering analyses 
A small amount of the purified PCR product from each target pool for various 
selection rounds (e.g., hHSF1 round 5) was PCR-amplified by use of primers that 
contain a unique 6 nt barcode and the necessary adapters for the HiSeq 2000 
(Illumina) sequencing platform. Sequences of the primers and the barcodes are 
available upon request. The barcoded adapter-ligated PCR products were PAGE-
purified, phenol:chloroform and chloroform extracted, ethanol precipitated, and then 
re-suspended in 10 mM Tris-HCl pH 7.5 buffer.  High-throughput sequencing (100 nt 
67 
 
single-end reads) was performed by the sequencing core facility at Life Sciences Core 
Laboratories Center, Cornell University.  Up to twelve barcoded samples were 
successfully sequenced in a single lane of the HiSeq 2000 flow-cell.   
Sequences that contained any ambiguity or had a quality score less than three 
(Illumina 1.8 encoding) were removed from analysis.  Remaining sequences were 
separated based on the barcodes using the ‘FASTX’ toolkit 
(hannonlab.cshl.edu/fastx_toolkit) by requiring a perfect match for barcode sequences.  
The forward constant regions were stripped via semi-global alignment using 
‘cutadapt’ [17]; given the length of the reads, the reverse constant region and Illumina 
sequencing adaptors were not present and did not need to be removed.  Remaining 
sequences containing between 64 and 72 nucleotides of the random region 
(inclusively) and identical in sequence were collapsed using the FASTX tool kit.  A 
two-stage clustering approach was applied to the collapsed sequences to account for 
sequencing error that may induce apparently distinct reads from a single aptamer.  
Sequences with multiplicity at most one in all pools (i.e., singletons) that are 
dissimilar from all other non-singleton sequences in their respective pools, as 
determined by using ‘USEARCH’ [18] to align each to a database of non-singleton 
reads, are likely to be spurious or present at relatively low levels.  For improved 
computational efficiency these were excluded from subsequent analysis.  Remaining 
sequences were aggregated across pools and those with 80% sequence identity were 
clustered using USEARCH.  The highest multiplicity read within each cluster, the 
cluster representative, was identified as the true aptamer sequence.  The multiplicity of 
this cluster was defined as the sum of multiplicities within the cluster.  Representative 
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sequences, multiplicities and enrichment factors (defined as the ratio of the fraction of 
a given cluster in a given pool/ fraction of the same cluster in the starting library) for 
each cluster were tabulated and sorted based on the multiplicity or the enrichment 
factor across different pools to select candidate aptamers for each target. The analysis 
pipeline is available upon request. 
 
Amplification of select aptamer sequences from pools 
 Candidate aptamer sequences were PCR amplified from the final 
Round 5 pool for each target using an aptamer specific oligo and the Lib-REV oligo 
with Phusion Polymerase (NEB), according to manufacturer’s instructions. Aptamer 
specific oligos span the forward constant region and ~30 nt of the random region (Tm 
of 60 °C) of each aptamer. The resulting PCR product was double-digested with 
EcoRI or BamHI, and PstI or HindIII, and ligated into a similarly cut pGEM3Z-
N70Apt plasmid, which has been obtained by cloning a random aptamer sequence 
together with the T7 promoter into the pGEM3Z vector (Promega) between NarI and 
HindIII sites. Multiple clones, typically 3 to 10, were sequenced to obtain a consensus 
for the full-length sequence of the candidate aptamer. Note, high-throughput 
sequencing only yielded the first 68 nt sequence of the 70 nt random region (100 nt 
sequencing – 26 nt forward constant region – 6 nt barcode). Therefore, all of the 
candidate aptamers that were used in subsequent assays were prepared from the 
sequence verified constructs to ensure the purity of the intended aptamer in each 
preparation. 
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Fluorescence Electrophoretic Mobility Shift Assay 
Candidate aptamer sequences were amplified from the final round 5 pool and 
prepared from sequence-verified plasmid constructs. The candidate aptamers were 3′-
end-labeled with fluorescein 5-thiosemicarbazide (Invitrogen) as described previously 
[19]. Binding reactions (50 μL) were prepared with 2 nM fluorescently labeled RNA 
and decreasing amounts of protein (2000 to 0 nM) in binding buffer containing 0.01% 
IGEPAL CA-630, 10 μg/mL yeast tRNA, and 3 units of RNase inhibitor (Invitrogen). 
Reactions were incubated at room temperature for 2 h, spiked with 6× loading dye, 
and then loaded into the wells of a refrigerated 1.5% agarose gel prepared with 0.5× 
Tris–borate–EDTA (TBE) buffer with 1 mM MgCl2. The gel was run for 80 min at 
100 V in refrigerated 0.5× TBE. Images were acquired at the fluorescein scan settings 
on a Typhoon 9400 imager (GE Healthcare Life Sciences). The resulting bands were 
quantified with ImageQuant software and the data were fit to the Hill equation by use 
of Igor (Wavemetrics) to estimate the equilibrium dissociation constant (KD). 
 
Fluorescence polarization (FP) assay 
Binding reactions were prepared by mixing 2 nM of 3’-end labeled RNA 
aptamer with protein concentrations that varied from 0.2 to 2000 nM in 1.5-fold 
increments in binding buffer containing 0.01% IGEPAL CA630, 10 µg/ml tRNA, and 
3U of SUPERase•In RNase Inhibitor (Invitrogen). The reactions were prepared in 
black 96-well half area microplates (Corning) and then incubated at room temperature 
for 2 hours.  The plates were read on a Synergy H1 Microplate Reader (BioTek); 
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fluorescence polarization was measured as (F║-F┴)/( F║+F┴) using the Ex: 485/20 
Em: 528/20 filter set. 
 
RESULTS AND DISCUSSION 
Fabrication of Microcolumns for Selection of Aptamers 
Our microcolumns were assembled from both custom-fabricated and 
commercially available parts. The column consists of a transparent biocompatible 
plastic rod fitted with a porous frit that retains the resin in the device (Figure 2.1.A). 
By varying both the length and internal diameter of the column, we were able to 
fabricate columns with a range of volume capacities from 2 to 50 μL. NanoPorts 
(IDEX Health and Science) that accommodate standard tubing connectors were 
bonded to either end of the column. Overall, this design has a number of important 
features: simple union connectors can be used to arrange multiple microcolumns into 
various configurations, the dead volume between the devices is minimized and is 
generally less than 1 μL, and they can be connected to common laboratory equipment 
to automate the selection steps. To perform the multiple target aptamer selection, we 
developed a workflow process wherein a set of microcolumns, each prefilled with a 
different target-immobilized resin, are arranged into a serial configuration (Figure 
2.1.B). With our pump system, a typical arrangement could contain up to 10 
parallelized assemblies of devices, but the general approach can easily be scaled up for 
a larger number of parallel processes. A single aliquot of the starting random library is 
then flowed through these devices, allowing the target binding aptamers to be captured 
on the resin within each individual column. The library molecules that do not bind to 
71 
 
any target are discarded and then the individual microcolumns are disconnected and 
reorganized into a parallel configuration (Figure 2.1.B). This arrangement allows for 
specific elutions from each target and thus separate processing of only the bound 
sequences to create target-specific amplified pools for the next selection round. Note 
that, following reverse transcription of the RNA aptamer into cDNA, we used 
quantitative PCR to determine the amount of nucleic acid recovered from each device. 
This information was used to determine the optimal number of PCR cycles and thus 
minimize the chance of amplification artifacts [20]. Although Figure 2.1.B shows the 
microcolumns arranged exclusively in a parallel configuration after the first selection 
round, it is also possible to use a serial configuration in later rounds. This arrangement 
would allow for negative or counter selections to be done simultaneously with the 
selection step to enhance specificity for the target. 
The size of our microcolumns was chosen for primarily two reasons. First, they 
are small enough that they require only small amounts of material for each selection 
round, yet their internal dimensions are sufficiently large enough that they could be 
easily filled with a variety of different resins. Second, we simulated the binding 
kinetics of a model library binding to a model target molecule within our device and 
discovered that aptamers with strong binding affinities for the target (i.e., equilibrium 
dissociation constant KD = 0.5 nM) were preferentially retained at the input end (i.e., 
in the first few microliters) of the microfluidic column (Figure 2.2). Aptamers with 
weaker binding affinities for the target (KD ≥ 50 nM) were distributed almost 
uniformly throughout the microfluidic column with concentrations nearly identical to 
the input concentration. Therefore, smaller columns increase the mean density of 
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strong binders, a condition that would require fewer selection rounds to identify 
aptamer candidates. A previous study used an affinity capillary column that was 
physically cut into smaller pieces to isolate the highest affinity aptamers in the earliest 
column segments [21]. 
We evaluated experimentally the binding distribution of an RNA aptamer, 
hereafter referred to as GFPapt, on microcolumns that were filled with various 
amounts of GFP-immobilized resin. It had been previously shown that this aptamer 
has a strong binding affinity (KD  5 nM) for GFP [13] and thus serves as a model 
molecule for the high-affinity target-binding aptamers that are presumed to be present 
in random libraries. In order to determine the amount of nonspecific, low-affinity (i.e., 
“background”) binding within the microcolumn, a small amount of the random RNA 
library (5 pmol) was included in addition to the GFPapt (0.064 pmol). We used 0.6 μg 
of GFP/μL of resin, binding and washing flow rates of 100 μL/min, and qPCR assays 
to quantify the amount of both the GFPapt and the random library captured on the 
microcolumn. The experimental results are shown in Figure 2.2 as a percentage 
density of the amount of both the GFPapt and the N70 random library loaded onto the 
device. The experimental results are well fit by the simulations for both high-affinity 
(KD = 5 nM for GFPapt) and low-affinity (KD ≥ 10 μM for the N70 random library) 
binding. 
 
Optimization of Aptamer Selection Conditions 
To optimize the performance of our devices and to further test our simulation 
predictions, we used microcolumns filled with GFP-immobilized Ni-NTA resin to  
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Figure 2.2. Dependence of aptamer recovery on microcolumn volume. Solid and dashed 
lines are the simulation results for the input-normalized concentrations of aptamers with 
various binding affinities (KD ranging from 0.5 nM to 5 μM) as a function of microcolumn 
volume. Data points are the experimentally measured binding densities, given as percent of the 
total, of high-affinity GFPapt (green solid circles) and low-affinity, nonspecific-binding N70 
random library (red solid diamonds) as a function of microcolumn volume. Input-normalized 
aptamer concentrations are defined as the bound aptamer concentration at a point along the 
column divided by the initial aptamer concentration. Probability densities for binding are 
defined as the probability per unit volume for molecules to bind in the vicinity at a point along 
the column. The two y-axes are related by the total loaded sample volume. The dashed vertical 
line at 10 μL marks the volume of the devices used for the optimization experiments. 
 
evaluate the binding behavior of GFPapt and the random N70 library over a wide 
range of experimental conditions. The results are shown as a percentage of the amount 
loaded onto the device (Figures 2.3.A and 2.3.C). For each condition, the GFPapt 
enrichment was calculated as the ratio of the percent amounts of GFPapt to random 
library (Figures 2.3.B and 2.3.D). 
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Affinity chromatography resins were developed primarily for protein 
purification applications and thus are capable of binding relatively large amounts of 
target molecules; the reported binding capacity of the resin used in our experiments is 
20–50 μg of protein/μL of resin. Despite the widespread use of these resins for 
aptamer selections, there is no information available on how this parameter affects the 
selection performance, since none of the previous studies optimized the resin binding 
conditions [7]. In order to determine the optimum amount of bound target, we 
prepared  five different batches of resin with varying amounts of immobilized GFP, 
from 0.024 to 15 μg of protein/μL of resin in 5-fold increments. The amount of 
GFPapt captured within the device was strongly dependent on the amount of GFP 
target on the resin (Figure 2.3.A). Interestingly, we found that the highest recovery 
(40%) was obtained at the intermediate value of 0.6 μg of protein/μL of resin (15 μM). 
Library recovery was essentially independent of the amount of target, and so the 
GFPapt enrichment was also maximized at the same intermediate value (Figure 2.3.B). 
We had initially hypothesized that saturating the resin with GFP would maximize the 
number of target binding aptamer molecules while also minimizing nonspecific 
binding sites on the resin surface, yielding the highest GFPapt enrichment. Kinetic 
simulations done by a similar approach to that described for determining the optimal 
device size, except with a higher fraction of strong-binding aptamers (1%) to match 
the experimental conditions, correctly predicted that there was no effect of target 
amount on recovery of the random library (Figure 2.4.B). However, the simulations 
predicted that the highest recovery of the strong-binding aptamer would occur at the 
conditions with the highest amount of bound target (Figure 2.4.A). We believe that  
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Figure 2.3. Optimization of microcolumn-based selection. (A) Percent recovery of GFPapt 
(green) and N70 random library (red) and (B) GFPapt enrichment for different amounts of 
GFP immobilized onto Ni-NTA resin in a 10 μL microcolumn; loading and washing flow 
rates were 100 μL/min. (C) Percent recovery of GFPapt (green) and N70 random library (red) 
and (D) GFPapt enrichment for different flow rates; the amount of GFP immobilized onto Ni-
NTA resin was 0.6 μg/μL. Solid lines show the effect of loading flow rate at a fixed washing 
flow rate of 100 μL/min; dashed lines show the effect of washing flow rate at a fixed loading 
flow rate of 100 μL/min. Error bars represent the standard deviation of triplicate experiments 
and measurements at each condition. 
 
this discrepancy between our experimental observations and simulation results is 
primarily due to steric hindrance, where macromolecular crowding effects on the resin 
surface decrease the binding affinity of the specific aptamer sequence; a similar 
phenomenon has been reported for the binding of soluble proteins to surface lipid 
vesicles [22]. Formation of the aptamer–target complex could also hinder the binding 
of other aptamer molecules. Our results support the use of concentrations below a 
critical packing density that is determined by the larger of the two biomolecules. All of  
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Figure 2.4. Simulation results for the effect of target protein concentration on percent 
recovery of (A) a strong binding aptamer (KD = 5 nM) and (B) random library molecules. The 
other simulation parameters were total resin volume = 10 μL, loading flow rate = 100 μL/min, 
and washing flow rate = 100 μL/min. 
 
the subsequent optimization experiments were conducted with resin prepared at the 
optimum value of 0.6 μg of protein/μL of resin. 
It is well known that the best affinity chromatography performance is realized 
when the loading step is operated at the lowest possible flow rates to approach 
equilibrium conditions. However, there is a practical limitation to the experiment time. 
In order to determine the optimum condition while also keeping within a practical 
experimental timeline, we varied the loading flow rate from 1 to 1000 μL/min. The 
recoveries of GFPapt and library were both strongly dependent on the flow rate but 
with considerably different trends (Figure 2.3.C). At the lowest flow rate, we observed 
the highest GFPapt recovery, the lowest library recovery, and thus the best GFPapt 
enrichment. By operating the process at higher flow rates, we observed a gradual  
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Figure 2.5. Simulation results for the effect of loading flow rate on percent recovery of (A) 
a strong binding aptamer (KD = 5 nM) and (B) random library molecules.  The other 
simulation parameters were total resin volume = 10 μL, concentration of immobilized target 
protein = 22 μM, and washing flow rate = 100 μL/min. 
 
decrease in performance as measured by a decrease in GFPapt enrichment (Figure 
2.3.D). Our kinetic simulations correctly predicted that the highest recovery of the 
strong-binding GFPapt molecule would be obtained at the lowest flow rate (Figure 
2.5.A). However, the simulations also predicted the same trend of decreasing recovery 
with increasing loading flow rate for the random library (Figure 2.5.B). This 
disagreement between simulation and experimental results for the library is discussed 
below. 
 After completion of the loading step, a fixed-volume washing step was 
employed to improve the separation performance by removing any unbound or weakly 
bound sequences. We varied the washing flow rate from 3 μL/min to 3 mL/min. We 
observed similar results to those seen before in that the recoveries of both GFPapt and  
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Figure 2.6. Simulation results for the effect of washing flow rate on percent recovery of 
(A) a strong binding aptamer (KD = 5 nM) and (B) random library molecules. The other 
simulations parameters were total resin volume = 10 μL, concentration of immobilized target 
protein = 22 μM, and loading flow rate = 100 μL/min. 
 
library had different trends with increasing flow rate. Whereas the GFPapt recovery 
increased at higher flow rates, the library recovery decreased (Figure 2.3.C). Thus, the 
best GFPapt enrichment was obtained at the highest washing flow rate (Figure 2.3.D). 
Together, all of the optimization experiments enabled us to choose the optimal 
experimental conditions that maximize the enrichment of strong-binding aptamers for 
each selection round, while keeping within practical experimental and time 
constraints. These conditions are particularly important for the earliest selection 
rounds when there are only a few copies of each aptamer sequence. Our results also 
revealed the importance of empirical validation and characterization of different 
selection conditions, since the kinetic simulations were unable to properly predict all 
the experimental trends. For example, simulation results for the washing step predicted 
a gradual increase in the recovery of random library (Figure 2.6)—the exact opposite 
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trend to that seen experimentally. In our simulations, the behavior of each species was 
determined by the on- and off-rate kinetic constants. They do not include other 
phenomena such as shear or pressure-related flow effects that could preferentially 
affect the behavior of weak binders and the ultimate separation performance of our 
microcolumns. 
After fully characterizing the operating conditions to maximize the enrichment 
of strongly binding aptamers in our microcolumns, we then proceeded to validate our 
selection strategy empirically by monitoring the enrichment of GFPapt molecules in 
de novo selections with multiple protein targets, including GFP. For each round, three 
microcolumns were filled with Ni-NTA resin that had been preimmobilized with 
either GFP or two unrelated proteins, CHK2 and UBLCP1. The latter two were chosen  
because they have similar size and charge properties as the specific target GFP and 
were readily available with hexahistidine affinity tags (Table 2.1). An empty 
microcolumn was also included as a control to enable us to discriminate target-binding 
from device bias. 
 
Table 2.1. Properties of the target proteins 
Protein Molecular 
Weight (kDa) 
Isoelectric 
Point 
Affinity tag 
GFP 27 5.5 Hexahistidine (N-terminus) 
UBLCP1 37 6.1 Hexahistidine (C-terminus) 
CHK2 61 5.6 Hexahistidine (N-terminus) 
hHSF1 86 5.3 GST* (N-terminus) 
hHSF2 88 4.9 GST *(N-terminus) 
dHSF 80 4.9 Hexahistidine (N-terminus) 
                   *GST tag ~ 30 kDa 
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For the first selection round, four devices were arranged in a serial 
configuration in the following order: empty, UBLCP1, CHK2, GFP. The GFP target 
was put at the end so that all of the GFPapt molecules that were combined with the 
random RNA library would have an opportunity to bind to the other targets; the 
loading solution for the first selection round contained 40 nmol of the random RNA 
library (5 copies of each sequence in the 5×10
15
 library) and 6.4 fmol of GFPapt in 1 
mL of binding buffer. Thus, the initial molar ratio of library to GFPapt molecules was 
greater than 6 million to one. Enrichment of GFPapt was determined for each 
microcolumn from qPCR analyses of the eluted samples (Figure 2.7). Only the 
microcolumn filled with GFP-loaded resin showed significant GFPapt enrichment. In 
the first round, the recoveries of the GFPapt and the random library were 20% and 
0.022% of the corresponding inputs, respectively, yielding a GFPapt enrichment of 
approximately 900-fold. However, for the other three devices, the GFPapt enrichments 
were all near unity, indicating that there was no affinity for GFPapt over the random 
library. To decrease the material used in the selections, for the next two rounds the 
amount of the amplified RNA pool loaded onto each device was decreased by 20-fold 
from the amount used in the previous round. An appropriate amount of GFPapt was 
“spiked-in” with the amplified RNA pool to maintain the same molar ratio that was 
recovered in the previous round. After round 3, the amounts of GFPapt that were 
recovered on the three non-GFP devices were well below the qPCR detection limit, 
and therefore, no GFPapt enrichment results could be obtained. However, for the GFP 
device the GFPapt enrichments were much greater than 100-fold per selection round,  
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Figure 2.7. Validation of specific aptamer-target enrichment for multiplex SELEX. 
UBLCP1, CHK2, and GFP were preimmobilized on Ni-NTA resin at a density of 0.6 μg of 
protein/μL of resin and an empty microcolumn was also included as a control. The loading 
flow rate for all the rounds was 1 μL/min. The enrichment of GFPapt was monitored on all 
four microcolumns for three consecutive selection rounds. Results are presented in the same 
order that the four devices were arranged in the serial configuration used in round 1. GFPapt 
enrichment was calculated as the ratio of the percent amounts of GFPapt to random library. 
The error bars represent the standard deviation of triplicate measurements for each 
microcolumn. 
 
giving rise to a cumulative enrichment of over 108-fold. At the end of round 3, 
approximately 95% of the GFP selected pool was composed of GFPapt. 
 
Microcolumn SELEX for Human Heat Shock Factor Proteins 
To conclusively demonstrate the multiplex utility of the microcolumns, we 
performed multiplex SELEX for a set of GST-tagged proteins: hHSF1, hHSF2, and 
four other related proteins. hHSF1 and hHSF2 are transcription factors that regulate 
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stress response, including heat shock in human cells, and hHSF1 plays a critical role 
during tumor formation and maintenance [23]. However, important questions remain 
unanswered regarding their molecular interactions and the specific mechanisms that 
are used to execute their functions. An RNA aptamer against the Drosophila 
melanogaster HSF (dHSF) has been selected previously and used to inhibit the binding 
and recruitment of dHSF to the promoters of heat shock genes [24,25]. However, only 
moderate cross-reactivity with the hHSF proteins limits the use of this aptamer in 
functional studies in human cells [26]. Given the biological importance of HSF, we 
decided to select for aptamers directly to hHSF1 and hHSF2, which can be used as 
inhibitory tools to dissect the mechanisms of actions of these proteins. 
Each protein was preimmobilized onto glutathione–agarose resin at 
approximately 1 μg of protein/μL of resin. The GST tag was also included as a control 
and thus seven 20 μL microcolumns were arranged in a serial configuration for round 
1. Following the procedure outlined above, another aliquot of the starting RNA library 
(5 copies of each sequence in the 5×10
15
 library) was loaded onto the seven-
microcolumn assembly and then separated into a parallel arrangement for all the 
subsequent rounds. 
A total of five selection rounds were completed. For rounds 2 through 5, in-
line negative selections were done by connecting a 10 μL microcolumn filled with 
GST-immobilized resin to the inlet of each of the six microcolumns for the GST-
tagged proteins. These precolumns were removed after the loading step for the 
subsequent wash and elution of the target protein-bound aptamers from each 
microcolumn. 
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We analyzed the sequences from the RNA pools from rounds 3 and 5 for both 
hHSF1 and hHSF2 by high-throughput sequencing [27,28]. The total number of 
sequencing reads per pool ranged from 6 million to 9 million. For both proteins, there 
was a noticeable shift toward higher multiplicity values from round 3 to round 5. In 
round 3, the top 20 highest multiplicity sequences for each protein represented only 
0.04% of the total pool. However, in round 5, the top 20 sequences represented 85.0% 
and 76.5% of the hHSF1 and hHSF2 selected pools, respectively (Table 2.2). In 
addition, of the top 20 highest multiplicity sequences in round 3, between a quarter 
and a half of them were also among the top 20 highest multiplicity sequences in round 
5 for hHSF2 and hHSF1. The detection of enriched candidate aptamer sequences in 
earlier selection rounds was possible because of the high-throughput sequencing, 
which allowed us to select candidate aptamers for subsequent analysis. 
We decided to investigate the potential binding of one of the top candidate sequences 
for hHSF1 and hHSF2. We chose the highest ranked sequences from the round 5 pools 
that were also highly ranked in round 3. For hHSF1, this was the first-ranked sequence 
in round 5, hereafter referred to as hHSF1-R5-1, which was also the 11th-ranked 
sequence in round 3 (Table 2.2). For hHSF2, this was the second-ranked sequence in 
round 5, hereafter referred to as hHSF2-R5-2, and also the sixth-ranked sequence in 
Round 3 (Table 2.2). The full-length sequences and predicted structures of these two 
aptamer candidates are in Figure 2.8. These two candidates represented 13.4% and 
6.8% of the corresponding round 5 pools. The full-length aptamer candidates 
(including the constant regions) were PCR-amplified from their respective pools by  
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Table 2.2. The top twenty highest multiplicity candidate aptamers from Round 5 pools 
for hHSF1 and hHSF2 (total number of sequencing reads = 5,930,382 and 8,644,268 
respectively) and the corresponding Round 3 ranks and multiplicities (total number of 
sequencing reads = 8,072,400 and 9,350,602 respectively).  To compare multiplicity values 
from different pools, the results are presented as multiplicity per 10 million reads. 
hHSF1 Sequencing Results (per 10 Million Reads) 
ID Round 5 Multiplicity Round 3 Rank Round 3 Multiplicity 
hHSF1-R5-1 1340479 11 133 
hHSF1-R5-2 1274151 9 152 
hHSF1-R5-3 1261696 6 190 
hHSF1-R5-4 621764 22 98 
hHSF1-R5-5 550234 54 55 
hHSF1-R5-6 530607 24 93 
hHSF1-R5-7 469695 3 164 
hHSF1-R5-8 405537 30 79 
hHSF1-R5-9 358828 7 165 
hHSF1-R5-10 272611 27 84 
hHSF1-R5-11 271480 10 147 
hHSF1-R5-12 191659 1 500 
hHSF1-R5-13 170782 5 190 
hHSF1-R5-14 156627 41 66 
hHSF1-R5-15 143621 26 89 
hHSF1-R5-16 127020 2 347 
hHSF1-R5-17 98130 40 68 
hHSF1-R5-18 97392 8 154 
hHSF1-R5-19 84796 35 73 
hHSF1-R5-20 76493 43 64 
 
hHSF2 Sequencing Results (per 10 Million Reads) 
ID Round 5 Multiplicity Round 3 Rank Round 3 Multiplicity 
hHSF2-R5-1 1627399 51 87 
hHSF2-R5-2 682671 6 205 
hHSF2-R5-3 660708 47 93 
hHSF2-R5-4 569105 33 103 
hHSF2-R5-5 567516 511 27 
hHSF2-R5-6 558955 49 89 
hHSF2-R5-7 485019 342 33 
hHSF2-R5-8 384008 9 197 
hHSF2-R5-9 370668 69 73 
hHSF2-R5-10 304918 93 64 
hHSF2-R5-11 225959 295 36 
hHSF2-R5-12 212557 116 59 
hHSF2-R5-13 176490 162 50 
hHSF2-R5-14 146975 41 98 
hHSF2-R5-15 139564 650 22 
hHSF2-R5-16 123854 45 97 
hHSF2-R5-17 121634 108 61 
hHSF2-R5-18 117221 10 189 
hHSF2-R5-19 87884 1 242 
hHSF2-R5-20 86977 11 161 
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Figure 2.8. Mfold predicted secondary structures of (A) hHSF1-R5-1 and (B) hHSF2-R5-
2; the full sequences for these putative RNA aptamers were 5’-
GGGAAUGGAUCCACAUCUACGAAUUCCACUCCAUAGUAUCUAGAAGCCCUGCC
GAAAACGAGAGCGCUUACGCUUAUAAAUGAUCAACCUACCUCGUUCACUGCAG
ACUUGACGAAGCUU-3’ and 5’-GGGAAUGGAUCCACAUCUACGAAUUCAAUCAAG 
UCCCCAGACUCAGCAACACUGGACAGCGAUAUGCAGAUAACCAAGACCAAUUC
ACUCCAGUUCACUGCAGACUUGACGAAGCUU-3’ respectively. The two constant 
regions corresponding to the library design are denoted by underlines. The structures are 
annotated using p-num with the color representing the probability according to the color 
legend. 
 
use of a candidate-specific forward oligo and the reverse constant region oligo, and 
then cloned into plasmid vectors to obtain a pure template. 
The putative RNA aptamers were fluorescently end-labeled and then tested for 
binding to their hHSF targets by F-EMSA and FP assays [19]. An image of a typical 
F-EMSA result is shown in Figure 2.9.A for hHSF1-R5-1 aptamer binding to hHSF1 
protein. The fraction of bound aptamer was calculated as a function of protein  
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Figure 2.9. Evaluation of candidate aptamers binding to target proteins. (A) Typical F-
EMSA results for hHSF1-R5-1 aptamer binding to a two-thirds dilution series (from 2000 nM 
to 0.2 nM) of hHSF1 protein. (B, C) Binding curves measured by F-EMSA for hHSF1-R5-1 
and hHSF2-R5-2 aptamers to hHSF1, hHSF2, dHSF, and GST tag. The same dilution series in 
panel A was used in panels B and C. The solid lines are the best fits of the Hill equation to the 
experimental data for each aptamer–target pair with the appropriate KD values given in the 
figure legends. 
  
87 
 
concentration and then plotted as shown in Figures 2.9.B and 2.9.C for various 
aptamer–protein pairings; KD values were determined by fitting each data set to the 
Hill equation. Overall, both aptamers showed high-affinity binding to hHSF1 and 
hHSF2 (KD < 20 nM). Interestingly, both aptamers also bound to hexahistidine-tagged 
dHSF, although slightly more weakly (KD ~ 70 nM), and no binding was observed to 
the GST-tag alone. The F-EMSA results were confirmed by the FP assays (Figures 
2.10 and 2.11). Thus, the observed binding is not due to the affinity tags on the protein 
targets but rather to specific domains of the targets themselves. Given that the highest 
degree of sequence similarity between hHSF1, hHSF2, and dHSF is in the DNA 
binding and trimerization domains (DBD-TD) [29] and that the previously selected 
dHSF aptamer was found to bind the DBD-TD of dHSF, [24] we predict these novel 
hHSF aptamers are likely to bind the HSF proteins in a similar fashion. Contrary to 
their functional similarity, these two aptamers did not show any similarity in 
secondary structure as predicted by mFold [30] (Figure 2.8). Although beyond the 
scope of the present work, the detailed mechanism of these and other potential 
aptamers’ binding to HSF proteins as well as the consequences of binding await 
further study. However, successful selection of two distinct high-affinity aptamers, 
hHSF1-R5-1 and hHSF2-R5-2, targeting two closely related proteins, hHSF1 and 
hHSF2 respectively, in a single selection demonstrates that our microcolumn-based 
SELEX technology is capable of yielding high-affinity aptamers (K < 20 nM) in as 
little as five rounds of selection, whereas most conventional SELEX methods require 
typically 12 rounds of selection [7]. 
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Figure 2.10. Fluorescence polarization (FP) assay results for binding of hHSF1-R5-1 
aptamer to GST-hHSF1 (A), GST-hHSF2 (B), hexahistidine-dHSF (C), and GST-tag (D).  
The solid line in each panel (except D) is the best-fit of the Hill equation to the experimental 
data with the given KD value. 
  
89 
 
 
 
Figure 2.11. Fluorescence polarization (FP) assay results for binding of hHSF2-R5-2 
aptamer to GST-hHSF1 (A), GST-hHSF2 (B), hexahistidine-dHSF (C), and GST-tag (D). 
The solid line in each panel (except D) is the best-fit of the Hill equation to the experimental 
data with the given KD value. 
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CONCLUSIONS 
 We have developed a microcolumn-based technology for the efficient selection 
of nucleic acid aptamers for multiple targets. Our microcolumns have a number of 
advantages over other chromatography-based processes. First, they can be readily 
assembled in various configurations to accommodate multiple targets during the 
selection step; as a proof of principle, we used a single aliquot of starting RNA 
aptamer library to perform selections for seven different immobilized target proteins in 
separate microcolumns. Second, as either assembled or disassembled units, they do 
not require any specialized equipment to perform the selection step; we used a 
multirack syringe pump to control the solution flow rates during the selection step. 
Third, they require very small amounts of resin and target molecules. For this study, 
we focused on the selection of RNA aptamers; however, our approach would also 
work for DNA aptamers. The multiplex selection presented in this work is simpler and 
thus easier to perform than previous microfluidic techniques that use sol–gel chemistry 
[8]. Also, compared to filter-plate-based methods [9], our modular columns allow 
“counter-selections” to be done simultaneously with the selection step to enhance 
target specificity. 
 The overall performance of our devices was evaluated in two different sets of 
experiments. In the first, we looked at a single selection step and optimized its 
performance by monitoring the enrichment of GFPapt, a known RNA aptamer for 
GFP. The performance was strongly dependent on the amount of target immobilized 
onto the resin and the flow rates for both the loading and washing steps. In the second, 
we used the optimal conditions as part of a selection and amplification strategy to 
verify specific GFPapt partitioning over three protein preparations (UBLCP1, CHK2, 
and GFP), followed by a complete multiplex selection against hHSF1 and hHSF2. 
High-throughput sequencing analysis of the selected pools from multiple rounds 
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showed an enrichment of specific aptamer sequences. For hHSF1 and hHSF2, the 
sequences from round 5 with the highest multiplicity values also had high interround 
enrichments. Those sequences were target-specific and could be easily identified as 
being preferentially enriched after just three selection rounds. We tested a single 
candidate each to hHSF1 and hHSF2 and found both to be high-affinity aptamers to 
full-length hHSFs. 
 Although HSF proteins have been extensively studied and characterized, we 
are still limited by the available methods and lack approaches to perturb the activity of 
specific factors to tease apart molecular interactions. Aptamers can act as inhibitors 
that bind to a protein surface and disrupt specific interactions or functions. When 
expressed in vivo in a temporally and spatially controlled manner, these aptamers 
provide a way to rapidly disrupt targeted domains of proteins and efficiently assess 
their primary functions and mechanisms of actions. We previously demonstrated the 
utility of inhibitory RNA aptamers to study macromolecular interactions in vivo 
[24,25,31]. However, there were some limitations on the methodology used to select 
those aptamers, and we believe that our new method will significantly improve the 
SELEX efficiency by: (1) allowing the selection of aptamers for many targets, 
including different domains of a single protein, at the same time and (2) reducing the 
number of SELEX rounds to achieve the selection of high-affinity aptamers. With this 
multiplexed technology, we believe it will be possible to efficiently select aptamers 
that bind to the distinct domains of HSF and other proteins, which will be extremely 
valuable to study the interactions of these proteins. 
 Extensions of the microcolumn devices and approach developed in this work 
could be used for selection strategies with various combinatorial libraries, including 
but not limited to genomic sequences [32], mRNA display [33], and peptide nucleic 
acids [34]. Also, our multiplex approach would easily facilitate the discovery of 
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multivalent aptamers to distinct target binding sites [35] by performing a final 
selection by use of serially arranged microcolumns with different target subunits in 
each. Finally, our microcolumn devices could be used to discriminate for aptamers 
based on their on- or off-rate binding characteristics by enforcing certain restrictions 
on the flow rates used for the loading step and washing step, respectively [36]. 
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CHAPTER 3 
RAPID-SELEX FOR RNA APTAMERS
‡
 
 
ABSTRACT  
 Aptamers are high-affinity ligands selected from DNA or RNA libraries via 
SELEX, a repetitive in vitro process of sequential selection and amplification steps. 
RNA SELEX is more complicated than DNA SELEX because of the additional 
transcription and reverse transcription steps. Here, we report a new selection scheme, 
RAPID-SELEX (RNA Aptamer Isolation via Dual-cycles SELEX), that simplifies this 
process by systematically skipping unnecessary amplification steps.  Using affinity 
microcolumns, we were able to complete a multiplex selection for protein targets, 
CHK2 and UBLCP1, in a third of the time required for analogous selections using a 
conventional SELEX approach. High-throughput sequencing of the enriched pools 
from both RAPID and SELEX revealed many identical candidate aptamers from the 
starting pool of 5×10
15
 sequences.  For CHK2, the same sequence was preferentially 
enriched in both selections as the top candidate and was found to bind to its respective 
target.  These results demonstrate the efficiency and, most importantly, the robustness 
of our selection scheme. RAPID provides a generalized approach that can be used 
with any selection technology to accelerate the rate of aptamer discovery, without 
compromising selection performance. 
 
                                                          
‡The following sections are reprinted with permission from: Szeto, K.*, Latulippe, D.R.*, Ozer, A., 
Pagano, J.M., White, B.S., Shalloway, D., Lis, J.T., and Craighead, H.G. 2013. RAPID-SELEX for 
RNA Aptamers. PLoS ONE. 8(12) e82667, doi: 10.1371/journal.pone.0082667, with modifications to 
conform to the required format. 
* KS and DRL are co-first authors. 
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INTRODUCTION 
 Aptamers are high-affinity ligands selected from large libraries of random 
oligonucleotides that can contain up to 10
16
 unique sequences. SELEX (Systematic 
Evolution of Ligands by EXponential enrichment) [1-3], an in vitro selection method, 
can isolate aptamers with high-affinity and specificity for a wide range of target 
molecules from DNA or RNA libraries [4-6]. This is achieved by iteratively selecting 
and amplifying target-bound sequences to preferentially enrich those sequences with 
the highest affinity to the target. Traditionally, after 10 to 15 iterations, one or several 
aptamers may be identified from the enriched pool, a process that may take months to 
complete. If an RNA aptamer is desired, this process takes even longer due to 
additional steps required for reverse transcription to amplifiable cDNA and subsequent 
transcription back to RNA. A disproportionate amount of time and effort is dedicated 
to amplifying RNA pools compared to the actual selection steps where aptamer 
enrichment takes place. 
Recent work has focused on improving selection efficiency and enriching for 
aptamers with particular target-binding properties.  This has resulted in modifications 
to the conventional SELEX strategy including the use of multiple targets to control 
specificity [7-9], changing the characteristics of the nucleic acid library [10-16], using 
different substrates for presentation of target molecules [1,17-20], and varying the 
separation technique [1,17,21,22]. Work has also been done to improve the throughput 
of aptamer discovery by utilizing high-throughput sequencing [17,23-26] or by 
performing parallel selections [19,27]. A number of automated selection strategies 
have also been introduced [28]. However, fully automated systems lack the quality 
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controls and evaluations that are applied when manual selections are performed [29]. 
Recently, we reported a multiplexed microcolumn technique that optimized selection 
parameters based on enrichment of a specific aptamer and demonstrated the ability to 
efficiently perform selections against multiple targets in parallel [30]. However, there 
is still a lack of thorough characterization and knowledge about the most efficient or 
effective methods and conditions for performing selections with emerging 
technologies. Improvements in this domain would not only increase the rate of 
aptamer selections, but have the potential to improve the rate and quality of 
downstream aptamer identification and refinement [30,31] 
 Despite many advances, only a few selection approaches diverge from the core 
methodology of traditional SELEX. To our knowledge, only one method breaks from 
the typical cycle of iterative and sequential selection and amplification steps; Non-
SELEX [32] was shown to quickly generate DNA aptamers by repeated selections 
from an enriched library without any amplification steps. This methodology only takes 
about an hour to complete and is particularly useful for libraries that cannot be 
amplified. However, the capillary electrophoresis-based platform used for Non-
SELEX requires tiny injection volumes (~150 nL) to achieve efficient separations and 
only a small fraction of the sequences recovered from a given selection cycle are re-
injected for the subsequent cycle. This constraint significantly lowers the total number 
of sequence candidates that can be investigated, decreasing the complexity and 
diversity of the injected library by 5 or 6 orders of magnitude. Despite these 
restrictions, Non-SELEX was successfully used to identify DNA aptamers to h-RAS 
protein, bovine catalase and signal transduction proteins [32-34], which suggests that 
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in some cases aptamers may be much more abundant in random pools than previously 
thought. However, without the amplification steps utilized in traditional SELEX, this 
technique makes identifying aptamer candidates via population-based methods 
difficult. This limits the potential for using high-throughput sequencing, which has 
been used to characterize sequence distributions and their cycle-to-cycle dynamics, 
and has proven to be a powerful technique for identifying enriching aptamers with 
great sensitivity [17,23,25,26,30]. 
 Here we propose a new scheme, RNA Aptamer Isolation via Dual-cycles 
SELEX (RAPID-SELEX or RAPID for short), which combines the efficiency of Non-
SELEX with the robustness of conventional SELEX and provides a generalized 
approach for accelerating the rate of aptamer selections. RAPID significantly 
decreases the time required for RNA aptamer selections by systematically eliminating 
unnecessary amplification steps and performing amplifications only when higher 
numbers of certain sequences (referred to as the copy number) or higher pool 
concentrations are required. This results in a process that maximizes enrichment per 
unit time, rather than enrichment per cycle. For each additional selection cycle 
performed without amplification (Non-Amplification Cycle), the additional effort 
associated with RNA specific processes, such as reverse transcription and transcription 
is eliminated in addition to the typical PCR amplification of DNA templates. 
Furthermore, RAPID can be applied to any selection mode and used with any 
technology, including those that utilize whole cells and target cell surface proteins as 
in Cell-SELEX [18]. We demonstrate the improved efficiency of RAPID, by 
comparing and analyzing its sequence candidates to those generated from 
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conventional SELEX using our previously described, microcolumn-based platform [30] 
to the target proteins, CHK2 and UBLCP1. CHK2 and UBLCP1 are a kinase and a 
phosphatase, respectively, and were chosen because they were readily available and no 
aptamer selections had been previously performed against them. After completing six 
selection cycles, RAPID had enriched many of the same candidates, but in only a third 
of the time required for conventional SELEX. 
 
MATERIAL AND METHODS 
Protein preparation 
  As previously described [30], recombinant hexahistidine-tagged CHK2 and 
UBLCP1 proteins were expressed in BL21(DE3)-RIPL E. coli cells (Agilent 
Technologies). LB cultures supplemented with 100 µg/ml ampicillin were inoculated 
with starter LB culture derived from a single colony and grown at 37 °C until OD600 
reached 0.6. Protein expression was induced with 0.2 mM IPTG at 18-22 °C for ~16 
hours. After centrifugation, the bacterial pellet was collected and processed according 
to the manufacturer’s instructions for Ni-NTA Superflow resin (Qiagen). SDS-PAGE 
was used to determine the purity and quality of the final protein product. The resulting 
proteins were dialyzed with 1×PBS with 5 mM 2-mercaptoethanol and 0.01% Triton 
X-100. The proteins were evaluated for purity (~90-95%) and were stored in small 
aliquots with 20% glycerol. 
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RNA library preparation 
 As previously described [30], a synthesized DNA library was purchased from 
GenScript. To increase the diversity of the initial library and to include higher order 
RNA structural classes, we chose to use a random region of 70 nucleotides (nt); this 
length averages about 4.5 structural features (vertexes) [35]. Including flanking 
constant regions, sequences in the library have 120 nts, as described by the scheme: 
5’-AAGCTTCGTCAAGTCTGCAGTGAA-N70-
GAATTCGTAGATGTGGATCCATTCCC-3’.  This length is the practical limit for 
efficient commercial synthesis of DNA templates.  The single-stranded DNA template 
library was converted to double-stranded DNA while introducing the T7 promoter 
using Klenow exo- (NEB) and the Lib-FOR oligonucleotide, 5’-
GATAATACGACTCACTATAGGGAATGGATCCACATCTACGA-3’. The 
resulting library was later amplified in a 1 L PCR reaction using Taq DNA polymerase, 
Lib-FOR oligonucleotide, and the Lib-REV oligo, 5’-
AAGCTTCGTCAAGTCTGCAGTGAA-3’. A single aliquot capturing the complexity 
of the entire library (5×10
15
 unique sequences) was transcribed with T7 RNA 
polymerase in an 88 mL reaction yielding 1200-fold amplification. An aliquot of this 
RNA library, corresponding to an average of 4 to 6 copies of each unique sequence, 
was used as the starting pool for each selection method. 
 
Multiplex SELEX and RAPID 
 The protein immobilization was described previously [30]. Briefly, a new 
batch of resin was prepared for each protein target. Ni-NTA Superflow resin was 
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incubated in binding buffer (25 mM Tris-HCl, pH 8.0, 10 mM NaCl, 25 mM KCl, 5 
mM MgCl2) with each protein to the optimal final concentration of ~0.6 µg protein/µl 
of resin and then loaded into custom fabricated microcolumns [30]. For both SELEX 
and RAPID, three microcolumns were serially connected beginning with an Empty 
microcolumn, followed by UBLCP1 and ending with CHK2. Fresh aliquots of the 
RNA Library were prepared in 1 mL binding buffer by heat denaturing at 65˚C for 5 
minutes, renaturing at 25˚C for 30 minutes and finally adding 200U of Superase-In 
RNase Inhibitor (Invitrogen).  10 µL samples were taken as 1% standards for 
subsequent quantitation by qPCR. 
For the SELEX cycles, 1 mL of blocking buffer (binding buffer supplemented 
with 0.3 µg/µL yeast tRNA) was injected into the microcolumn assembly at a rate of 
100 µL/min. The library was injected at the optimum rate of 1 µL/min using a multi-
rack syringe pump (Harvard Apparatus) [30]. After binding the library, the 
microcolumns were reconfigured to run in parallel, and a 3 mL washing step was 
performed at the optimum rate of 3 mL/min with binding buffer containing 10 mM 
imidazole. Finally, the protein and bound sequences were collected from the 
microcolumns by flowing 400 µL of elution buffer (binding buffer supplemented with 
50 mM EDTA) at 50 µL/min. By chelating the nickel ion (Ni
+2
) from the resin with 
EDTA, protein-resin binding was disrupted allowing the recovery of all protein-RNA 
complexes and thus avoiding elution bias against potential Mg-independent binding 
aptamers. Each RNA sample was then phenol:chloroform and chloroform extracted, 
ethanol precipitated together with 1 µL of GlycoBlue (Ambion) and 40 µg of yeast 
tRNA (Invitrogen), and re-suspended in 20 µL of DEPC-treated water. These were 
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then reverse transcribed, PCR amplified, and transcribed into RNA (see below for 
details) for the next selection cycle. Five more SELEX cycles using the three 
microcolumns were completed in parallel, decreasing the washing flow rate by 10-fold 
at Cycles 3 and 6 to accommodate possible increases in the bulk affinity of the 
enriched pools. The input material was also decreased by 20-fold each cycle from 
Cycle 2 to 4 to decrease the time and reagents needed. 
 For the RAPID cycles, 1 mL of blocking buffer was injected into the serial 
microcolumn assembly at 100 µL/min. The library injections were performed at 10 
µL/min to allow the completion of multiple selection cycles in one day. For the wash 
step, we used a 3 mL two-step wash at 1 mL/min for 1 minute, followed by 70 µL/min 
for 29 minutes. This combined the observed benefits of a brief, harsh wash for 
eliminating weakly bound or unbound molecules, with that of a longer wash for 
discriminating among more strongly bound molecules [30]. Elution buffer was then 
injected to recover bound sequences, which were then phenol:chloroform and 
chloroform extracted, ethanol precipitated, re-suspended in 1 mL binding buffer, and 
then used as the input pool for the next selection cycle. We took 1% standards/samples 
from each new pool and then the selection steps were repeated with all of the 
microcolumns in parallel. Following the completion of the elution step after the 
second cycle, each RNA sample was extracted, precipitated, and re-suspended in 20 
µL of DEPC-treated water and processed for the next selection cycle. Two more 
RAPID “dual-cycles” (one Non-Amplification and one Amplification Cycle) were 
completed using the three microcolumns in parallel, decreasing the input material by 
20-fold after each amplification cycle (Cycle 3 and 5). 
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 The amplification and quantification of both the SELEX and RAPID pools 
were performed in the same way. All the resuspended samples and standards were 
reverse transcribed in 60 µL reactions with MMLV-RT and 30 pmol of Lib-REV 
primer. The cDNA samples were treated with RNaseH (Ambion) and a small amount 
analyzed on a LightCycler 480 qPCR instrument (Roche) to determine the amount of 
RNA that was recovered and to determine the optimal number of PCR cycles. 400 µL 
PCR reactions with 300 pmol of each primer were performed for each pool, followed 
by phenol:chloroform and chloroform extractions, and finally purified using DNA 
Clean & Concentrator (Zymo Research) spin columns. A small fraction (~1/4) of the 
purified PCR product was used to generate new RNA pools in 72 µL transcription 
reactions with T7 RNA polymerase. The template DNA was removed by DNaseI 
digestion and the resulting RNA pool was purified by phenol:chloroform and 
chloroform extractions and ethanol precipitation. 
 
High-throughput sequencing and analysis 
 A detailed description has been reported [30]. Briefly, PCR products from each 
target pool for various selection rounds were PCR amplified using 6 nt barcoded 
primers with adapters for the HiSeq 2000 (Illumina) sequencing platform. The 
barcoded PCR products were PAGE-purified, phenol:chloroform and chloroform 
extracted, ethanol precipitated, and then re-suspended in 10 mM Tris-HCl pH 7.5 
buffer.  High-throughput sequencing was performed by the sequencing core facility at 
Life Sciences Core Laboratories Center, Cornell University. After removing 
ambiguous and poor scoring sequences the remaining sequences were separated into 
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pools based on the barcode sequences. Then sequences with 85% sequence identity 
were clustered together. This identity threshold is set to ensure that truly unique 
sequences with 85% identity (or higher) are unlikely to be present even within our 
large library size (2.5×10
15
) due to the vast potential 70 nt random sequence space (4
70
 
= ~1.4×10
42
) and thus such detected sequences account for PCR and sequencing errors.  
The sequence with the highest number of reads, hereafter referred to as the sequence 
multiplicity, within each cluster was identified as the cluster’s true sequence and used 
as the representative sequence for that cluster.  The total multiplicity of a cluster was 
defined as the sum of multiplicities within the cluster.  All the representative 
sequences in each pool were sorted based on their multiplicity to identify candidate 
aptamers for each protein target.  The top 10,000 highest multiplicity sequences for 
each pool are available online. Sequence comparisons, histograms and scatterplots 
were performed and generated in MATLAB (Mathworks). 
 
Candidate sequence purification 
 The DNA templates for candidate aptamers were PCR amplified from the final 
Cycle 6 pool using Phusion Polymerase (NEB), the Lib-REV oligonucleotide, and an 
aptamer-specific oligonucleotide that spans the forward constant region and 
approximately 30 nt of the candidate’s unique, random region. The resulting PCR 
product was double-digested with BamHI and PstI, and ligated using low melt agarose 
“in-gel” ligation (EZ Clone Systems) into a similarly cut pGEM3Z-N70Apt plasmid. 
PGEM3Z-N70Apt plasmid was obtained by cloning a random full-length aptamer 
template from the N70 library together with T7 promoter into the pGEM3Z vector 
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(Promega) between NarI and HindIII sites. Three clones were sequenced to obtain a 
consensus for the full-length sequence of each candidate aptamer. The RNA aptamer 
was transcribed from the candidate’s DNA templates, which were generated by PCR 
from the sequenced plasmid using the same primers. 
 
Fluorescence EMSA and Polarization assays 
 The RNA samples were 3’-end labelled with fluorescein 5-thiosemicarbazide 
(Invitrogen) as described previously [36].  50 µL binding reactions were prepared with 
2 nM fluorescently-labelled RNA and decreasing amounts of protein (2000 to 0 nM) 
in binding buffer containing 0.01% IGEPAL CA630, 10 µg/ml yeast tRNA, and 3U of 
SUPERase•In RNase Inhibitor. Reactions were prepared in black 96-well half area 
microplates (Corning) and incubated at room temperature for 2 hours. The plates were 
scanned on a Synergy H1 microplate reader (BioTek) using the Ex: 485/20 Em: 
528/20 filter set to determine the Fluorescence Polarization (FP). The polarization P is 
determined from the total parallel and perpendicular polarized fluorescence according 
to: 





FF
FF
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||
||
  (1) 
For Fluorescence Electrophoretic Mobility Shift Assays (F-EMSA), the same samples 
used for the FP measurements were spiked with 6× loading dye and loaded into the 
wells of a refrigerated 5% agarose gel prepared with 0.5×TBE buffer. The gel was run 
for 90 minutes at 120 volts in refrigerated 0.5×TBE buffer. Images were acquired 
using the fluorescein scan settings on a Typhoon 9400 imager (GE Healthcare Life 
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Sciences) and the resulting bands were quantified with ImageJ. The dissociation 
constant, Kd, was determined by fitting the binding results, Y, from the FP and F-
EMSA to the Hill equation: 
n
d
MAX
X
K
YY
YY
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
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
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1
0
0   (2) 
where YMAX is the maximum signal from binding, Y0 is background, n is the Hill 
coefficient, and X is the protein concentration. 
 
RESULTS 
SELEX versus RAPID 
 Traditional SELEX is performed with a random library via iterative cycles of 
sequential steps (binding, partitioning, and amplification of target-bound sequences) 
until an aptamer emerges. To improve the efficiency of these selections, we developed 
and tested a hybrid selection scheme between SELEX and Non-SELEX that utilizes 
two cycles; one that includes amplifications and one which does not.  For simplicity, 
we differentiate these two cycles as Amplification and Non-Amplification Cycles 
(Figure 3.1.A). By systematically eliminating certain amplification steps, RNA 
selections can be performed in much less time, and require less reagents and other 
costly materials. In addition, removing unnecessary amplification steps minimizes 
their potential biases [24,37] and also reduces large input libraries and pools to more 
convenient size scales when performing amplifications. Thus, rapid sequence 
convergence can be obtained via Non-Amplification Cycles, while diverse sequence 
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populations with high aptamer copy numbers are maintained through critical periodic 
Amplification Cycles.  
 To illustrate the validity of the RAPID method for RNA aptamer selections, we 
compared the simplest RAPID protocol (a single non-amplification cycle followed by 
an amplification cycle) to conventional SELEX (amplification at every cycle).  
Representative timelines for two cycles of RAPID and conventional SELEX 
conducted with the exact same selection conditions are shown in Figure 3.1.B. 
Completion of one cycle of conventional SELEX takes about 24 hours, over 80% of 
which is needed for the amplification step. In contrast, by adding one Non-
Amplification Cycle, RAPID completes two selection cycles in nearly the same 
amount of time. For both methods, we define a selection “round” to necessarily 
include the amplification steps. In this way, a round of RAPID is comparable in time 
and effort to a round of SELEX; a round and a cycle are interchangeable terms in 
conventional SELEX. 
 To evaluate the advantage of using RAPID, we completed six selection cycles 
on the same set of targets using both the RAPID and conventional SELEX methods. 
As shown in Figure 3.1.C, SELEX took a total of 255 hours using the optimal 
parameters for aptamer enrichment on the microcolumns as determined in our 
previous work [30]. RAPID took only 84 hours to complete the three rounds with six 
selection cycles (Figure 3.1.C).  However, different parameters were used to allow for 
the completion of two selection steps within one working day (i.e. a 10 hour time 
period).  With this simple design, RAPID was straightforward to execute and took one 
third the time to complete as SELEX.  If the same selection step parameters were used 
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Figure 3.1. RNA Aptamer Isolation via Dual-cycles (RAPID). (A) Diagram of the RAPID 
process. The starting library or the enriched pool from the previous selection step can either go 
through the (inner) Non-Amplification Cycle and be used immediately in the next selection or 
go through the regular (outer) Amplification Cycle. (B) An example of processing times for 
SELEX and RAPID to complete two full selection cycles. Each selection is indicated with 
black blocks and arrowheads (▼) on top. (C) The total time required to complete six cycles of 
SELEX under optimal enrichment conditions, and six cycles of RAPID performed by 
alternating between Non-Amplification and Amplification Cycles; each colored block 
represents the total processing time between amplification steps. Asterisks (*) indicate the 
enriched and amplified pools that were analyzed via high-throughput sequencing. 
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for both processes, RAPID would have been completed in half the time needed for 
SELEX (Figure 3.1.B). 
 
Ensemble binding of enriched aptamer pools  
 To monitor the progress of the selections, the recovery of bound RNA during 
each selection step was measured using quantitative PCR (qPCR). Figure 3.2.A shows 
the results for all six SELEX cycles to the Empty, UBLCP1 and CHK2 microcolumns. 
An increase in the fraction of bound RNA was observed from cycle to cycle for all 
three samples. The empty microcolumns generally bound an amount of RNA 
comparable to that bound to the microcolumns containing the two protein targets. This 
is because nearly all the recovered sequences in early selection cycles represent 
background and non-specific binding sequences. However, the two protein targets 
show higher recoveries than the Empty microcolumn, with the CHK2 target 
demonstrating the highest levels for the later cycles.  Figure 3.2.B shows the results 
for all six cycles of RAPID to the same three targets. The recovery of the aptamer 
library with the RAPID method showed fluctuations from cycle to cycle that we 
believe are characteristic of the varying input concentrations since the total amount of 
material available following a Non-Amplification Cycle (1, 3, and 5) is lower 
compared to that following an Amplification cycle.  This effect causes an increase in 
the recovery observed during the Amplification cycle. Despite these concentration 
induced fluctuations, CHK2 consistently showed the higher recovery of the two 
protein targets. 
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Figure 3.2. Binding of RNA after each selection cycle. (A) Percent RNA recovery for 
SELEX cycles for Empty (orange circles), UBLCP1 (red squares), and CHK2 (blue triangles) 
microcolumns. In this mode, there is a clear distinction between the protein-bound and the 
Empty microcolumns. (B) Percent RNA recovery for RAPID cycles for the same targets. In 
this mode, there are significant increases in the percent aptamer recoveries following 
selections with non-amplified pools at Cycles 2, 4, and 6, followed by a concentration induced 
drop with the amplified pools at Cycles 3 and 5. (C) Test of enriched pool binding to CHK2 
protein preparation. F-EMSA shows the progression of bulk binding affinity increase for both 
SELEX and RAPID enriched pools with the RAPID Cycle 6 pool showing higher bulk 
binding than the SELEX Cycle 6 pool. 
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To evaluate improvements in target binding, Fluorescence Electrophoretic 
Mobility Shift Assays (F-EMSA) were performed with the initial random library and 
five enriched pools from the selection cycles for the CHK2 protein: RAPID cycle 2, 
SELEX cycle 3, RAPID cycle 4, SELEX cycle 6, and RAPID cycle 6.  For each pool, 
the percent of input RNA that was bound at the highest protein concentration and the 
apparent ensemble dissociation constant, Kd-app, were calculated.  The latter was 
determined by fitting the F-EMSA data to the Hill equation.  The results shown in 
Figure 3.2.C indicate a general improvement in bulk affinity and an increased pool 
binding fraction at later cycles.  The input library had a Kd-app value greater than 1 µM, 
with 59% of input RNA bound.  For SELEX, the Cycle 3 pool had a Kd-app = 315±26 
nM (69% bound) while the Cycle 6 pool had Kd-app = 281±24 nM (86% bound). For 
RAPID, the Cycle 2, 4, and 6 pools had Kd-app values of 390±34 nM (65% bound), 
209±19 nM (72% bound), and 191±7 nM (87% bound), respectively.  Across the 
cycles, the fraction of bound RNA increased monotonically from 59% for the starting 
library to 87% for the RAPID cycle 6 pool. In addition, the RAPID Cycle 6 pool 
showed a slightly higher bulk affinity for the protein than the SELEX Cycle 6 pool, 
which suggests that RAPID was enriching pools comparably to SELEX. 
 
Population distributions from high-throughput sequencing analysis of selection pools 
 High-throughput sequencing was performed on selected pools to identify 
candidate aptamers and to compare the cycle-to-cycle enrichments of specific 
sequences from both the RAPID and conventional SELEX pools.  As indicated in 
Figure 3.1.C, the four SELEX pools for Cycles 3, 4, 5, and 6 and all three of the 
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amplified RAPID pools were sequenced. Because the total number of sequencing 
reads for each pool varied between 5.6 and 9.4 million reads, the multiplicity of each 
sequence (number of times each sequence appeared) was normalized to 10
7 
reads. We 
chose to analyze the sequences with the highest multiplicity (top 10,000) from each 
pool, because this was sufficient to cover 10-20% of the total sequence reads from the 
Cycle 6 pools. The top 10,000 sequences for each pool are plotted as a histogram to 
compare the population distributions for each of the RAPID and SELEX pools in 
Figure 3.3.A and 3.3.B, respectively. The histograms clearly show the convergence of 
the protein targets’ sequences toward higher multiplicities at higher cycle numbers. As 
expected, there was minimal increase in multiplicity observed in the Empty columns 
which is consistent with the notion that RNA molecules bind randomly and non-
specifically to the Empty column without enriching any specific RNA sequence. 
Overall, the two methods appear to be converging sequences at similar rates 
suggesting that RAPID’s Non-Amplification cycles perform comparably to SELEX 
cycles. A quantitative comparison shows that the RAPID pools are actually more 
converged than the SELEX pools (Figure 3.4). 
 
Multiplicity versus Cycle 4 to Cycle 6 enrichments 
 To further investigate and compare the evolving RNA pools obtained with 
RAPID and SELEX, the enrichments of individual sequences were calculated from the 
ratio of multiplicity values from two cycles [17].  The multiplicity values for the top 
10,000 sequences in Cycle 6 were plotted versus their corresponding enrichment 
values from Cycle 4 for both selection methods (Figure 3.5).  For both protein targets,  
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Figure 3.3. Sequence multiplicity distributions for various cycles of SELEX and RAPID. 
(A) Distributions of the top 10,000 Empty, UBLCP1 and CHK2 sequences for SELEX Cycles 
3 to 6. (B) The same Sequence multiplicity distributions of RAPID Cycles 2, 4 and 6 for the 
same targets.  
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Figure 3.4. The similarity between RAPID and SELEX pool distributions. For each target, 
similarity between pools is determined by calculating the percent overlap of each RAPID 
cycle’s distribution with each SELEX cycle’s. The highest valued SELEX cycle against a 
given RAPID cycle is considered to be most similar to the given RAPID cycle. For both 
protein targets, the RAPID pools Cycle 2 and 4 distributions are most similar to the “later” 
SELEX Cycle 3 and 5 distributions, respectively. For the Empty columns, the overlap values 
are close to 100% between all of the pools confirming that there was negligible sequence 
convergence beyond the initial library within the Empty column’s pools. 
 
these two metrics were well correlated.  However, the RAPID pools (Figure 3.5.D and 
3.5.F) have higher multiplicities at equivalent enrichments than the SELEX pools 
(Figure 3.5.C and 3.5.E), and more of the top enriched sequences were identified in 
Cycle 4 of RAPID. In the RAPID pools, UBLCP1 and CHK2 had 6,565 and 5,063 
sequences, respectively, in common between the Cycle 4 and 6 pools’ top 10,000 
sequences. For comparison, in the SELEX pools, UBLCP1 and CHK2 had 3,281 and 
3,262 sequences, respectively, ranking in the top 10,000 of both pools. Thus, the 
RAPID pools have almost twice as many preserved sequences between cycles over 
SELEX, which is consistent with the improved convergence and enrichment data. In 
contrast, Figures 3.5.A and 3.5.B show that the Empty column had very few sequences 
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Figure 3.5. The relationship between sequence multiplicity and enrichment. (A and B) 
Scatter plots of sequences’ multiplicity and enrichment within the top 10,000 highest 
multiplicity sequences from Cycle 6 of SELEX and RAPID for the Empty microcolumns. 
Multiplicity values have been normalized to counts per 10
7
 and enrichment is calculated as the 
ratio of Cycle 6 multiplicities to Cycle 4 multiplicities for any sequence found in both pools. 
Some data points are obscured due to overlapping values. (C and D) Scatter plots of sequences’ 
multiplicity and Cycle 4-to-Cycle 6 enrichment within the top 10,000 highest multiplicity 
sequences from Cycle 6 of UBLCP1 SELEX and RAPID. (E and F) Scatter plots of sequences’ 
multiplicity and enrichment within the top 10,000 highest multiplicity sequences from Cycle 6 
of CHK2 SELEX and RAPID. RAPID sequences show significantly higher multiplicities at 
lower enrichments than SELEX. 
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in both pools with only 4 in SELEX and 8 in RAPID. In addition, the majority of the 
Empty-column sequences had enrichment values less than one between the two cycles, 
which is expected if the binding and copy number for those sequences is random.  
 
Independent RAPID and SELEX enrich identical sequences. 
 A closer examination of the sequencing results for the two Cycle 6 pools of 
each protein revealed identical sequences that had achieved very high multiplicities in 
both RAPID and SELEX.  Among the top five candidates, UBLCP1’s highest- 
ranked sequence in RAPID was ranked fifth in SELEX and its top-ranked sequence in 
SELEX was ranked third in RAPID (Figure 3.6.A). Furthermore, the top-ranked 
CHK2 sequence in RAPID was also the top ranked sequence in SELEX (Figure 3.6.B). 
This analysis was done using the entire random region of each candidate (i.e. not a 
short sequence motif), so each sequence represented the identical sequence that was 
selected from the 5×10
15
 random sequence library using RAPID and SELEX.  
 To extend this analysis, we searched for additional sequences common to each 
target’s RAPID and SELEX Cycle 6 pools and found that many sequences among 
their top 10,000 were common and highly represented in both methods. Scatter plots 
relating the multiplicities of sequences represented in both pools are shown in Figures 
3.6.C and 3.6.D. In total, we found 687 sequences that were common in both UBLCP1 
pools, and 1317 sequences that were common in both CHK2 pools. Analysis for the 
Empty column yielded only a single common sequence with negligible multiplicities. 
It is difficult to prove that identical sequences identified in multiple selections are not 
the result of cross-contamination between simultaneous side-by-side selections;  
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Figure 3.6. Relationship of the SELEX and RAPID selected sequences in Cycle 6 pools. 
(A and B) The first 40 random bases of the top 5 UBLCP1 and CHK2 sequences from Cycle 6 
in RAPID (top) and SELEX (bottom). Identical sequences between both methods are 
highlighted with matching colors. The ranks of each sequence at earlier cycles (4, 5 and 6) are 
also shown. (C) A scatter plot of the 687 common sequences for UBLCP1 in SELEX and 
RAPID Cycle 6 pools; the dashed line represents a 1:1 correlation between multiplicities in 
the two pools. (D) The same analysis for CHK2 yielded 1317 common sequences. On average, 
RAPID pools were enriched above SELEX pools. 
 
however, RAPID and SELEX were performed independently of each other at different 
times making contamination between methods unlikely. In addition, almost all of the 
common sequences were unique to each target (Figure 3.7) and most appeared more 
highly enriched in the RAPID Cycle 6 pools. On average, the RAPID selected 
sequences represented higher fractions of their pools having enriched approximately 
3-fold more than from SELEX: UBLCP1 by a factor of 2.6 ⋇ 2.3 (1.1 – 6.0-fold) and  
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Figure 3.7. Sequences that are common to both UBLCP1 and CHK2 selected RAPID 
Cycle 6 pools. Of the 2004 sequences of interest (687 and 1317 sequences common between 
Cycle 6 of RAPID and SELEX pools for UBLCP1 and CHK2, respectively), only 8 of them 
were also common between the two target pools. This is likely due to a trace cross-
contamination and strongly suggests that the unique sequences in each pool are target specific. 
 
CHK2 by a factor of 2.8 ⋇ 2.2 (1.3 – 6.2-fold). These were determined by finding the 
geometric mean and standard deviation for the enrichments, thus the enrichments and 
their standard deviations are expressed as multiplicative factors. 
 
Aptamer binding to CHK2 protein 
 The sequence for CHK2 identified as the top-ranked one in both selection 
methods, hereafter referred to as C6M1, was tested for its binding affinity to CHK2.  
After C6M1 was isolated from the Cycle 6 pools, it was labeled with fluorescein, and 
then evaluated via the Fluorescent Electrophoretic Mobility Shift Assay (F- 
121 
 
 
Figure 3.8. Binding test of the CHK2 protein prep’s highest multiplicity Cycle 6 aptamer 
candidate C6M1. The sequence is given by the two flanking constant regions, and the 
random region: 
GATCGGTTCCAACGCTCTGTCGCCTAAGTGAACAGATGAAGAAAAAATAGCCCAA
TAAGAGGCAACAATCT . (A) Gel image of F-EMSA for C6M1 aptamer incubated with no 
protein or the CHK2 protein prep ranging from 1.4 nM to 2000 nM, in 1.5-fold increments. (B) 
Binding curves for C6M1 using F-EMSA and FP. The left axis shows the calculated fraction 
bound from F-EMSA (solid line, black circles), while the right axis shows the fluorescence 
polarization from C6M1 (dotted line, white circles). The fitted Kd for the two curves are 
180±13 nM and 299±53 nM, respectively 
 
EMSA). Figure 3.8.A shows an image of the resulting gel shift assay. The fraction of 
bound RNA was evaluated from the gel image and plotted as the filled symbols in 
Figure 3.8.B.  The solid line fit to the data was done using the Hill equation which 
yielded a Kd value of 180 ± 13 nM. In order to ensure that the observed binding was 
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Figure 3.9. Fluorescent polarization binding assays of bulk SELEX pools to CHK2. The 
fitted Kd’s for the Cycle 3 and Cycle 6 pools are higher than F-EMSA (Fig. 2). All of the 
tested pools and C6M1 have calculated dissociation constants 1.6-fold higher when measured 
from fluorescence polarization compared to F-EMSA.  
 
not a gel artifact, a Fluorescence Polarization (FP) assay was also performed. The 
polarization results and curve fit are shown as the open symbols and dashed line in 
Figure 3.8.B. The calculated Kd is 299 ± 53 nM, which is 1.6-fold higher than 
determined with F-EMSA. This factor is consistent with other FP assays performed on 
some of the labeled bulk SELEX pools (Figure 3.9). Currently, we have not ruled out 
potential aptamer binding to a contaminant in our protein preparation. If this were the 
case, given the purity of our preparations, the binding affinity of C6M1 would be 
underestimated by at least an order of magnitude and thus the approximate Kd value 
would be less than 20 nM. However, for the purposes of this manuscript, the results 
and conclusions of this work remain the same in either case. 
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DISCUSSION 
 RAPID SELEX is capable of isolating aptamers in less time than conventional 
SELEX. Standard binding assays with the amplified pools clearly revealed cycle-to-
cycle affinity enrichment for two protein targets, CHK2 and UBLCP1, using both 
RAPID and conventional SELEX.  Further, higher affinities and total binding to 
CHK2 were observed for pools from later selection cycles. We found that the two 
Cycle 6 pools bound with comparable affinity, although the RAPID pool bound 
slightly better (~1.5-fold higher). Even though the RAPID selections were not 
performed with the optimal conditions used in SELEX, this suggests that the Non-
Amplified RAPID pools did not suffer in performance compared to the SELEX pools, 
which would support the use of RAPID in many if not most selection strategies.  
 As with the binding affinities, we found that despite having half the 
amplification steps as SELEX, the RAPID pools had slightly more converged 
sequence distributions. This is in good agreement with the ordered binding curves 
mentioned above, which suggested that the RAPID pools should have slightly more 
converged distributions. This is in fact what we observed (Figure 3.3 and 3.5), and 
recalling our definition of a selection “round” that necessarily includes amplification 
steps, we found that one RAPID round was most similar to three SELEX rounds in 
terms of convergence (Figure 3.4). Similarly, two RAPID rounds yielded convergence 
similar to five SELEX rounds. This is particularly noteworthy since we found that our 
top candidate aptamers had acquired their high rankings after just two rounds of 
RAPID (four cycles). 
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 Finally, we found that among the top 10,000 ranked Cycle 6 sequences from 
both selections, a large percentage (7% and 13%) were identical.  This kind of 
reproducibility from different SELEX experiments has been addressed before; 
however, in this past study, sequencing was done at much less depth (less than 100 
clones) and the identified aptamers generally contained short motifs which were 
determined to be highly represented in starting pools [38]. We found no sequence 
motifs in any of our pools and therefore restricted our analysis to the entire sequence 
of the ~70 nt random region.  Independent enrichment of the identical rare sequences 
(~1 in 10
15
) in both selection methods demonstrate the effectiveness and the 
robustness of our selection protocols. However, in further support of RAPID, we 
found that among those identical sequences, the great majority were more enriched an 
average of ~ 3-fold, in the RAPID Cycle 6 pools over the SELEX pools. As mentioned 
previously, the top aptamer candidates were actually resolved by Cycle 4 in both 
selections. This reflects the power of high-throughput sequencing for identifying 
enriching aptamers with great sensitivity many cycles before complete convergence. 
From these data, we chose to isolate our best candidate aptamer for CHK2, C6M1, and 
showed that the raw aptamer was indeed able to bind to its target. Further development 
and characterization of CHK2 and UBLCP1 specific aptamers is beyond the scope of 
this work and therefore not fully investigated. However, RAPID was able to generate 
the same results as SELEX in only one third the time. 
 In addition to specific protein binding results, we studied the impact that the 
empty microcolumns and downstream processing had on the selections.  Interestingly, 
we noticed that the empty microcolumns generally bound a comparable amount of 
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RNA as the two protein targets (Figure 3.2). This is not surprising because aptamers 
are assumed to be rare in the starting library; nearly all the recovered sequences in an 
initial selection represent background and non-specific binding sequences. Despite this, 
there was negligible sequence convergence from cycle to cycle (Figure 3.3). The 
collective set of high-throughput sequencing results for the Empty microcolumns also 
suggest that there was negligible sequence bias in the starting library [17] as well as 
negligible contributions from the microcolumns and the enzymatic processes (PCR, 
transcription, etc.) to the overall sequence enrichment in the two protein target pools 
[24].  
 While we demonstrated RAPID using the simple pairing of one Non-
Amplification Cycle followed by one Amplification Cycle, the efficiency of RAPID 
may be further improved. In general, more Non-Amplification Cycles can be 
performed between Amplification Cycles, though the number will be limited by 
practical considerations. Non-Amplification Cycles have the potential to significantly 
increase the efficiency of selections through the rapid accumulation of affinity 
enrichments in a short period of time. However, despite higher binding efficiencies, 
this process also depletes the population of high affinity sequences. Assuming (or 
requiring) a minimum binding probability, PA, for a population of aptamers, the 
number of Non-Amplification cycles can be increased as long as an acceptable copy 
number of high affinity aptamers, Nmin, is estimated to always be present before each 
cycle (Nmin should be chosen such that Nmin ≥ (PA)
-1 
so that at least one copy of an 
aptamer is expected to remain after the last cycle). This can be expressed as: 
  1min


i
AA PNN   (3) 
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where NA is the initial (or amplified pool’s) copy number of the aptamer population 
and i-1 is the maximum number of Non-Amplification Cycles, with the i
th
 cycle being 
an Amplification Cycle which must be done to replenish the pool’s sequence 
populations. In addition, each Non-Amplification Cycle decreases the input material 
for the subsequent cycle which may result in increased binding fractions and reduced 
enrichment yields, diminishing the practicality of continued Non-Amplification Cycles. 
Using a simple measurement of total binding, the number of Non-Amplification 
Cycles can be increased as long as an acceptable enrichment, Emin, of high affinity 
aptamers is estimated to have resulted after each cycle. This can be expressed as: 
),(
min
inP
P
E
B
A   (4) 
where PB(n,i) is the background binding probability at the n
th
 total selection cycle with 
i cycles since the last amplification. If this expression ever proves false, amplification 
of the pool can be used to increase the concentration and selection stringency to 
improve future enrichments.  
 Together, the above two expressions place upper limits on the total number of 
Non-Amplification cycles that can be performed between Amplification Cycles, and 
maximizes the potential efficiency of RNA selections. Applying these expressions to 
our simple RAPID protocol required a minimum binding probability for aptamer 
candidates of about 40% (to ensure 1 copy survives the first round) which is typical of 
binding efficiencies demonstrated on our microcolumns [30]. Taking into account the 
amount of amplification and the measured background binding over the six cycles, our 
highest candidates should represent between 1 in 100 -1000 sequences. In fact our top 
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candidates are represented in the middle of this range. Altogether, our results make a 
compelling case for RAPID both in its efficiency, and its cycle-to-cycle performance. 
 Although we used our microcolumn-based processes to perform all selections, 
RAPID may be used in combination with any selection mode or technology to save 
time, reagents, and to rapidly converge selected pools. RAPID could be particularly 
useful for slow selections requiring many cycles, or when complete sequence 
convergence is needed so that conventional cloning methods can be used to identify 
candidates. Although the time-saving benefits would be less compared to RNA-based 
selections, RAPID can also be extended to DNA selections. We used high-throughput 
sequencing to quantify selected pools as described by histograms of converging 
multiplicities, and scatter plots of sequence enrichments and identical sequences 
derived from two independent selection methods. Similar detailed analyses could be 
used to gain higher confidence in aptamer candidates through replicate selections, or 
to make more quantitative evaluations of different selection schemes and technologies. 
In particular, with a standardized pool and target, these analyses could be used to 
objectively rank, compare, and optimize different selection techniques.  
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CHAPTER 4 
HIGH-THROUGHPUT BINDING CHARACTERIZATION OF RNA 
APTAMER SELECTIONS USING A MICROPLATE-BASED MULTIPLEX 
MICROCOLUMN DEVICE
‡
 
 
ABSTRACT  
 We describe a versatile 96-well microplate-based device that utilizes affinity 
microcolumn chromatography to complement downstream plate-based processing in 
aptamer selections. This device is reconfigurable and is able to operate in serial and/or 
parallel mode with up to 96 microcolumns. We demonstrate the utility of this device 
by simultaneously performing characterizations of target binding using five RNA 
aptamers and a random library. This was accomplished through 96 total selection tests. 
Three sets of selections tested the effects of target concentration on aptamer binding 
compared to the random RNA library using aptamers to the proteins green fluorescent 
protein (GFP), human heat shock factor 1 (hHSF1, and negative elongation facto E 
(NELF-E). For all three targets, we found significant effects consistent with steric 
hindrance with optimum enrichments at predictable target concentrations. In a fourth 
selection set, we tested the partitioning efficiency and binding specificity of our three 
proteins’ aptamers, as well as two suspected background binding sequences, to eight 
targets running serially. The targets included an empty  
                                                 
‡The following sections are reprinted with permission from: Szeto, K., Reinholt, S.J, Duarte, F.M., 
Pagano, J.M., Ozer, A., Yao, L., Lis, J.T., and Craighead, H.G. 2014. High-throughput Binding 
Characterization of RNA Aptamer Selections using a Microplate-based Multiplex Microcolumn Device. 
Analytical and Bioanalystical Chemistry. 406(11) pp2727-2732, doi: 10.1007/s00216-014-7661-7, with 
modifications to conform to the required format. 
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microcolumn, three affinity resins, three specific proteins, and a non-specific protein 
control. The aptamers showed significant enrichments only on their intended targets. 
Specifically, the hHSF1 and NELF-E aptamers enriched over 200-fold on their protein 
targets, and the GFP aptamer enriched 750-fold. By utilizing our device’s plate-based 
format with other complementary plate-based systems for all downstream biochemical 
processes and analysis, high-throughput selections, characterizations, and optimization 
were performed to significantly reduce the time and cost for completing large-scale 
aptamer selections. 
INTRODUCTION 
Systematic Evolution of Ligands by EXponential enrichment (SELEX) is an in 
vitro selection method used to generate high affinity ligands for specific target 
compounds [1-3]. These selected molecules, called aptamers, are derived from large 
libraries of nucleic acids with random sequences through an iterative process of 
binding, partitioning, and amplification of sequences that bind to the target. This 
process enriches the initial random library for higher binding affinity sequences, and 
the cycle is repeated until the molecules in the enriched pools converge on the highest 
affinity sequence. Since this method was first introduced, aptamers have become 
valuable tools in biotechnology, diagnostics, and therapeutics [4].  
There is interest in improving SELEX technology to obtain highly specific 
aptamers much more rapidly. However, despite their potential, many technologies are 
difficult to scale for multiplexed or parallel selections. For example, Park et al. and 
Ahn et al. used microfluidic sol-gel devices that could utilize up to five targets for 
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multiplexing [5,6], but currently, no large-scale microfluidic selections have been 
demonstrated. Large-scale parallel selections have been done with microplate 
technologies, which are of particular interest due to the availability of protocols and 
automated liquid handling devices [7,8]. However, in contrast to microfluidic devices 
that utilize flow and other dynamic behavior, most of these selections rely on 
traditional equilibrium solution binding [9] or interactions with target molecules that 
are bound or adsorbed to the plate surface [10,11]. 
Despite advances toward more sophisticated and automated SELEX, little has 
been done to characterize and optimize new or current technologies and recent binding 
studies show significant discrepancies with existing theory [12,13]. Therefore, 
empirical methods have been used to optimize selection conditions and aid the 
development of new models [14]. As new high-throughput technologies emerge, these 
studies will become even more important in order to obtain the most effective and 
robust selections under the available parameters. 
To address these issues, we have developed a high-throughput device called 
Microplate-based Enrichment Device Used for the Selection of Aptamers (MEDUSA). 
This device is designed around a 96-well microplate format, which not only allows for 
high-throughput selections, but also complements existing plate-based methods and 
technologies for sample handling and has the potential for automation. MEDUSA is a 
substantial expansion of our previously reported modular and multiplexable 
microcolumns, which achieve non-equilibrium selections by utilizing dynamic flow 
rates shown to optimize the enrichment of aptamers [13]. We demonstrate the use of 
MEDUSA by performing 96 simultaneous selection tests to characterize the binding of 
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a number of RNA aptamers against various targets. In total, the characterization tests 
performed on MEDUSA shed light on the critical binding behaviors of specific and 
background binding aptamers that fundamentally limit the performance and sensitivity 
of solid-phase affinity selections. 
 
MATERIAL AND METHODS 
Preparation of recombinant protein targets 
Recombinant proteins were expressed in BL21(DE3)-RIPL E. coli cells 
(Agilent Technologies) transformed with plasmids that encode for hexahistidine-
tagged GFP, Drosophila NELF-E, and UBLCP1, or GST-tagged hHSF1 (Table 4.1). 
Two or four liter LB cultures supplemented with 100 μg/mL ampicillin were 
inoculated with starter LB culture derived from a single colony and grown at 37°C 
until the OD600 reached approximately 0.6. Protein expression was induced by the 
addition of IPTG to a final concentration of 1 mM. After an additional incubation, 
bacteria were collected by centrifugation and the resulting pellet was processed 
according to the manufacturer’s instructions for Ni-NTA Superflow (Qiagen) or 
Glutathione-agarose (Thermo Scientific) resins. SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) was used to verify the purity and quality of the final 
protein product. Resulting protein preps were dialyzed against 1× PBS (supplemented 
with 5 mM 2-mercaptoethanol and 0.01% Triton X-100) and stored in small aliquots 
after addition of glycerol to a final concentration of 20%. NELF-E was prepared 
slightly differently [15]. 
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Table 4.1. Properties of the target proteins 
Protein Molecular 
Weight (kDa) 
Isoelectric 
Point 
Affinity tag 
GFP 27 5.5 Hexahistidine (N-terminus) 
 hHSF1  86 5.3 GST* (N-terminus) 
NELF-E 36 8.9 Hexahistidine (N-terminus) 
UBLCP1 37 6.1 Hexahistidine (N-terminus) 
                   *GST tag ~ 30 kDa 
 
Protein immobilization on affinity resins 
Nickel-nitrilotriacetic acid (Ni-NTA) Superflow or glutathione-agarose (GSH) 
resins were extensively washed with binding buffer [10-mM N-2-
hydroxyethylpiperazine-N′-ethanesulfonic acid −KOH pH 7.6, 125-mM NaCl, 25-mM 
KCl, 5-mM MgCl2, and 0.02% Tween-20]. Hexahistidine- or GST-tagged proteins 
(see Table 4.1) were immobilized at the desired concentrations onto the washed resin 
in 10% slurry with binding buffer and incubated at 4°C with constant mixing for 1 h.  
 
RNA library and aptamers 
The random RNA library used in the experiments, hereafter referred to as N70 
library, contains ∼5×1015 sequences of 120-nucleotide (nt) RNA molecules and was 
prepared as described previously [13]. This library consists of a 70-nt random region 
flanked by two constant regions. Green fluorescent protein (GFP)-, human heat shock 
factor 1 (hHSF1)- and negative elongation factor E (NELF-E)-binding aptamers, 
GFPapt, HSFapt, and NELFapt, as well as the background binding sequences (BBSs), 
BBS1 and BBS2, were all derived from previous multiplex SELEX experiments 
[13,15-17]. HSFapt was previously identified as hHSF2-R5-2 using the N70 library 
and characterized elsewhere [13]. NELFapt was previously identified as Napt1 using 
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the N70 library [15]. The background binding sequences BBS1 and BBS2 were 
identified in several previous multiplex SELEX experiments using the N70 library for 
dozens of target proteins [13,15,16]. The GFP-binding RNA aptamer, GFPapt, used in 
this work was selected using a different library with a smaller random region and 
different constant regions; and was previously identified as AP3-1 [17]. 
The 84-nt GFP-binding RNA aptamer has the following sequence: 5’-
AGCUUCUGGACUGCGAUGGGAGCACGAAACGUCGUGGCGCAAUUGGGU
GGGGAAAGUCCUUAAAAGAGGGCCACCACAGAAGCU-3’. The forward and 
reverse oligos used for qPCR analyses were GFPapt-FOR: 5’-
GCTTCTGGACTGCGATGGGAGCA-3’ and GFPapt-REV: 5’-
GCTTCTGTGGTGGCCCTCTTTTAAGGACT-3’.  
The 117-nt hHSF1-binding RNA aptamer has the following sequence: 5’-
GGGAAUGGAUCCACAUCUACGAAUUCAAUCAAGUCCCCAGACUCAGCAA
CACUGGACAGCGAUAUGCAGAUAACCAAGACCAAUUCACUCCAGUUCAC
UGCAGACUUGACGAAGCUU-3’. The two constant regions corresponding to the 
library design are denoted by underlines. The forward and reverse oligos used for 
qPCR analyses were HSFapt-FOR: 5’-AATCAAGTCCCCAGACTCAGCAACA-3’ 
and HSFapt-REV: 5’-CTGGAGTGAATTGGTCTTGGTTATC-3’.  
The 120-nt NELF-E-binding RNA aptamer has the following sequence: 5’- 
GGGAAUGGAUCCACAUCUACGAAUUCCCAACGACUGCCGAGCGAGAUUA
CGCUUGAGCGCCCCACUGAGGAUGCCCACGGGCGAUUGGGGCACGGCUU
CACUGCAGACUUGACGAAGCUU-3’ The two constant regions corresponding to 
the library design are denoted by underlines. The forward and reverse oligos used for 
138 
 
qPCR analyses were NELFapt-FOR: 5’-CCAACGACTGCCGAGCGAGATTAC-3’ 
and NELFapt-REV: 5’-GCCGTGCCCCAATCGCCCGTG-3’. 
BBS1 has the following sequence: 5’-
GGGAAUGGAUCCACAUCUACGAAUUCCGCAGGGCUAGCCGCAUGCUCAG
GCCUGGCGGGUAGGGAGUUAGGGUAGGGAGACCAGGAGAGCUGGCUUC
ACUGCAGACUUGACGAAGCUU-3’. The forward and reverse oligos used for 
qPCR analyses were BBS1-FOR: 5’-CGCAGGGCTAGCCGCATG-3’ and BBS1-
REV: 5’-GCCAGCTCTCCTGGTCTCC-3’.  
BBS2 has the following sequence: 5’-
GGGAAUGGAUCCACAUCUACGAAUUCCGAAGCUCGUGACGGUACCUCCU
AAAAUGUCCAUGGGGAAGGGAGGGAAUGGGAAGGACAAUCGGACACCG
UUCACUGCAGACUUGACGAAGCUU-3’. The forward and reverse oligos used for 
qPCR analyses were BBS2-FOR: 5’-CGAAGCTCGTGACGGTACC-3’ and BBS2-
REV: 5’-CGGTGTCCGATTGTCCTTC-3’.  
The N70 library forward and reverse oligos used for qPCR analyses were Lib-
FOR oligo: 5’-GATAATACGACTCACTATAGGGAATGGATCCACATCTACGA-
3’ and Lib-REV oligo: 5’-AAGCTTCGTCAAGTCTGCAGTGAA-3’.  
All of the oligos used in this work were obtained from Integrated DNA 
Technologies. 
 
Preparation of protein- and background-binding aptamers 
Sequence verified DNA templates for each one of the specific aptamers used in 
this study were transcribed using T7 RNA Polymerase. After transcription, the 
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samples were treated with DNase I (Ambion), PAGE-purified, phenol:chloroform and 
chloroform extracted, isopropanol precipitated, and then re-suspended in DEPC-
treated H2O. 
 
RNA selections and quantification 
For the sequence specificity-study with serially configured microcolumns, each 
triplicate of eight targets was exposed to 1 mL of a mixed RNA pool in binding buffer 
[4.75-nM N70 library, 50-pM GFPapt, 50-pM HSFapt, 50-pM NELFapt, 50-pM 
BBS1, 50-pM BBS2, and 10-µg/mL yeast tRNA (Invitrogen)]. Similarly for the 
protein concentration studies with parallel microcolumns, the mixed RNA pools 
consisted of 4.95-nM N70 library and 50-pM specific aptamer. The RNA pools were 
injected at a rate of 33 μL/min for 30 min with a 10 μL aliquot of each pool set aside 
and used as a standard for quantitative polymerase chain reaction (qPCR) analysis. All 
buffers and solutions were degassed prior to use and introduced into the microcolumns 
via programmable multichannel syringe pumps (Harvard Apparatus) with MEDUSA 
placed onto a 96-well format liquid waste reservoir. 
After binding to the library, the serially configured microcolumns were 
reconfigured to run in parallel by removing the caps and silicone layers permitting the 
connectivity of microcolumns, and reassembling the device with the appropriate caps 
for a parallel configuration. Each of the 96 microcolumns was then washed with 3 mL 
of binding buﬀer at a rate of 300 μL/min to remove unbound RNA. Finally, MEDUSA 
was placed directly onto a 2-mL 96-well microplate, and the RNA/RNA-protein 
complexes were eluted from the individual microcolumns by ﬂowing elution buﬀer 
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[binding buﬀer + 50 mM ethylenediaminetetraacetic acid (EDTA pH 8.0) for 
selections with Ni-NTA resin; binding buffer + 10 mM glutathione for selections with 
GSH resin; binding buffer + 10 mM maltose for selections with amylose-resin] at a 
rate of 50 μL/min for 12 min. The RNA elution samples and the input standards were 
phenol/chloroform-extracted and ethanol-precipitated together with 1 μL of 
GlycoBlue (Ambion) and 40 μg of yeast tRNA (Invitrogen), and the resulting pellet 
was resuspended in 20 µL of RNase-free water, and reverse transcribed with Moloney 
Murine Leukemia Virus Reverse Transcriptase (MMLV-RT) in two 96-well 
microplates. The N70 library, HSFapt, NELFapt, BBS1, and BBS2 all contain the 
same 3’ constant region and were reverse transcribed using Lib-REV primer 
complementary to the 3’ constant region in the RNA. For the experiments containing 
GFPapt, 4 µL of the resuspended pools and the standards were reverse transcribed 
using the GFPapt-REV primer specific to GFPapt. A 10-µL volume of each of the 
cDNA products was used for quantitative PCR analysis using 384-well plates on a 
LightCycler 480 instrument (Roche) to determine the amount of RNA library and of 
each specific aptamer that was recovered from each microcolumn. Diﬀerent sets of 
oligonucleotides (see above) were used to independently evaluate the amount of N70 
library and specific aptamers in each pool. 
 
Design and fabrication of MEDUSA 
MEDUSA was modeled after a 96-well microplate. The 96 units of our device 
were based off of our previously reported modular and mutliplexable affinity 
microcolumns, which were shown to minimize reagent consumption while 
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Figure 4.1. Diagram of the layers of MEDUSA in the order of assembly. (A) An exploded 
view of the customized device layers for configuring all 96 microcolumns to run in parallel. 
The flow path is shown in the lower boxed inset with no connections between microcolumns. 
The layers numbered 1 to 3 are the plastic layers: the middle layer (1) containing the 
microcolumns, the next outer two layers being the caps (2) and washers (3). The outermost 
layers (4) consist of inlet and outlet ports that are bonded to the final device. The two layers 
numbered (5) are silicone layers, which are bonded to the microcolumn layer (1) to hold 
porous frits against both sides of the microcolumns to retain affinity resin and to make liquid-
tight seals across the entire device. A photograph of MEDUSA assembled in parallel is shown 
in the upper inset. (B) The customized device layers for configuring 24 of the microcolumns 
to run in series. The two additional silicone layers (6) shown in blue, as well as the smaller 
complementary plastic layers (2 and 3) on the left, are specifically programed to connect three 
sets of eight microcolumns within the device. The flow path is shown in the lower boxed inset 
with microcolumns connected in series via a serpentine route through eight microcolumns. 
MEDUSA assembled to run in series and parallel is shown in the upper inset 
 
demonstrating significantly improved performances through optimizations of the 
selection parameters [13]. In order to allow for simple and versatile multiplexing and 
connectivity between microcolumns, our device was designed to be assembled in 
layers, with some of the layers “programed” for establishing connections within the 
device (see Figure 4.1). To fabricate the layers of MEDUSA, a two-dimensional CAD 
for each layer was designed and then cut using a CO2 laser at 10.6 µm (Universal 
Laser Systems, VersaLaser). The speed, intensity, and density of laser pulses were 
optimized for each layer to obtain the highest quality and most reproducible cuts. 
Each layer of MEDUSA was fabricated from either transparent biocompatible 
poly(methyl methacrylate) (PMMA) plastic or silicone. As seen in Figure 4.1.A (lower 
boxed inset), for parallelized microcolumns, there are 5 layers of plastic and 2 layers 
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of silicone as well as NanoPorts (IDEX Health and Science) for inputs and outputs on 
each side. The center most plastic layer (number “1” in Figure 4.1.A) is 1/2" thick and 
contains 96 microcolumns that each hold 10 µL of total volume. The next pair of 
layers (numbered “5” in Figure 4.1.A above and below the microcolumns) are 1/16” 
silicone layers for making a liquid tight seal across all 96 microcolumns. These layers 
contain 2 mm diameter holes for inserting porous polyethylene frits above and below 
each microcolumn to retain target-bound affinity resins, and have adhesive on one side 
for bonding to the microcolumn layer. The next pair of layers (numbered “2” in Figure 
4.1.A) are 1/4" plastic capping layers which have small holes and NanoPorts 
(numbered “4”) bonded around them to allow solutions to flow in and out of the 
microcolumns. The outer most plastic layers (numbered “3”in Figure 4.1.A) are 1 mm 
thick and designed to simultaneously aid the alignment of the NanoPorts to the 
capping layers, as well as to bear and distribute forces from the assembly of all the 
layers by acting as a washer. All of the layers contain 35 evenly-spaced holes, with the 
middle microcolumn layer being threaded, for sealing the device together with screws 
(Figure 4.1.A and 4.1.B upper inset photographs). For serialized microcolumns 
(Figure 4.1.B, lower boxed inset), the design and assembly is similar. However, there 
are 2 additional layers of silicone (numbered “6” in Figure 4.1.B). These layers are 
fabricated in 1/32” silicone (no adhesive) and are programed to allow for the 
connectivity of microcolumns through small interconnecting channels.   
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RESULTS AND DISCUSSION 
MEDUSA as an adaptable platform 
MEDUSA was designed for high-throughput aptamer selections and 
characterizations of the SELEX process, and for versatility, allowing any combination 
of serial and parallel experiments. Due to the availability of plate-based processes and 
the potential for automation, we designed our device using the standard 96-well 
microplate layout, which easily couples with a typical 96-well plate for further post-
selection sample processing. Furthermore, laser-cutting MEDUSA was ideal for rapid 
prototyping, requiring only 1 h to machine each device. For a universal device that 
does not necessitate customized plastic layers, a third layer of silicone could be used to 
similarly program the accessibility of all 96 possible input and output ports to the 
microcolumns. However, due to the inexpensive and rapid fabrication methods used, 
we decided instead to fabricate custom capping and washer layers that relay the same 
flow program by containing only the necessary input/output holes and NanoPorts. For 
the three sets of eight serialized microcolumns shown, this required only six 
holes/ports on the top layers and none on the bottom layers. This configuration also 
allowed for visual assessment of solutions flowing through the serialized 
microcolumns. The ease of fabrication for different programed parts, especially in thin 
silicone, allows for customized and versatile selections that can contain any number of 
parallel or serially connected microcolumns, as well as utilizing both configurations 
simultaneously. In cases where more than 96 microcolumns are desired, such as when 
96 targets each require negative selections, additional microcolumn layers can be 
utilized in the assembly. As illustrated, our device was fabricated to accommodate 
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three sets of eight serialized devices, as well as 72 parallel selections (Figure 4.1). This 
combination was easily programed as described above. However, an even greater 
degree of versatility was achieved by dividing the capping, washer, and programed 
silicone layers into separately fabricated subsections that could be individually 
addressed and reconfigured without disrupting other microcolumns. This strategy also 
suggests the possibility of fabricating smaller versions of MEDUSA that contain the 
same general layout of a microplate, but occupy a smaller footprint by utilizing fewer 
microcolumns. This would allow users to handle smaller devices in less demanding 
applications, while benefiting from the standardized spacing and addressability of 
plate-based selections and sample processing. 
 
Parallel selections reveal critical target concentration for aptamer enrichments 
In our previous work, we found that GFP aptamer enrichments were limited by 
a critical GFP concentration that we attributed to steric hindrance [13]. Using 
MEDUSA, we decided to reproduce the GFP results with more data points, and to 
investigate the prevalence of this limiting effect by performing analogous studies with 
two additional proteins, hHSF1 and NELF-E, and their respective aptamers, HSFapt 
and NELFapt [13,15]. For each protein target, we chose to test eight concentration 
conditions starting at 10 µg/µL of resin with 2.5-fold dilutions down to 0.016 µg/µL in 
triplicate. The layout for all the samples on MEDUSA is illustrated in Figure 4.2 in the 
sections denoted II, III, and IV. 
The binding results and enrichments for all three proteins are shown in Figure 
4.3. The GFP microcolumns recovered a higher percentage of GFPapt and a lower  
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Figure 4.2. Layout for the 96 targets on MEDUSA according to its analogous microplate 
position given by the rows A-H, and the columns 1-12. In section I, the 8 indicated targets 
were connected in series from A to H to test the specificity and partitioning efficiency of 
various RNA aptamers. This was tested in triplicate in columns 1 to 3. Sections II, III, and IV 
tested the effects of target surface concentration on aptamer enrichments. The colored triangles 
indicate decreasing concentrations of each protein from 10 µg/µL (row A) to 0.016 µg/µL 
(row H) in 2.5-fold dilutions. Section II (green triangle) aimed to confirm previous enrichment 
behaviors shown with GFP. Sections III and IV tested the same concentrations of the proteins 
hHSF1 (blue triangle) and NELF-E (red triangle) to assess the prevalence of target surface 
concentration effects on binding due to steric hindrance or other effects in other aptamer 
selections 
 
percentage of N70 library than those reported previously (Figure  4.3.A), due to lower 
flow rates that were used to increase HSFapt and NELFapt binding, since they have 
higher Kds. This resulted in an expected increase in the enrichment of GFPapt over the 
N70 library; however, the characteristic shape and optimal concentration of 0.6 µg/µL 
for the enrichment curve are the same as previously reported (Figure 4.3.D). With 
hHSF1, the recovery of HSFapt followed a more typical sigmoidal shape, which 
saturated at increasing concentrations of hHSF1 (Fig. 2B). Similarly, the enrichment 
of HSFapt over the N70 library increased steadily and then saturated at higher 
concentrations (Figure 4.3.E). It is interesting, however, that HSFapt enrichment  
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Figure 4.3 Recoveries and enrichments of specific RNA aptamers over the N70 library as 
a function of protein concentration. (A) The recovery of GFPapt and N70 library at various 
concentrations of GFP. Analogous data for the recovery of (B) HSFapt and N70 library from 
hHSF1, and (C) NELFapt and N70 library from NELF-E. (D-F) The calculated enrichments of 
the specific aptamers (GFPapt, HSFapt, NELFapt) over the random library. The error bars 
represent the standard deviation in recoveries or enrichments calculated for each condition 
performed in triplicate 
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plateaued at the optimal concentration for GFP. With NELF-E, there is a very clear 
NELFapt recovery optimum at this same concentration, with significant losses in 
recoveries at concentrations above 0.6 µg/µL (Figure 4.3.C). In addition, the recovery 
of the N70 library increased significantly above the optimum concentration for 
NELFapt, likely due to the fact that NELF-E contains an RNA Recognition Motif and 
can bind RNA non-specifically [15]. These two binding trends result in a drastic 
decrease in enrichment at higher concentrations of NELF-E, resulting in de-
enrichment of NELFapt at the highest concentration of 10 µg/µL (Figure 4.3.F). 
The three concentration studies with GFP, hHSF1, and NELF-E make a strong 
case for the general steric hindrance of target molecules that are over packed in solid-
phase affinity selections. Although the GFP and hHSF1 aptamer recoveries do not 
show drastic decreases at high concentrations as with NELF-E, this binding behavior 
is affected by the selection flow rates and is clearly seen between our old and new 
GFP data. Importantly, the recoveries saturated well below 100%, which indicates the 
existence of some limiting effect. Most revealing is NELF-E, where the binding site 
for NELFapt appears to be particularly inaccessible at high concentrations, causing a 
significant loss in total aptamer binding. Furthermore, a simple calculation (assuming 
hard spheres for the resin) predicts that a critical surface density of proteins should 
occur between 0.1 and 1 µg/µL (depending on protein shape and size and the diameter 
of the resin beads). Since all three proteins are similar in size, it is not surprising that 
we observe the same critical concentration of 0.6 µg/µL, and the results suggest that 
the target concentration may be the most limiting parameter for enriching aptamers.  
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Multiplex serial selections show specificity of target and background binding 
sequences 
Previously, we performed multiple partitions to input pools and libraries by 
connecting several microcolumns in multiplex selections [13]. In particular, we 
showed the highly specific and efficient partitioning of GFPapt to GFP over non-
specific proteins and an empty microcolumn. This configuration is useful for 
multitasking DNA or RNA libraries on multiple unrelated selection targets, or to 
separate enriched pools for aptamers that bind to distinct sites on a complex target [18]. 
We decided to demonstrate similar multiplex selections using MEDUSA by extending 
this analysis to include several additional RNA aptamers and protein targets: GFP, 
hHSF1, NELF-E, and their respective aptamers. To thoroughly characterize the 
specific, non-specific, and background binding of each RNA aptamer, we also 
included a non-specific protein, UBLCP1, three commonly used affinity resins, GSH, 
Ni-NTA, and amylose, and empty microcolumns. Each of the four protein targets were 
immobilized onto their respective resins at 0.6 µg/µL. The eight targets were arranged 
in series for the multiplex selection and performed in triplicate to quantify the 
reproducibility of each aptamer’s partitioning efficiency and specificity. The order of 
targets was as follows: empty, GSH, Ni-NTA, amylose, His-GFP, GST-hHSF1, His-
NELF-E, His-UBLCP1, and is illustrated in Figure 4.1 in section I. 
In addition to the random N70 RNA library and the aptamers to our three 
proteins, our test pool also included two suspected BBSs, BBS1 and BBS2. For all 
previous multiplex selections, we have performed high-throughput sequencing, which  
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Table 4.2. Frequencies of BBS1 and BBS2 in previous selections 
Resin BBS1 Dominant BBS2 Dominant 
Ni-NTA 1 7 
GSH 3 4 
Amylose 3 4 
Empty (no Resin) 0 2 
Summary of the number of times BBS1 or BBS2 has been identified in all previous selections. 
The numbers indicate the instances in which BBS1 was more highly enriched than BBS2 (or 
vice versa) on each target, grouped according to the resin on which each target was 
immobilized. 
 
provided tremendous amounts of sequence data and sensitivity for early detection of 
aptamers [13,15,16]. However, comparison of the sequencing results for dozens of 
targets revealed several identical sequences that were frequently enriched, particularly 
in earlier cycles before target-binding aptamers began to dominate the pool. This was 
especially true for less aptagenic targets, where the two sequences, BBS1 and BBS2, 
were generally among the highest enriched candidates (see Table 4.2). From these data, 
we predicted that BBS1 would enrich on all targets by binding to the plastic device 
and the resins. This was also predicted for BBS2; however, we expected BBS2 to 
enrich more strongly than BBS1 on all targets, especially in microcolumns containing 
Ni-NTA (similar analyses have been used to identify sequences that bind specifically 
to Ni-NTA [19]). 
The partitioning results for each RNA aptamer are shown in Figure 4.4 as 
enrichments over the random RNA library. Our specific aptamers each show striking 
enrichments only on their intended target. GFPapt enriched an average of 750-fold on 
GFP microcolumns, but only an average of 0.6-fold (de-enriched) on all other targets 
(Figure 4.4.A), which reflects its strong specificity for GFP. Similarly, HSFapt 
enriched an average of 232-fold on hHSF1 microcolumns, and only an average of 2- 
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Figure 4.4. The enrichment of RNA aptamers over the N70 library on various targets 
connected in series. The enrichment of each protein-specific aptamer, GFPapt (A), HSFapt 
(B), and NELFapt (C), and non-specific aptamers, BBS1 aptamer (D), and BBS2 aptamer (E), 
on all 8 microcolumns. The error bars represent the standard deviation in enrichments 
calculated for each target performed in triplicate 
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fold on all other targets (Figure 4.4.B). NELFapt enriched an average of 262-fold on 
NELF-E, and only an average of 1.6-fold for all other targets (Figure 4.4.C). 
For BBS1 and BBS2, we found good agreement with the qualitative analysis 
of all previous sequencing data [13,15,16]. BBS1 enriched on all targets as predicted; 
however, it enriched three times more in Ni-NTA-containing microcolumns (Ni-NTA, 
GFP, NELF-E, UBLCP1), with enrichments averaging 1.7 for non-Ni-NTA targets 
and 5.1 for the Ni-NTA targets (Figure 4.4.D). BBS2 also enriched as predicted, with 
enrichments higher than BBS1 on all targets (Figure 4.4.E). More specifically, BBS2 
enriched an average of 13-fold on non-Ni-NTA targets and a surprising 311-fold on 
Ni-NTA targets suggesting that BBS2 has a specific affinity for Ni-NTA. In fact, for 
the first Ni-NTA target in the serial selection, blank Ni-NTA, enrichment averaged 
almost 1,000-fold. This is almost 80 times greater than non-Ni-NTA targets, and may 
reflect more accurately the specificity of BBS2 for Ni-NTA. In support of this 
hypothesis, we noticed that BBS2 was quickly depleted from the pool as it was 
injected across all the Ni-NTA-containing microcolumns, as seen by the 
monotonically decreasing enrichments of BBS2 to the Ni-NTA-containing targets 
from left to right.  
Although negative selections are often used to separate sequences with specific 
affinities for sources of background binding, these are rarely completely effective at 
eliminating enrichment of non-specific RNAs. In contrast, we have found the repeated 
occurrence of BBSs in different SELEX experiments to be valuable indicators of the 
selection progress. Perhaps more interestingly, selections for and/or identification of 
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BBSs can be used to generate non-specific blocking reagents that are more effective 
than commonly used yeast tRNAs. 
 
CONCLUSIONS 
We believe that MEDUSA can be used to significantly increase the 
productivity of large-scale aptamer discovery efforts. By utilizing the versatility and 
programmability of MEDUSA, a larger configuration space of potential SELEX 
designs can be explored. Just as importantly, selections utilizing affinity 
chromatography can be thoroughly characterized. These kinds of data not only allow 
us to optimize future aptamer selections, but also clearly show that performances can 
be improved, while simultaneously consuming much less reagent, such as protein, 
making aptamer selections more accessible to targets that are difficult to purify or 
express in large quantities. Furthermore, such characterizations would not only 
improve future aptamer selections, but also aid in the development of more functional 
and applicable SELEX theories in solid-phase affinity selections.  
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
SUMMARY AND DISCUSSION OF RESULTS 
High-throughput SELEX technologies 
 Aptamers have become powerful affinity reagents, demonstrating uses and 
functionalities far beyond antibodies. However, generating these high affinity 
molecules still requires a tremendous amount of time and effort. In addition, classical 
selections such as filter binding or affinity chromatography may consume, and 
potentially waste, large quantities of reagents. Finally, the complex and sophisticated 
selection schemes necessary to achieve aptamer qualities beyond tight binding (such 
as specificity) can be difficult to incorporate, and require significantly more time and 
effort to achieve. These difficulties only intensify when considering aptamer selections 
to multiple targets. 
 To address a number of these issues, we developed an affinity microcolumn- 
chromatography technology [1]. These microcolumns are orders of magnitude smaller 
in volume than traditional columns, which results in (at minimum) a proportional 
decrease in the consumption of target molecules. Under properly controlled 
conditions, the tiny volume of immobilized target molecules is sufficient to bind the 
majority of high affinity aptamers. The small volume also results in increased 
enrichments of aptamers, since high affinity sequences are quickly retained in small 
columns, where larger columns would predominantly recover background binding 
sequences. Due to their small size, the microcolumns can also be easily connected to 
one another. For this reason, we designed our microcolumns to be modular in nature, 
utilizing NanoPorts to facilitate standardized connections between multiple 
microcolumns and/or to fluid handling systems and other instrumentation. This serial 
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configuration of microcolumns allows for simple and simultaneous in-line negative 
SELEX to be performed against affinity resins, affinity tags or other sources of off-
target binding. Similarly, this configuration allows for simultaneous counter SELEX 
to be performed isolating aptamers with high specificities between similar targets. 
Perhaps most importantly, these microcolumns help to achieve multiplexed 
parallelized selections.  
 With the catalogue of available aptamers growing, acceptance and use of 
aptamers has expanded dramatically. This has led to a demand for higher throughput 
selection technologies, which can accelerate and parallelize the selection processes. 
The microcolumns can easily accommodate multiple targets in parallelized selections, 
and by exploiting the non-equilibrium characteristics of our platform we can 
manipulate fluidic parameters, such as time and flow rates, to maximize the resulting 
aptamer enrichments. However, the microcolumns can also be used to parallelize the 
use of reagents, such as the random library. In most selections, the majority of the 
library is discarded with only a tiny fraction being bound and recovered. In general, it 
can be assumed that the subset of high affinity sequences are mutually exclusive 
among random targets. Therefore, in cases where dissimilar targets are being 
considered, this discarded library can be further partitioned. We demonstrated the 
ability to isolate aptamers to multiple targets through multiple partitions of the library, 
as well as through the continuous use of negative SELEX against the target’s affinity 
tag (as well as the microcolumn). Multiplex SELEX was also demonstrated among 
targets bound to different kinds of resins simultaneously due to the variety of available 
affinity tags used for protein or target purifications. 
 At an even higher level of parallelization, aptamers can be simultaneously 
isolated to distinct domains of a large target complex. This can be achieved by an end-
stage partitioning of an enriched aptamer pool [2]. This pool can be run across several 
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microcolumns, each containing a smaller subunit of the whole target, thus partitioning 
the mixed pool into subpools that each recognizes a specific region of the target. This 
is not only easier and less costly than performing individual selections to each domain 
separately, but also guarantees that the aptamers isolated to each subdomain properly 
recognize the whole complex, removing the possibility of isolating aptamers that bind 
to regions of the domains that are otherwise obscured in the complex. 
 To scale this microcolumn technology further, we designed a 96-well 
microplate formatted multiplex device called MEDUSA [3]. This format simplifies the 
handling of multiple targets by grouping them together into a single device. In 
addition, by constraining the layout of the device, MEDUSA couples directly to a 
microplate so the selection has the potential to be automated through liquid handling 
systems. Even more importantly, samples are eluted directly into a microplate and can 
be processed in a high-throughput and similarly automated manner through other 
microplate-based technologies. This device also retains the ability to perform 
selections in series and/or parallel, and the footprint of the device can be adjusted to 
accommodate smaller and less demanding numbers of selections. We demonstrated 
the use of MEDUSA utilizing all 96 available microcolumns to characterize the 
binding of various RNA aptamers in both serial and parallel formats. 
 Although the microcolumn platform is quite simple compared to other 
miniaturized SELEX technologies, our work shows that there is still a role for affinity 
chromatography in future high-throughput selections. In contrast to more complex and 
expensive technologies, the simplicity and ease of use of our microcolumns make 
them more accessible to researchers who want to perform aptamer selections, as the 
basic protocols, operating principles, and even fluidic equipment are already well 
understood and available in many labs. Not only are the microcolumns based on one 
of the most commonly used methods for aptamer selections, but the simple application 
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of controlled fluidics allows researchers to manipulate and tune a wider range of 
parameters. Ultimately, the multiplex nature of our technology can not only be used to 
highly parallelize the selection process, but to also exercise much more complex and 
sophisticated selection schemes. 
  
 
The SELEX method and binding characterization 
 Traditionally, the SELEX method is treated as an equilibrium solution-phase 
binding problem. The associated theories on optimal SELEX strategies are quite 
complex, and generally emphasize the importance of target and ligand concentrations 
assuming some specific and background binding characteristics of the library or the 
enriched pool [4]. Some simple “rules of thumb” have been deduced from these 
theories suggesting “competitive” regimes for selections. The concentration of target 
molecules is often set relative to the existence of an aptamer with an assumed 
dissociation constant (Kd), and the library is set to be in certain excess relative to the 
target concentration (i.e. 10:1 or 100:1) [5]. However, outside of solution-phase 
SELEX, target molecules are bound to a solid support, and accurately describing their 
concentration can become difficult as local (surface) concentrations can be much 
larger than the average solution (volume) concentration. Properly interpreting target 
and ligand concentrations is made even more difficult when the target is confined to a 
small volume as in our microcolumns, and a much larger volume of ligand solution is 
flowed across it. Most importantly, the finite size and orientation of surface bound 
target molecules cannot be ignored.  
 In solid-phase selections, high target concentrations can allow adjacent target 
molecules to interact with each other. In all of our specific protein-binding aptamer 
tests, increasing concentrations of target was shown to eventually result in a 
 159 
 
phenomenon consistent with steric hindrance, which lowered the accessibility and 
effective concentration of target proteins to the aptamers [1,3]. This resulted in an 
observed optimum target concentration that can be estimated easily through geometric 
arguments alone. In contrast, studies with background binding to peptide targets 
demonstrated significant cooperativities, where non-specific aptamers interacted 
strongly with multiple nearby target molecules, and significantly increased the amount 
of background binding (in some cases by over 2 orders of magnitude!) [6]. In general, 
there are additional sources of background binding other than the target molecules. 
This can include any surfaces and substrates that library molecules can come into 
contact with including tubes, filters, and in our case the affinity resins and the 
microcolumns themselves. Importantly, this form of background binding cannot be 
simply reduced by lowering the target concentration. In fact, lowering target 
concentrations too far ultimately increases the proportion of background binding over 
target binding aptamers. 
 Combining the effects of both steric hindrance and cooperativity at high 
concentrations of target molecules significantly complicates the aptamer enrichment 
process. Particularly, if either of these effects varies among high (or low) affinity 
binders, differential binding can make proper identification of the highest affinity 
aptamer difficult, as this determination may be dependent on the target concentration. 
Using common metrics such as the highest multiplicity sequence in a pool, or even the 
fastest enriching sequence between pools, may not successfully identify the aptamer 
with the highest 1:1 binding affinity as in solution-phase binding or surface-/solid-
phase environments where target molecules are not tightly packed (i.e. multiple target 
molecule interactions are negligible). In fact, there may not be any agreement between 
the ranks of aptamer candidates based on their actual 1:1 binding affinity and their 
effective binding affinity in high target concentration environments.  
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 Given the binding trends that have been observed from high to low target 
concentration regimes, the results support a local optimum target concentration that is 
determined primarily on the basis of background binding and the size of target (and 
aptamer) molecules, instead of on an assumed aptamer Kd or other idealized 
theoretical parameters. Using our microcolumns in conjunction with the observed 
optimum target concentration of ~ 0.6 µg/µL, we demonstrated improved aptamer 
enrichments and significantly reduced the time and cost to isolate aptamers. 
Furthermore, by miniaturizing the traditional column and using non-saturating 
optimum target concentrations, the reduction in the total consumed target molecules 
and other reagents have made aptamer selections accessible to a wider range of targets 
that are difficult to purify in large quantities. This is even more apparent as the number 
of selection cycles needed has been significantly reduced compared to classical 
methods. 
 Even when enrichments for specific aptamer binding have been maximized, it 
is important to note that background binding may not always be non-specific. To the 
contrary, concurrent selections for specific background binding aptamers and target 
binding aptamers are likely taking place [7]. In our own work, we have identified two 
noteworthy sequences that have appeared in at least 25 selections, which we believe 
were due to their preferential or specific background binding characteristics [3]. This 
was tested and verified in our MEDUSA experiments, which showed that these 
sequences enriched over the random sequence library on the affinity resins and the 
empty device. This highlights one unexpected advantage of multiplex SELEX, which 
has allowed us to perform many selections under identical or similar conditions and 
compare their sequence content to identify bias, processing artefacts, or reoccurring 
sequences indicating background binding to a common source.  
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 Ultimately, lists of background binding sequences can be used to diagnose 
background binding in future selections, and be accounted/corrected for to aid in 
target-binding aptamer identifications, since the presence of these kinds of sequences 
are likely inevitable and impractical to completely eliminate. However, these 
sequences could be used to generate specific and more effective blocking reagents to 
minimize background depending on the materials being used in the selection. 
Furthermore, these sequences are likely unique to each random library and selection 
technology, in which case their unique sequence signatures can be used to indicate the 
status of individual selections whose target-binding aptamers must compete with 
background sources for sequence sampling. Rare and/or weakly binding aptamers (or 
the absence of an effective aptamer) would be sampled less frequently than abundant 
and/or high affinity aptamers compared to background binding sequences. These 
qualitative trends could be used to indicate poor selection performances, possibly due 
to the ineffective parameters and/or selection design being utilized, or due to a non-
aptagenic selection target, which is often the case. 
 Throughout this work, we have encountered several factors that have 
significant implications not only on how to most effectively perform aptamer 
selections, but also how to adequately perform the subsequent sequence analysis in 
identifying true high affinity target-binding aptamers. It has become quite clear that 
despite improving the overall rate of aptamer selections and streamlining of the 
various processes, new (and even established) technologies pose a significantly more 
complex optimization problem for SELEX. As new technologies emerge and demands 
for faster and cheaper aptamer selections increase, a deeper understanding of how to 
adequately model and optimize their particular binding behavior will be necessary. 
These efforts have been and will continue to be greatly aided by new and more 
powerful sequencing and analysis techniques.  
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High-throughput sequencing and analysis 
 As more sophisticated SELEX technologies and methodologies emerge, more 
powerful analytical methods will become necessary. This is not only to facilitate more 
detailed sequence analysis, but also to identify aptamers with much greater sensitivity. 
This can be done by searching for and identifying consensus sequence motifs, or by 
identifying conserved secondary structures [8]. However, the simplest and arguably 
most important improvement to sensitivity can be achieved by identifying rare 
sequences via high-throughput sequencing.  
 With today’s sequencing technologies it is now possible to acquire 108 
sequencing reads from any given pool, which has allowed researchers to identify 
highly enriched sequences (high multiplicity) after many fewer selection cycles than 
would be necessary for the pool to fully converge to that sequence. This sensitivity has 
also opened up other modes of analysis, such as round-to-round enrichments and 
enrichment trajectories [9,10]. Enrichment analysis can overcome biases or 
contamination in selection pools by ranking sequences based on how rapidly they are 
converging rather than on their multiplicity. Some groups have monitored both 
enrichments and multiplicities of sequences over many rounds and revealed quite 
dynamic and unexpected phenomena [11]. With so many sequences available, the 
evolution of aptamers throughout various cycles and selection conditions can be used 
to model the binding behavior and help to generate better protocols and predictive 
methods for identifying the best binding aptamers through population-based metrics 
alone. 
 As selection schemes become more complex, high-throughput sequencing and 
comparative sequencing methods can be used to identify and/or correct for a number 
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of other sequencing phenomena. As mentioned previously, by comparing sequence 
content between targets, similarities can be identified, such as common background 
binding sequences. Sequences can also be divided into specific and non-specific 
binding candidates based on whether or not they are uniquely represented in any one 
pool. In fact, searching the sequence content among many targets, similarities may 
emerge revealing a deeper connection between aptamer sequence and structure to the 
characteristics of the selection target. Finally, the improved sequence sensitivity can 
be used to identify mutations of sequences, which, through appropriate analysis, may 
prove to be better binders than their parent sequence, or simply an inconsequential 
effect from PCR or sequencing errors. We have developed clustering algorithms to 
reduce pool complexities to more representative levels by grouping together nearly 
identical sequences which we believe are (more often than not) artefacts from 
imperfect processing of the pools [1].  
 By using new high-throughput sequencing and analysis tools with a 
standardized target and library, researchers can finally begin to objectively rank and 
characterize the effectiveness of the wide array of different SELEX technologies and 
methods, which are currently still evaluated primarily on the basis of success or failure 
to isolate aptamers. Many researchers cite their technology’s ability to isolate higher 
affinity aptamers than previous attempts; however, this can be due to slight changes in 
selection conditions rather than the technology itself.  Even more importantly, 
sequence and affinity differences may be the consequence of simple sampling 
variations due to differing source libraries.  
 The sampled sequence space of about 10
15
 different sequences for libraries 
larger than about 25 randomized bases can be safely assumed to be mutually exclusive 
for independent but identically synthesized libraries. This is especially true for larger 
libraries such as our N70 library which has more than 10
42
 possible sequences. 
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Different, but identically synthesized pools may contain superior sequence candidates 
for different targets, resulting in a randomly acquired advantage, that may be unfairly 
credited to the selection method or technology. In addition, sequence libraries can be 
synthesized from a variety of different natural and modified nucleic acids, as well as 
vary significantly in length from each other; and it’s currently unclear if/how 
technologies differing in these ways can be fairly compared. Even when all the 
selection parameters are identical, the “winningest” aptamer sequence can vary 
between selections simply because of the stochastics of binding and recovery of 
sequences in the first cycle or two when copy numbers are very low. In addition, 
losses and amplification errors can be incurred during post-selection processing of the 
enriched pools. These sampling problems make comparisons of selections unfair when 
based purely on success and the characteristics of a single aptamer. 
 With the resources available today, and given the wide array of different 
selection technologies, rigorous and unbiased methods of comparison and 
characterization are needed. A fair and quantitative comparison could be achieved by 
standardizing the target molecule and the library, and comparing thousands or millions 
of enriched sequences generated using different technologies, methods or selection 
parameters. By identifying identical sequences and characterizing their affinities, 
scoring metrics could be designed that do not rely solely on success as defined by a 
single sequence, but rather on the populations of unique and identical sequences 
compared to previous methods. We used this format as well as the above sequencing 
and analysis tools to test and validate our RAPID-SELEX method, which proved to be 
much more efficient compared to traditional SELEX [10]. 
 The use of high-throughput sequencing represents a tremendous advancement 
in aptamer selection technologies. Its ability to detect enriching sequences at such low 
levels has accelerated and even enabled otherwise impossible identification of high 
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affinity aptamers. Furthermore, the improved sophistication in sequence analysis has 
led to many new and powerful techniques for identifying and optimizing aptamer 
sequences and structures. However, these methods are still in their infancy, and have 
yet to be used in rigorous characterizations of SELEX technologies or methods.  
 
Time as an explicit variable of SELEX 
 Since its inception, many innovations around the SELEX method have focused 
on reducing the time needed to isolate high affinity aptamers. More accurately, new 
methods and technologies advertise their potential to reduce the number of SELEX 
cycles needed to converge an aptamer. This paradigm is consistent with the numerous 
equilibrium solution-phase SELEX theories, which aim to describe the most optimal 
library/pool and target concentrations that converge an aptamer in the least number of 
cycles. Not surprisingly though, time is not considered explicitly in these theories, and 
in laboratory selections the times used to complete various steps are often poorly, if 
ever, justified. Although citing the number of cycles does illustrate to some extent the 
amount of time as well as the amount of reagents consumed, the true length of a 
“cycle” can vary widely among different methods and technologies obscuring their 
actual advantages or even potential disadvantages. 
 There are three scales of time that are important in describing each 
technology’s potential to “save time”. These include the times allocated for each step 
in the selection cycle, the total cyle time (the sum of the individual step times), and the 
total selection time (the sum of all cycles). The individual selection step times are 
probably the most poorly characterized of all three time scales. In many cases, these 
times seem to be chosen arbitrarily, or based on unproven assumptions. Perhaps the 
most important time-dependent steps are the binding and washing steps. The time for 
these steps is especially important in non-equilibrium SELEX formats, such as our 
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microcolumns, and can be used to manipulate the binding kinetics within the device. 
Intuitively, one would expect that short binding times would discriminate sequences 
based on their on-rate (kon), which should (on average) preferentially bind higher 
affinity aptamers over lower affinity aptamers. Similarly, long wash times would be 
expected to discriminate sequences based on their off-rate (koff), which should (on 
average) preferentially eliminate low affinity aptamers over high affinity aptamers.  
 The example above illustrates the possibility to utilize a fluidic platform to 
manipulate kinetic parameters, and highlights the potential advantage of using 
technologies such as our microcolumns to improve aptamer enrichments. However, 
when these parameters were tested in model selections with fixed volumes (i.e. fixed 
concentrations), the results were surprising [1]. To control the binding time, we varied 
the flow rate of a 1 mL model library, which in turn adjusted the exposure time of 
individual sequences to target molecules in the microcolumns. Although the aptamer 
behaved as expected in the microcolumns by binding less with shorter binding times, 
we found that the random library bound more non-specifically with short binding 
times. This is in complete disagreement with simple kinetic binding theory, and the 
result was an enrichment trend that varied inversely with time compared to 
predictions. Similarly, the washing time was controlled by varying the flow rate of a 3 
mL washing buffer. As before, the aptamer behaved as expected in the microcolumns 
binding less with longer washing times, but we found that the random library bound 
more non-specifically with longer washing times. This too is in complete 
disagreement with kinetic theory and resulted in a similarly inverse enrichment trend 
compared to predictions. Surprisingly, the observed trends are ideal for selections as 
they suggest that the conditions that most efficiently bind and retain high affinity 
aptamers are also the same conditions that minimize background binding. This means 
that the most conservative conditions for aptamer binding result in the highest 
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enrichments, eliminating design considerations that would require deliberately losing 
potential aptamers for the sake of improved enrichments. 
 These results not only demonstrate the potential to utilize fluidic parameters to 
optimize aptamer selections, but also reveal the importance of characterizing selection 
performances for the relevant and tunable parameters. As our results show, high 
affinity aptamers are well modeled by kinetic theory; however, background and non-
specific binding (as discussed in the previous sections) is much more complex and 
seems to be much more sensitive to the flow rate than to the step time. This is likely 
due to flow characteristics near surfaces such as shear, high pressures, and other more 
complex phenomena (such as the compressibility of the affinity resin) that may 
preferentially affect low affinity binders. These complex phenomena are beyond the 
capacity of basic kinetics, and its failure to qualitatively predict the observed 
enrichment trends points to the dangers in using simple arguments and assumptions, 
like the ones illustrated above, to choose the temporal conditions for aptamer 
selections. In our case, the assumed “optimal” conditions within the tested range 
would have resulted in little to no aptamer enrichments. These kinds of operational 
and design mistakes likely occur unnoticed in many selections, requiring significantly 
more selection cycles or resulting in failures that are incorrectly attributed to the 
difficulties of the particular selection target. 
 The selection time is the most commonly reported metric and, as mentioned, is 
usually given in number of cycles. This number can be easily reduced depending on 
the methods used for sequencing aptamer candidates. If high-throughput sequencing is 
used, aptamers can theoretically be identified with sensitivities down to 1 in 10
8
; and 
with pools that start with unique sequences at about 1 in 10
15
, high-throughput 
sequencing can effectively cut the number of rounds needed in half. Although the 
information content from high-throughput sequencing is immense and can often make 
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a critical difference in identifying aptamers, it also is quite costly and can require 
significant time to complete and fully analyze. This time is rarely if ever considered 
when reporting a successful aptamer candidate relative to less powerful but simpler 
methods, and it is conceivable that in some cases, the application of high-throughput 
sequencing saves neither time nor costs in identifying candidates despite eliminating 
many SELEX cycles. In fact, with today’s current methods, SELEX technologies that 
accelerate aptamer selections and high-throughput sequencing analysis are at odds 
with each other. On one hand, SELEX technologies aim to converge to the highest 
affinity aptamer as efficiently as possible, which presumably has the absolute 
performance limit of binding and recovering only a single sequence of the highest 
affinity in a single cycle. However, from a sequencing standpoint a single recovered 
sequence makes it impossible to distinguish between a successful and an unsuccessful 
selection, and all population-based metrics become meaningless for discriminating 
aptamers from non-aptamers. In contrast, high-throughput sequencing methods require 
a rich diversity of sequences that can be used to determine one or more sequence 
motifs or secondary structural elements that are critical to an aptamer. This 
information can even be used to generate a higher performing consensus-based 
aptamer that may not be fully represented in any one sequence. However, the ideal 
diversity and analytical power of these tools scales proportionally with the capacity of 
the sequencing method used, which limits the desired efficiency of the SELEX 
technology being utilized. As more efficient methods for converging aptamers are 
developed, the potential richness and value from high-throughput sequencing and 
analysis may be diminished, requiring new approaches that maximize the utility of 
both. 
 The potential for methods, such as high-throughput sequencing, to simply 
reduce time and costs in selections is largely dependent on the number of selection 
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cycles that are avoided and the time required to complete each cycle. In some cases, 
selection cycles can be done daily or even more frequently [12]. This diminishes the 
value of such costly analysis for simple selections, especially those that are well 
executed and free from bias and other potentially constraining phenomena. In contrast, 
in one of our multiplex SELEX experiments using our microcolumns under optimal 
temporal (and target concentration) conditions, we required an average of 42.5 hours 
of work for each round, which was typically achieved over the course of one week [1]. 
After 5 rounds, we performed high-throughput sequencing, that revealed that not only 
had we almost completely converged our pools onto the candidate aptamers, but also 
that we were able to confidently identify these sequences as candidate aptamers after 
only 3 rounds. This suggests that we could have saved 1 or 2 weeks’ worth of time and 
reagents, cutting our SELEX efforts nearly in half. In other selections, sequences were 
far from converged even after 6 rounds of SELEX, and aptamers candidates were only 
identified because of the sensitivity of high-throughput sequencing [10]. 
 Although technologies like our microcolumns and high-throughput sequencing 
have been shown to drastically decrease the number of cycles of SELEX needed to 
confidently identify aptamer candidates, little work has been done to address the 
efficiency of SELEX as a whole. Despite more than two decades of progress, only a 
few studies have been done to globally optimize SELEX. We first introduced our 
microcolumns by utilizing parameters that maximize enrichments at each selection 
step. However, no discussion was made about the potential net gain or loss in 
efficiency that could have resulted from the optimal selection steps, such as the 1 
µL/min binding flow rate that required almost 17 hours to complete [1]. In general, the 
appropriateness of these conditions depends also on the total time to complete the 
selection cycle (and potentially on reagent consumption), since the total enrichment of 
aptamers can accumulate faster despite using less efficient parameters, provided that 
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they allow for much more rapid completion of each cycle of SELEX. In addition, only 
one previous study had diverged from the traditional SELEX method of iterative 
binding, partitioning, and amplifying enriched pools. This Non-SELEX method was 
shown to effectively isolate aptamers to targets despite several cycles of binding and 
partitioning without any amplification [12]. This resulted in tremendous savings in 
time and reagents, since amplifications are often the rate-limiting steps, and also 
brought into question the effectiveness of the traditional SELEX method, especially in 
later selection cycles. 
 In search of the global SELEX optimum, as well as a more efficient SELEX 
method, we developed a new selection method called RAPID-SELEX, and compared 
its performance to traditional SELEX [10]. For traditional SELEX, six cycles of 
selections were performed under optimal conditions for each parameter (~17 hour 
binding step, and a “tuned” wash), with amplifications performed after every cycle. 
However, for RAPID, only every other selection had its pool amplified allowing two 
selection cycles to be performed quickly back-to-back in each full RAPID-SELEX 
“round” (here, a round is defined to include amplifications). In addition, the binding 
steps were shortened to less than 2 hours to speed up the selection process, and the 
wash steps were set to 30 minutes and performed at two different flow rates to 
mitigate binding in the high and low affinity regimes. Together, these changes 
significantly simplified and accelerated the selection steps (especially for RNA pools), 
such that RAPID was completed in one third the time as SELEX. However, despite 
using less optimal selection parameters, high-throughput sequencing revealed that the 
RAPID selections had enriched thousands of aptamers identical to those from 
conventional SELEX. In fact, these sequences were enriched approximately 3-fold 
more in RAPID, and detailed analysis of the various pools clearly showed that RAPID 
had consistently outperformed SELEX. This not only revealed the feasibility of 
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eliminating amplification steps to save time and reagents, but also brought into 
question the necessity for amplifying pools to maintain “competitiveness” at every 
cycle. These results suggest that the pool concentration may be another poorly 
understood quantity in solid-phase affinity selections. Ultimately, a more general 
method like RAPID-SELEX can allow for more efficient selections than traditional 
SELEX by eliminating amplifications, unless sequence copy numbers are too low or 
higher pool concentrations are needed to increase enrichments.  
 Although the primary goal of most new SELEX techniques is to reduce the 
time to generate aptamers, time often is not considered directly. The majority of 
SELEX technologies aim to simply reduce the number of selection cycles, with a 
reduction in time being an assumed and natural consequence. However, this can be a 
misguided approach to optimizing the SELEX process. In every experiment we have 
performed to date, time has played an unexpectedly important role in selection 
efficiency as oftentimes our intuition about how to manipulate time for the most 
efficient processing proves to be incorrect. Most importantly, with new technologies 
and a more explicit treatment of time, the SELEX optimization problem has become 
much more complex. Unfortunately, little development of new theoretical methods, 
empirical characterization, or modeling has been done to explain and accommodate 
the increasing complexity of the aptamer enrichment process within ever more 
sophisticated technologies. Our work represents only a small step in what we hope 
will be a new and continued effort to characterize selection technologies, and to use 
this in conjunction with methods, such as RAPID and high-throughput sequencing, to 
develop a more global approach to optimization. 
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FUTURE DIRECTIONS 
Demonstrating our full capabilities 
 Although our microcolumns are ideal for multiplexing due to their small and 
modular nature, we have yet to demonstrate many of the advantages of using the 
microcolumns. Multiplex selections have been used to generate aptamers to multiple 
targets, but the use of negative and counter selections to yield a highly specific 
aptamer between similar targets has not yet been demonstrated. This would involve a 
careful selection scheme between targets, which requires these multi-microcolumn 
methods for success. Similarly, our columns could be used to isolate unique aptamers 
to multiple domains of a large target complex, that would involve initial selections to 
the complex, and end with multiplex selections with its individual domains. 
Experiments utilizing this configuration have yet to be demonstrated, but methods 
such as this could become standard for generating multiple non-interfering aptamers to 
a single target. Finally, using the microcolumns, selections have been performed using 
RAPID, which significantly reduced the time and effort needed to enrich aptamers. 
However, we have yet to utilize the quantitative selection scheme that would 
maximize the use of RAPID. This would not only reveal the full capacity for RAPID 
to reduce selection cost and time, but could also be used to further optimize selection 
protocols. 
 
Possible modifications to our microcolumn processes 
 To date, our microcolumns and their associated processes have been used 
successfully to select for novel aptamers, and MEDUSA has demonstrated tremendous 
promise for increased throughput and potential automation for large scale selections. 
However, currently no novel large-scale multiplex or parallel selections have been 
demonstrated using MEDUSA, as selections of this magnitude are generally 
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unprecedented in most laboratory settings where the diversity of potential targets 
needed to fully utilize its capabilities are not available. Specific applications for using 
this device will need to be considered given the current environment of simple small-
scale or single target selections. In addition, the full compatibility of MEDUSA’s 
microplate layout has not been fully exploited or demonstrated. Although all test 
selections were performed and quantified using plate-based processes, these were still 
executed manually. Eventually, selections with MEDUSA should be automated to 
make use of the standardized fluidic manipulation and plate-based handling available 
with robotic workstations. This would make large-scale selections easier and more 
efficient for researchers to perform. 
 One of the advantages of the microcolumns is their capacity to be multiplexed 
through reconfigurable connections that facilitate serial/parallel fluid networks. 
However, this has always been performed manually and is likely an undesirable 
intervention for future and more automated versions of the microcolumns, especially 
MEDUSA. Although simple to execute, the multiple programed layers within the 
device that allow for the microcolumns’ connectivity rely on an array of screws to 
form tight liquid seals, which must be removed when changing configurations. This 
process can be a nuisance if not tedious as fluidic connections need to be disconnected 
and reconnected as well. More elegant solutions for alternating between modes may 
need to be explored. Using similar programming strategies, simple valving layers 
could be introduced into the device which would act as basic switches between serial 
and parallel modes [13]. However, generalizing this onto a device would be difficult 
and may require customized devices, limiting its practicality. 
 Aside from improving the operation of the microcolumns, there are a number 
of additional features that have not yet been explored for the microcolumns. For 
example, Cell-SELEX is often considered a separate entity in aptamer selections, as 
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most selection methods for aptamers cannot be simply extended to cells. Instead, 
specific protocols have been designed to accommodate the complications of handling 
living cells. Initial attempts to form packed columns of cells within the microcolumns 
were unsuccessful as cells would either flow through the frits or form a dense plug that 
solutions could not flow through. Some work was done to immobilize cells onto 
affinity resins in order to improve flow through the column, but the immobilization 
proved highly inefficient and required chemical modifications to the cells surface. 
Future work could look into culturing cells onto microbeads as a means of 
immobilizing a high density of cells onto a solid column matrix. This would provide a 
more general mechanism of immobilization than chemical modifications, and would 
open up a potentially new avenue for cell selections in microcolumns that has not 
currently been explored. 
 Finally, only flow and time have been used as a means to manipulate the 
binding characteristics within the microcolumns. However, there exist a number of 
ways by which additional thermodynamic thresholds can be applied to selections. For 
example, sequence binding can be purposely biased through competition by forcing 
candidate aptamers to dissociate from other complexes [14,15]. This would only allow 
aptamers to be recovered that have affinities high enough to overcome the barrier of 
association with anchoring molecules, such as biotin-streptavidin or dsDNA to 
ssDNA. Sequence dissociation from targets can be purposefully biased through long 
washes or in the presence of competitor molecules [16]. This can also be achieved by 
manipulating the effective binding affinity of aptamers, which can be done by eluting 
bound sequences in gradients of increasing temperature or salts [17,18]. This has the 
effect of reducing the binding affinity causing more weakly bound sequences to 
dissociate earlier in the gradient. The highest affinity sequences could be recovered at 
the end of the gradient, either through sufficient reduction in its binding affinity, or 
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through an unbiased chemical elution, which allows recovery of the target along with 
bound sequences. 
 
Further elucidating the SELEX process 
 Throughout this work, much effort has been dedicated toward optimizing and 
characterizing as many of the selection parameters as possible. In particular, we have 
found a crucial dependence of target concentration with target (or aptamer) size. 
However, currently, only similarly sized molecules have been tested, and a stronger 
case could be made by revealing similar behavior with differently sized targets and/or 
aptamers. Also, although it was briefly investigated in developing RAPID-SELEX, the 
effect of library concentration in aptamer enrichments has not been rigorously 
explored in experiments. Theory suggests that optimal target concentrations should 
vary with the library concentration and with the evolving bulk binding affinity of the 
pool; however (as mentioned above), our results suggest that the optimum target 
concentration is geometrically constrained and dominated by molecule size rather than 
affinity. It is currently unclear how these new factors will ultimately affect the binding 
dependence on the library concentration, but current results using RAPID have been 
surprising given the less “competitive” nature of their selections compared to 
traditionally executed SELEX.  
 In addition to concentration, the effect of library length on aptamer frequency 
or binding affinity to targets of various sizes has not been investigated experimentally 
[19]. It is conceivable that in general, small targets are more likely to have short, high 
affinity aptamers compared to larger targets. This, of course, is dependent on the type 
of target being selected against, such as DNA or RNA binding proteins that may 
associate strongly with a specific short sequence. However, aside from the added 
potential complexity gained by using large libraries, ultimately the number of 
 176 
 
sequences, and thus aptamer structures, that can be probed is limited to the same 
number for all libraries larger than ~25 nt. Assuming there exists a highest affinity 
aptamer configuration of some unique sequence and length, it is an obvious statement 
to say that longer or shorter libraries will generate poorer affinity aptamers due to 
insufficient nucleotides for base pairing and other interactions, or from excess 
nucleotides forming structures that interfere with or abolish the ideal aptamer 
configuration. For example, many researchers find the need to minimize aptamers by 
removing excess and unneeded nucleotides through trial and error. A systematic study 
has yet to be done to help generate rules in choosing the ideal library length given a 
target’s general characteristics, such as its size. This would not only help researchers 
to choose library lengths that might maximize the likelihood of isolating an aptamer, 
but also may reduce the work needed to optimize or minimize the resultant aptamer 
sequence. 
 Finally, much of the available theory on optimal SELEX overly simplifies the 
selection process given the array of complex and sophisticated technologies available. 
However, perhaps their greatest weakness lies in the number of assumptions that are 
necessary in order to rigorously apply the theories, as well as to evaluate their 
accuracy. With the invention of techniques such as HiTS-FLIP and HiTS-RAP, which 
couple high-throughput sequencing of pools to high-throughput affinity 
measurements, not only can the guess work in identifying an aptamer be completely 
eliminated, but detailed snapshots of the affinity profile for various enriched pools and 
the random library can be obtained [20,21]. This would eliminate assumptions that are 
made about the affinity distribution of the starting pools, and allow detailed modeling 
of sequence evolutions between cycles. Applying these techniques could also help 
address existing analytical questions about the effectiveness of the more conventional 
methods that we have used for identifying aptamers, such as clustering, multiplicity or 
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enrichments. Furthermore, coupling this with analysis of predicted secondary 
structures may prove quite powerful compared to sequence (or consensus sequence) 
populations alone. 
 
OUTLOOK 
 Selection technologies have come a long way in the last two decades. 
However, the complex processes and lack of detailed understanding of new methods 
has hindered progress in the field toward the development of more robust and 
accessible technologies. Although new methods are constantly emerging, the field has 
still not matured into a carefully controlled and detailed science. Despite such little 
work that has been done to address these gaps, this presents a tremendous opportunity 
for engineers and physicist to apply their rigorous and systematic methods in order to 
decipher the inner workings of the selection process within ever more complex 
technologies. We have only begun to scratch the surface in applying these methods to 
a simple affinity chromatography-base technology. Similar studies could not only 
improve the performance of other technologies, but also help develop more integrated 
and automated technologies. These would be more complex and more difficult to 
control than other technologies, but would make selections easier and less costly to 
perform, assuming our understanding of the processes and performance characteristics 
was sufficiently detailed.  Ultimately, characterization of aptamer selections is only 
just beginning, and will enable a revolution in future aptamer selections.  
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